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Abstract
Many bio-pharmaceutical production processes are based upon the use of mammalian cell lines, 
such as Chinese hamster ovary (CHO) cells, capable of proliferation as single cells in suspension in 
a  synthetic  environment.  Routine  use  of  CHO  cells  as  production  vehicles  requires  a  lengthy 
“adaptation” process from the wild-type adherent clone to clones capable of proliferation in  a 
suspension environment depleted of exogenous growth factors and cell-matrix contacts. Different 
approaches have been applied in this study to gain a better understanding of the changes on the cell  
surface occurring as a response to changes in their environment, comparing four cell lines (CCL61, 
AML, S cells and CHO-S) adapted to suspension or adherence growth condition. 
Biochemistry and mass spectrometry methods showed differences in surface protein composition 
for the cell lines. The comparison of the expression of cell-to-cell adhesion molecules revealed a 
highly variable bimodal distribution on S cells  which was not seen on CCL61. Analysis of the 
expression  level  of  integrins,  the  main  interaction  partner  of  serum components,  indicated  that 
integrin expression is not generally down-regulated on suspension-adapted CHO cells. The integrin 
conformation  on  the  cell  surface,  analysed  by  confocal  microscopy,  revealed  a  specific 
conformation,  especially  with  regard  to  integrin  beta  1,  characterised  by  an  even,  net-like 
distribution of integrin clusters over the surface of the cells. This specific integrin conformation, 
which has only been found on suspension-adapted cells, was underlined by a sub-cortical sheet of 
actin,  forming  a  ball-like  structure  directly  under  the  cell  membrane;  this  actin  conformation 
required re-organisation of the actin cytoskeleton from a typical fibrillar morphology in adherent 
cells. The actin content was higher in suspension cell lines compared to adherent cells, but actin up-
regulation  was also  found in non-suspension adapted  cells  after  they had been transferred into 
suspension.. Sphere-like integrin beta 1 clustering on CCL61 grown in suspension could be induced 
by treatment  with  cytochalasin  D,  followed  by suspension  culture  without  the  drug,  however, 
despite the change in integrin beta 1 conformation these cells could not grow in suspension. 
The  data  suggests  that  adaptation  to  suspension  growth  requires  conservation  of  integrins, 
presumably with respect to their role as structural elements anchoring the plasma membrane to the 
sub-cortical actin sheath, but it also requires  additional changes in the interplay between integrin 
beta 1 and actin, for example, changes in the regulation of the associated proteins for successful  
suspension adaptation of CHO cells. 
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1.   Chapter 
Introduction
In this chapter the basic background of the research undertaken is explained and the objectives of 
the research project and different approaches used are described.  
1.1 Basic background
The biopharmaceutical industry, which has grown continuously since the first human 
recombinant protein, human insulin, has been put onto the market in 1982 (Pavlou and Reichert, 
2004) is assumed to grow further in particular due to the increase in use of human antibodies as 
therapeutics (van Dijk and van de Winkler, 2001; Trikha et al., 2002) but also due to the possibility 
of high sales such as seen for Erythopeitin which has reached over 1 billion US dollar sales (Wurm, 
2004). Mammalian cell lines are used widely in the biopharmaceutical industry (Godia and Cairó, 
2001) for the production of recombinant products, such as antibodies (Dinnis and James, 2005) and 
other recombinant proteins, such as cytokines (Browne and Al-Rubeai, 2007). Mammalian cells 
enable post-translational modifications such as glycosylation, which are necessary to be able to use 
recombinant proteins widely as drugs in humans and are not possible to achieve in bacterial 
production processes to the same extent (Birch and Racher, 2006). The successful establishment of 
a mammalian production cell line, however, is far more expensive than establishing a bacterial 
production culture (Kuystermans et al., 2007). The growing demand for therapeutic products can 
only be met by optimisation of specific productivity and increased viable cell density of the cell 
lines used (Browne and Al-Rubeai, 2007). Modern mammalian cell culture processes can now 
achieve product concentrations above 5g/ L (Birch and Racher, 2006) but the aim is to achieve even 
higher production efficiencies by not only increasing production rates (Qp) but achievable cell 
densities. To reach this aim choosing cell lines showing good stability and growth in suspension 
conditions based on a chemically defined and animal component free medium (Birch and Racher, 
2006) is required. Together with optimal cell culture condition the mammalian expression vector 
used for expression of  the recombinant gene needs to allow efficient transcription of the gene 
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product and in addition needs to allow for selection of stable transfectants. Selection often occurs 
based on the absence of an essential metabolite in the non-transfected cells (Wurm, 2004). For 
stable transfectants the vector needs to be integrated into the genome to allow replication and 
inheritance of the vector during cell division (Ludwig, 2006). Numerous selection methods have 
been developed to allow reliable selection of high producing cell lines, with limited dilution cloning 
still being the most commonly used traditional method (Browne and Al-Rubeai, 2007) but the trend 
clearly goes to automated systems, such as the Clonepix from Genetix, which allow high throughput 
approaches to clone selection (Browne and Al-Rubeai, 2007). Optimisation of the specific 
productivity of the cell line in question is another key factor in the development of a stable 
production process that is to deliver appropriate amounts of product at an acceptable price (Birch 
and Racher, 2006). In general, for large scale production processes the preferred culture format is a 
single cell suspension reactor, in recent years together with chemically defined, animal component 
free media (Butler, 2005). As wild type mammalian cell strains usually grow adherently and require 
serum supplementation, establishing a cell line that is capable of growing in a serum free 
suspension culture is a major step in process development. It can either be applied to a non-
transfected cell line, to be used for creation of a production cell line later, or to a transfected cell 
line that has already undergone selection with regards to transcription and translation of product and 
usually requires a transfer of the cell line in question into suspension conditions followed by a  
stepwise reduction of the serum concentration (Sinacore et al., 2000). The strategy of adaptation to 
suspension growth is necessary as the required product concentrations with yields in the g/ L range 
cannot be achieved by the classical culturing approaches using adherent cell cultures in, for 
example, roller bottles (Wurm, 2004). Furthermore, using serum free media reduces the risk of 
introducing viruses or other transmissible agents; in addition, upstream processing of secreted 
product becomes much more feasible when no serum is supplemented. Serum is also a major cost 
factor in large scale production and in addition can introduce variations in production yields due to 
batch to batch variation (Rodrigues et al., 2012). The original cell lines of Chinese hamster ovary 
cells (epithelial-like (ATCC)/ fibroblast-like (Puck, 1958)), NS0 cells (myeloma cells (ATCC) ) and 
baby hamster kidney cells (fibroblasts, ECACC), which are all used frequently in the 
biopharmaceutical industry (Kuystermans et al., 2007; Hossler et al., 2009), are anchorage and 
serum dependent and hence their growth depends on signalling interactions with serum components 
and inter-cellular signalling. Usually, the transformation to serum free suspension growth goes hand 
in hand with an increase in productivity due to the possibility of reaching high final cell densities 
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during the adaptation process. As noted earlier, the adaptation process is a long multi-step process; 
the design of serum free media is an important part of this process and no single solution even for 
clones from the same parental cell line has been found (Butler, 2005). Consistent control of the 
growth and production capability of the cell lines during adaptation is necessary  and the final 
adaptation to serum free conditions might only be possible by supplementation of the media with 
defined proteins or small molecules (Rodrigues et al., 2012). In general, this process is still not 
100% successful which is also due to the fact that little is known about the changes in the cell itself 
that allow successful adaptation to a new synthetic environment. For instance, interruption of 
integrin cell signalling due to disruption of extracellular matrix-cell contact, due to, for example 
serum withdrawal, has been shown to lead to apoptosis (Streuli, 2009). The loss of cell surface 
contact in suspension growth will hence induce changes in the cell membrane itself. Also, changes 
in protein expression and cell metabolism have to occur during the adaptation process to allow for 
successful proliferation in the new environment. These changes might be due to changes in protein 
expression on the cell membrane and/or switching on/off different pathways involved in cell 
proliferation (Pontier and Muller, 2009). 
1.2 Objectives and Approaches used
In this thesis different approaches to gain a more detailed understanding of the changes in the 
cell surface as a response to a change in environment have been applied. The cell surface of 
different cell lines growing in different environments was analysed for different parameters, 
comparing Chinese Hamster ovary cell lines adapted to suspension and/or adherence growth 
conditions. Those cell lines had not been further modified for production of biopharmaceuticals, e.g 
not transfected, to ensure the main selection pressure the analysed suspension cell lines have 
undergone was aimed at suspension adaptation only. The aim is to gain a detailed understanding of 
the changes that occur on and close to the cell surface due to the adaptation to the required synthetic 
cell culture environment and how the surface phenotype of the suspension cell line differs from the 
original adherent cell line as a result of the variation in culture conditions. 
First, the hypothesis that changes in the surface protein composition may occur was tested. 
Biochemistry in combination with mass spectrometry was used to gain an overview on surface 
proteins expressed on the suspension cells. 
Using flow cytometric analysis based on antibody staining the next step was to analyse up- and 
down-regulation of the expression of a chosen subset of surface proteins in the different cell lines. 
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One focus was on integrins, as integrins are the main molecules interacting with the serum in 
adherent growth conditions, using antibodies against  integrin beta 1, integrin alpha 4 and integrin 
alpha 1; as no serum has been added in suspension conditions it was hypothesized that integrins 
may become down-regulated in suspension (Ruoslathi and Reed, 1994). In addition, a subset of 
proteins involved in cell-to-cell signalling was analysed as a second group of surface proteins 
involved in interaction with the environment, as several proteins of this type had been identified in 
the mass spectrometry analysis of the suspension cells in previous (Ahram, 2005) and in this study. 
This was followed by a confocal microscopy analysis of those proteins identified as being stable 
expressed on the suspension cell lines, which allowed information to be gathered on structural 
conformation of those markers. Confocal microscopy and flow cytometry of the cytoskeleton of the 
cell lines was included as the cytoskeleton is known to be an important  interaction partner of 
integrins on the intracellular side of cells (DeMali et al., 2003). The information gathered was 
questioned by treating cells with cytochalasin D, a reagent influencing adherence and actin 
conformation (Lub et al., 1997), to determine  whether the identified phenotype characterised by a 
conformational change in integrin and actin expression could be induced for the adherent cell line 
and by this, allow successful suspension growth.
1.3 Summary of the main results
Using  flow cytometric analysis as an ideal method to determine expression levels of proteins on 
the cell surface, it was demonstrated that integrins are not generally down-regulated in suspension 
adapted CHO cells, with different integrins either being up- or downregulated on the analysed 
suspension cell lines. This led to the conclusion that decrease in integrin expression level is not a 
common phenotypic feature of suspension CHO cells despite previous studies showing a loss of 
adhesion for cell lines down-regulating integrin expression (Giancotti and Rouslathi, 1990). 
The actin content of the different cell lines was shown to depend mainly upon the cell environ- 
ment by flow cytometric analysis, as actin content was shown to be up-regulated in non-suspension 
adapted CHO cells after being transferred into suspension conditions.. 
Analysing the conformation of the three integrins on the cell surface by confocal microscopy 
revealed a specific conformation especially with regard to integrin beta 1 for suspension adapted 
cells. This was characterised by an even distribution of the integrin sub-chain over the entire surface 
of the cells. Studying the three-dimensional geometry, this distribution formed a regular net of 
integrin beta 1 on the surface covering the entire cell. This net of integrin sub-chains on the cell 
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surface was lined by a thick sub-cortical sheet of actin forming a strong ball-like structure directly 
under the cell membrane, usually seen for suspension cells such as lymphocytes (Lub et al., 1997).
Further analysis aiming at the interaction between integrins and actin structure  revealed that the 
specific integrin beta 1 conformation seen for suspension adapted CHO cells can be induced even in 
non-suspension adapted CHO cells by using Cytochalasin D as an actin structure influencing drug. 
Nevertheless, this treatment did not allow the cells to grow in suspension, indicating that further 
changes, for example in the intracellular signalling, are needed for successful growth in serum free 
suspension culture. The intracellular signalling changes of the cell lines in question have been 
analysed in a parallel PhD study using western blotting and flow cytometric analysis. 
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2.   Chapter 
Chinese hamster ovary cells as a production 
vehicle that requires suspension adaptation
In this chapter CHO cells are introduced as a production vehicle and the importance of a better 
understanding of the molecular level of suspension adaptation is explained.  An overview of 
research on cell surface protein expression in different areas will be given to illustrate the large 
variety of cell surface changes occurring in adaptation (forced or by chance) to a new environment. 
In this context, integrins as the main surface receptor proteins which interact with extracellular 
matrix proteins will be introduced together with some of their interaction partners. More details 
about cell to cell adhesion molecules, the role, structure and characteristics of integrins and how 
integrins interact with the actin cytoskeleton can be found in chapters 6, 7 and 8, respectively. 
Furthermore, using a proteomics approach to cell surface analysis as a starting point of this project 
is justified.
2.1 Chinese hamster ovary cells for biopharmaceutical production
Biopharmaceuticals, meaning therapeutic proteins such as monoclonal antibodies and anti-
inflammatory cytokines produced through engineering processes, will be increasingly important for 
future drug development  and account for around a quarter of all newly developed drugs in the US 
market (Browne and Al-Rubeai, 2007).  Mammalian cell lines are the vehicles of choice, due to 
their capability to produce proteins with post-translational modifications and glycosylation patterns 
similar to human proteins (Hossler et al., 2009). The Chinese hamster ovary (CHO) cell line, 
established by Puck et al. in 1958, is one of the earliest established mammalian cell lines. It is an 
adherent epithelial cell line that in standard growth conditions, which include fetal calf serum, 
shows fibroblast-like growth patterns (Auersperg et al., 2001). CHO cells have been used since 
1986  as a production vehicle (Wurm, 2004; Dinnis and James, 2005) in large scale bio-
pharmaceutical production due their capability to produce high protein concentrations and the 
consistency in product characteristics (Birch and Racher, 2006; Wurm, 2004) in combination with 
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their ability to produce therapeutics with highly N-linked glycosylation (Hossler et al., 2009; Farges 
et al., 2008). Hossler et al. (2009) clearly show the predominance of CHO as production vehicle for 
FDA approved glycosylated therapeutics. The original Chinese hamster ovary cell line from Puck 
requires serum to grow successfully (Ham, 1964) whereas today in biopharmaceutical large scale 
production only suspension cells in serum-free chemically defined medium are used. CHO cells 
have also been used for production of recombinant proteins in micro-carrier based cultures. These 
allow to achieve high cell densities in cultures where cells can still grow attached to a surface. 
Those culture conditions enable a protection of the cells from the shear forces but growth can be 
reduced compared to suspension culture (Spearman et al., 2005). Micro-carrier culture results can 
be greatly influenced by the culture vessel, not only with respect to growth behaviour but also 
heterogeneity of product with respect to glycosylation profile (Costa et al., 2013).  The adaptation 
to serum free chemically defined media has been driven by factors such as high cost of serum, risk 
of product contamination and batch to batch variation. Nevertheless, serum is known to contain 
numerous factors relevant for cellular functions enabling,or example, proliferation. Hence, serum 
free adaptation needs to be carefully monitored to ensure stability of the cell lines in question in 
terms of growth, viable cell densities reached and protein production (LeFloch et al., 2006). 
Successfully suspension adapted cells are able to grow to a high density of around  1 x 107 cells/ml 
(Wurm, 2004) and therefore enable a reliable, economically viable production process with product 
titers in the gram per liter culture volume range (Wurm, 2004). Adaptation to suspension growth in 
combination with serum-free culture conditions is a time consuming process (Sinacore et al., 2000) 
that fails in some cases (Rodrigues et al., 2012). A number of serum replacement components 
(Farges at al., 2008) have been tested to enhance the success of suspension adaptation. This 
includes insulin and zinc (Wong et al., 2004) and transferin (Glassy et al. 1988; Schröder et al., 
2004). A deeper understanding of the changes that cells undergo during suspension adaptation 
would enhance cell engineering possibilities (Kuystermans et al., 2007) or allow faster selection 
methods for the best suspension adapted cell lines and hence allow speeding up the complex 
procedure of cell line development. Understanding the basic mechanism involved in suspension cell 
adaptation with respect to the cell surface might also help avoid negative effects of optimization 
processes later in the process development besides enabling faster establishment of stable 
production cell lines.
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2.2 Cell surface changes as a reaction to a new environment
It is proposed that the adaptation to suspension growth will include changes on the cell surface, 
such as changes in protein expression levels. This study concentrates on cell surface proteins found 
in the lipid bilayer forming the plasma membrane as those are known to be the main structure of the 
cell surface which enable interaction of the cell with the environment. Without any cell surface 
protein changes as reaction to the new environment the cell will die due to the loss of cell to matrix 
adhesion. Cell death due to loss of cell to matrix adhesion is called anoikis (Frisch and Francis, 
1994) and describes the apoptotic reaction of cells to the absence of cell matrix interactions, 
stressing the importance of this interaction for cell proliferation. Anoikis has also been described as 
apoptosis induced by loss of cell adhesion (Ruoslathi and Vaheri, 1997). Induction of anoikis, which 
can be seen as an apoptotic signalling process, is mediated by different pathways. The main signal 
is thought to come via integrin signalling from the cell surface (Gilmor, 2005) but the specific 
pathways signalling anoikis depend on the cell type and the integrins involved (Chiarugi and 
Giannoni, 2008). The loss of binding partners for integrins, such as proteins of the extracellular 
matrix or serum, is responsible for the loss of the so called 'outside-in' (Arnaout et al., 2002) 
signalling and hence the starting point for anoikis. Integrins are hetero-dimers consisting of non-
covalently bound class I transmembrane proteins; each integrin contains an alpha and a beta chain 
(Wiesner et al., 2005). So far, 18 alpha and 8 beta subunits have been found in humans; those can 
assemble into 24 different integrin receptors (Eble and Haier, 2006, Wiesner et al., 2005). The 
combination of the subunits determines the ligand of the integrin and hence the function, e.g. 
integrin alpha 1 beta 1 belongs to the group of collagen binding integrins whereas integrin alpha 4 
beta 1 binds to different sites in fibronectin (Eble and Haier, 2006). Integrin signalling is split into 
inside-out and outside-in signalling; inside-out being defined as activational signalling based on 
conformational changes due to inter-cellular signalling events, outside-in signalling as the signalling 
events following receptor-ligand binding. Inside-out and outside-in are closely interlinked as, for 
example, clustering and ligand affinity, both requiring conformational changes, depend not only on 
the interaction with the actin cytoskeleton as their inter-cellular interaction partner but also on the 
shear forces (outside signals) the cell experiences (Schymeinsky et al., 2011).
All the anoikis signalling pathways described so far merge in the activation of caspases, leading 
to activation of endonucleases, DNA fragmentation and cell death. The protein Bcl-2 is a key part of 
the process, as demonstrated by Lee and Ruoslathi (2005). Bcl-2 protein expression has been shown 
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to be regulated not only by the expression of certain types of integrins but also to depend on the 
proteins the integrin interact with. Hence, different integrin ligands, such as vitronectin or 
fibronectin, influence Bcl-2 regulation (Matters and Ruoslathi, 2001). Some of the signal proteins 
only play a role in certain cell types, e.g. BH3-only proteins seem to be important in fibroblast 
anoikis. Anoikis has also been shown to be induced by a change in cell shape (Chen et al., 1997); 
this has been proposed to be due to clustering of FAS ligands on the cell surface (Chiarugi and 
Giannoni, 2008). Epithelial cells have been shown to regulate anoikis through integrin /growth 
factor receptor cross-talk; a number of mammalian epithelial cells require a combination of 
adhesion signalling and growth factor signalling for survival, with only one activated pathway not 
being sufficient (Gilmor, 2005). Protection from anoikis has been found to occur under conditions 
such as cell migration and in professional non-adherent cells such as leukocytes. In these cases it 
has been shown that certain cytokines, depending on the cell type and surrounding, can provide 
survival signals during cell migration (Freitas and Rocha, 1999). Resistance to anoikis has also been 
seen to be induced by treatment with motility factors that cause a breakdown of normal epithelial 
cell-to-cell interactions (Frisch and Francis, 1994). Resistance can also be gained by cells based on 
other mechanisms such as autocrine growth factor loops, changes in integrin expression, ligand 
independent activation of growth factor receptor and up-regulation of N-cadherin on the cell surface 
(Chiarugi and Giannoni, 2008). The number of signalling molecules proposed to be involved in 
anoikis has grown over the last ten years; Redding and Juliano (2005) mention epithelial growth 
factor (EGF), Bim, Bcl-2 and Bax as the main apoptotic proteins involved in the signalling cascades 
related to anoikis, but stress the importance of further protein interactions involving integrin 
signalling via talin, vinculin and paxillin, proteins linking integrins to the actin cytoskeleton, 
together with signalling cascades linked by PI3, integrin linked kinase (ILK) and focal adhesion 
kinase (FAK). The interaction between EGF and integrin signalling cascades has been demonstrated 
to influence the actin stress fibre formation. Shahal et al. (2012) have shown that EGF and integrin 
adhesion interaction, thought to involve the signalling proteins Src, depends not only on protein 
levels but also on densities of points of adhesion and the form of EGF, whether it is soluble or 
immobilised; this indicates the importance of structural distribution in the form of clusters apart 
from general protein expression levels.
Changes in cell surface protein expression levels have also been seen as a reaction to fluid shear 
stress (Morigi et al., 1995). The down-regulation of the fibronectin receptor integrin alpha 5 beta 1 
has been demonstrated in three different fibroblast cell lines; this was demonstrated to happen in 
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conjunction with a down-regulation of the cell derived fibronectin (Dalton et al., 1992).  The 
importance of the integrin alpha 5 beta 1 receptor in survival signalling in CHO cells has been 
shown in a number of studies, such as by Lee and Ruoslathi (2005) who analysed in detail the 
signalling pathways of integrin alpha 5 beta 1 and integrin alpha V beta 1, concentrating on 
PI3/AKT signalling, and demonstrated that different signalling mediators such as AKT and NF- 
kappa B are involved in up-regulation of the anti-apoptotic protein Bcl-2. The complexity of the 
involved signalling pathways has been summarised by Chiarugi and Giannoni (2008) who describe 
three different situations, cell survival, anoikis and anoikis resistance, which differ in the signalling 
pathways involved. The main difference between general cell survival and anoikis resistance as 
described by them is to be found in constitutive activity of PI3/AKT and MAPK/ERK signalling, 
possibly induced by a change in the pattern on integrin expression in anoikis resistant cells. 
Furthermore, reactive oxygen species influence downstream integrin signalling events (Chiarugi, 
2008) in combination with ligand-independent activation of growth factor receptors and can provide 
anoikis resistance (Chiarugi and Giannoni, 2008). 
The adaptation from adherent growth to suspension growth is also found in the process of 
metastasis. Metastatic cancer cells have been shown to lack the dependency on extracellular matrix 
contact for proliferation, which is thought to be a necessary step for development of metastasis; 
metastatic cancer is only possible due to cells overcoming attachment and acquiring the ability to 
move freely around in the body while still capable of proliferation. Hence, studies related to 
development of metastatic cancer can give further clues regarding changes in intra- and 
extracellular cell signalling that is possibly involved in the transition from adherent to suspension 
cell growth of mammalian cell lines.
In a study by Li et al. (2001) E-cadherin, one of the major adhesion molecules in adherent 
junctions between cells, was shown to become down-regulated during melanoma development; this 
down-regulation could be counteracted by over-expression of desmosomal cadherins, such as 
Desmoglein 1, due to the cross-talk between desmosomes and adherent junctions. Chiarugi and 
Giannoni (2008) link anoikis resistance to up-regulation of N-cadherin expression; this indicates a 
role for cadherin expression in adherence regulation. Another mechanism shown to be important in 
melanoma cell lines is the self-stimulation by hepatocyte growth factor (HGF) which in tissue 
would be secreted by fibroblasts. The cell lines investigated all expressed c-Met, the HGF receptor, 
and showed increased proliferation when treated with HGF. Constant treatment with HGF also leads 
to a significant down-regulation of E-cadherin and Desmoglein 1 in melanoma cells. In contrast to 
 -26-
Analysing the surface of suspension growth adapted CHO cells                                                            
this is the up-regulation of integrin alpha 5 beta 3 in the same setting (Li et al., 2001); this illustrates 
that integrins can provide survival signals during cell migration. Integrins have been studied as 
tumor suppressors, with several integrins such as integrin 5 beta 1 and integrin alpha 3 beta 1 being 
shown to be down-regulated in metastatic cancer cells (Eble and Haier, 2006). As the development 
of metastatic cancer requires a number of steps from leaving the primary tumor to establishment of 
metastatic growth in the new environment, the role of integrins is assumed to be a combination of 
up- and down-regulation, partially depending on the type of the primary tumor and the new 
environment (Eble and Haier, 2006). Another study on melanoma cells (Satymoorthy, 2001) 
concentrated on the effect of insulin-like growth factor 1 (IGF-1). The IGF-1 receptor is known to 
be expressed on melanoma cells and shows an increase in expression during cancer progression. 
Paracrine stimulation of melanoma cells by IGF-1 from fibroblasts was demonstrated to activate 
several effector proteins of signalling pathways, including MAP kinase and AKT in early stage 
melanoma cells, pathways that are also regulated in integrin downstream signalling as described 
before. It has been suggested that by activation of MAP kinase and AKT, IGF-1 acts as an anti-
apoptotic survival factor for early stage melanoma cells. Furthermore, it was described that IGF-1 
can substitute for other growth factors, such as basic Fibroblast Growth Factor (Satymoorthy, 2001). 
Difference in adhesion of CHO cells to a fibronectin coated surface has been reported to be 
influenced by insulin supplementation, with a better adhesion demonstrated in the presence of 
insulin (Guilherme et al., 1998), again revealing the importance of growth factor signalling in 
adhesion regulation. As insulin, which can also interact with the IGF-1 receptor, is often included in 
serum-free media to enable serum-free suspension growth of cells, some of these mechanisms might 
play a role in suspension adaptation of cells.
The studies listed above indicate that signalling pathways affiliated to integrins and cadherins 
play a major role in suspension adaptation. In adherent conditions the major signalling pathways 
regulated by integrin signalling in combination with growth factor signalling involve FAK, which 
also provides a link to the cytoskeleton via adapter proteins such as talin, paxillin and vinculin (see 
also Fig. 8.1); FAK also interacts with PI3 via different adapter proteins, with PI3 interacting with 
AKT allowing anti-apototic signalling to take place as describe before (Giancotti et al., 1999).  
Furthermore, FAK can also indirectly lead to activation of the mitogen activated protein (MAP) 
kinase signalling pathway (Stupack and Cheresh, 2002), allowing regulation of cell cycle 
progression. It needs to be stressed that integrins have no catalytic function themselves (Wiesner et 
al., 2005). Instead, they signal by binding to a large number of effector proteins; a number of those 
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proteins, such as talin and vinculin, bind either themselves or via a binding partner to the actin 
cytoskeleton of the cell, thereby linking the integrins on the cell surface to the intracellular 
cytoskeleton. Hence, signalling pathways such as the RhoA/ROCK pathway (Hayes et al., 2011) 
might also be affected by suspension adaptation. The effector proteins linking integrins and the 
cytoskeleton are known to differ between different cell types and have mainly been studied on cell 
lines showing anchorage dependent growth.  
In addition, the integrin signalling is controlled by integrin conformation; clustering and 
switching between low-affinity and high-affinity conformation plays an important role in the 
regulation of cell growth via integrin signalling (Wiesner et al., 2005). For example, van Kooyk and 
Figdor (2000) proposed clustering as a major step in integrin activation and suggested that the 
release of cytoskeletal restrain is a step required for clustering. A more detailed study by Bakker et 
al. (2012) on the role of integrin clusters on leukocytes concentrated on the role of conformation, 
lateral mobility and ligand-induced microclustering of integrin alpha L beta 2. Leukocytes are 
professional suspension cells that are still capable to adhere. Bakker et al. (2012) concentrated on 
the behaviour of integrin nano-clusters that exist in non-adherent leukocytes, showing that in resting 
monocytes these clusters can diffuse within the cell membrane, but mobility depends on the 
conformation. Furthermore. they demonstrated that the mobility within the membrane is influenced 
by the calcium concentration of the cell environment, with low calcium concentration restricting 
diffusion; this was suggested to be due to conformational changes of integrin receptors in reaction 
to calcium concentration. The mobility of integrin alpha L beta 2 could also be linked to the actin 
cytoskeleton; treatment with a drug leading to the de-polymerisation of F-actin, cytochalasin D 
enhanced mobility besides low calcium concentration in the media demonstrating a link between 
integrin cluster mobility, integrin conformation and the cell environment. While the integrin nano-
clusters remained intact independent of the treatment and the cell culture environment, micro-
cluster formation and hence adhesions and cell spreading was restricted in a low calcium 
environment (0.04 mM). Bakker et al. (2012)  could demonstrate that mobile integrin nano-clusters 
exist on leukocytes in different conformations, e.g. primed or not extended, and that those clusters 
are anchored to the cytoskeleton, depending on their conformation. 
Altrock et al. (2012) studied the distribution of lipid rafts in hematopoietic stem cells (HSC) 
which are the source of leukocytes in the human body. The study on HSCs by Altrock et al. (2012) 
concentrated on the distribution of lipid rafts, transient membrane domains, characterised by 
enrichment of cholesterol and sphingolipids during adhesion to fibronectin, an integrin ligand. 
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Three-dimensional analysis using confocal microscopy revealed the occurrence of polarisation 
towards the adherent cell side for lipid rafts, integrin alpha 5 and integrin alpha V beta 3 
demonstrating an extensive reorganisation of the cell surface during HSC adhesion. In contrast to 
this, integrin beta 1 remained homogeneously spread over the entire cell surface. All integrins 
analysed in this study showed a clustered distribution in confocal microscopy analysis. 
Cytoskeletal reorganisation has been demonstrated by Barda-Saad et al. (2005) in a study using 
T cells. The study concentrated on the events occurring after activation via the T cell receptor 
(TCR) and showed the restructuring actin undergoes during the process of TCR activation in 
combination with adherence, leading to a clearly defined actin ring structure in activated cells. 
Hayse et al. (2011) proposed that cytoskeleton remodelling also occurs in CHO cells when 
adapted to suspension. They studied a phosducin like protein, PhLP3, that has been linked to beta-
tubulin and actin folding, and its influence on cytoskeletal remodelling by over-expression in CHO 
cells. Actin levels and assembly were unaltered by over-expression of PhLP3 but adherent cells 
were released into the supernatant; those cells did not remain viable. Knock-down of PhLP3 in 
CHO suspension cells resulted in a morphological change of the cells with an increase in actin 
stress fibre formation. In those cells the distribution of vinculin also changed. These changes were 
linked to a change in levels and distribution of activated MAP kinase, linking PhLP3 to cell death 
signalling. In the study by Hayes et al. (2011) knock-down of PhLP3 in suspension CHO cells 
seems hence to introduce a more adherent phenotype, leading to formation of actin stress fibres, 
focal adhesion formation and increase of MAP kinase phosphorylation. 
In contrast to the studies above that are mainly based on expression level analysis and 
conformational studies for the cell surface proteins, another method to analyse cell surface proteins 
is the analysis of the shedded proteins (Ahram et al., 2005b; Guo et al., 2002) using mass 
spectrometry approaches. A number of membrane proteases, also called sheddases (Guo et al., 
2002), has been identified over the last years (Hopper et al., 1997); membrane proteins are released 
by those sheddases from the membrane into the culture supernatant. It has been shown that adhesion 
proteins are released by this mechanism (Arribas and Borroto, 2002). The released proteins (either 
naturally occurring or induced by treatments) can be analysed to gain insight into the proteome 
composition of the cell membrane. 
 So far mostly separate aspects regarding the changes in cell surface and the underlying 
signalling pathways have been studied in the transition from an adherent mammalian cell line to a 
suspension cell line (or vice versa). One can assume that a complex combination of these 
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mechanisms plays a role in suspension adaptation of cell lines. To elucidate the large number of 
proteins possibly involved, a quantitative mass spectrometry based approach was proposed as a 
starting point in this study, as has previously been used for the analysis of the shedded proteins. 
Also, such an approach has been used in a number of surface protein studies to either identify cell 
surface proteins (Nunomura et al., 2005; Schindler et al., 2006) or elucidate differences between 
cell lines (Conn et al. 2008). More recent mass spectrometry studies of  membrane proteins (see 
also chapter 5) often used a variety of enrichment steps for membrane proteins to enable 
comprehensive identification of membrane proteins, for example biotinylation and affinity 
enrichment (Zhao et al., 2004) or gravity gradient centrifugation (Han et al., 2008). 
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3.   Chapter 
Experimental techniques 
In this chapter the methods and materials used in this study are listed including relevant details. 
Exceptions to the general methodology are given in the applicable result chapters.
3.1 Cell lines
The following cell lines were used within this project:
● adherent CHOK1 clone CCL61 from ATCC received from Pfizer,
● suspension adapted proprietary cell line S cells from Pfizer,
● adherent growing proprietary cell line AML from Pfizer,
● suspension CHO cell line Free StyleTM CHO-S cells from Invitrogen.
Cell banks were created for each cell line by harvesting during the exponential growth phase. 
Cells were pelleted (200g, 5 minutes) and re-suspended in their respective media with the addition 
of 10% dimethylsulfoxide (DMSO) (Sigma, St. Louis, USA) at 1 x  107/ml. 1.5 ml aliquots were 
frozen at  -80°C in Nunc cryovials (Thermo, Epson, Surrey) using a Mr Frosty container (Nalgene, 
Roskilde, Denmark) to ensure cooling at 1°C/ minute. Cells were transferred into liquid nitrogen 
after a minimum period of 48 h.
3.2 Cell culture conditions
3.2.1 Suspension culture
Suspension cell culture condition was 5% CO2, 37°C and 140 rotations per minute (rpm) 
(standard condition for suspension growth). Suspension cells were split after 3 or 4 days 
(alternating) with adjustment of seeding density. Cells were seeded after 3 days using 0.4 x 106/ml 
and after 4 days with 0.2 x 106/ml; CHO-S cells were always seeded at 0.2 x 106/ml. For suspension 
growth of Pfizer cell lines and CCL61, proprietary suspension media (PSM) from Pfizer (Andover, 
USA) containing 10 mg/ml insulin was used (PSM plus); CHO-S cells were cultured in CD-CHO 
medium  (Invitrogen, Paisley, UK) supplemented with 8 mM glutamine (Sigma Aldrich, St. Louis, 
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USA). Suspension cells were cultured in vented 25 ml Erlenmeyer shake flasks (Corning, Surrey, 
UK). Measurements of cell density and cell viability were performed using the Vi-cellXR cell 
viability analyser (Beckmann Coulter, High Wycombe, UK) which uses the trypan blue exclusion 
method. Cells were cultured up to a maximum of 30 passages (CHO-S: 20 passages). 
3.2.2 Adherent culture
Adherent cell culture conditions were 5% CO2  and 37°C (standard conditions for adherent 
growth). Cell cultures were split after 3 or 4 days (alternating) with adjustment of the seeding 
density after harvesting with 0.05% trypsin/EDTA (Gibco, Paisley, UK). For T75 flasks harvesting 
with 1 ml of the trypsin solution with an incubation of 5 to 10 minutes was used. CCL61 were 
seeded using 6500 cells/cm2 (4 days) or 8000 cells/cm2 (3 days). AML cells were seeded using 6500 
cells/cm2 or 13000 cells/cm2. For adherent growth conditions 10% FBS (Biosera, Ringmer, UK) 
was added to the media. For adherent growth of CCL61 Ham's modified F-12K medium (mF12) 
(LGC, Teddlington, UK) was used; AML cells were cultured in  proprietary adherent media (PAM) 
from Pfizer (Andover, USA). Cells were cultured in T75 flasks (Nunc, Roskilde, Denmark). 
Measurements of cell density and cell viability were performed using the Vi-cellXR cell viability 
analyser (Beckmann Coulter, High Wycombe, UK) which uses the trypan blue exclusion method. 
Cells were cultured up to a maximum of 30 passages. 
3.3 Cell preparation for flow cytometry 
Adherent cells were harvested using phosphate buffered saline (PBS) with 2 mM EDTA (Fisher 
Scientific, Lougborough, UK) and an incubation time of 5 to 10 minutes. Suspension and adherent 
cells were spun down and washed with PBS (Invitrogen, Paisley, UK) before fixation.  For fixation 
1 ml of a 1% para-formaldehyde (PFA)  solution (from a 1 to 4 dilution of a 4% PFA  in PBS stock 
(95%, Sigma Aldrich, Gillingham, UK)) per 5 x 106 was added to the cell pellet, followed by an 
incubation at  4°C for 20 minutes. Cells were washed with PBS and stored in PBS at a 
concentration of 1 x 107/ ml  for a maximum period of 10 days.
3.4 Cell preparation for confocal microscopy
For adherent cells cover-slips (0.13 - 0.17mm thick) in 6 well plates (Nunc, Roskilde, Denmark) 
were prepared by incubation with 1ml of FBS overnight (minimum) at  5% CO2, 37°C. Adherent 
cells were seeded at the usual seeding density for a four day split and stained before reaching 90% 
confluency (usually on day 3). For fixation cover-slips were washed twice with PBS and 1 ml 1% 
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para-formaldehyde solution was added to the well. Incubation was at room temperature for 20 
minutes. The same fixation conditions were used for 2.5 x 106/ml suspension cells. Cells were then 
washed twice with PBS. Cells were not stored at this stage. 
3.5 Flow cytometry – instrumentation set-up
Flow cytometric analysis was performed using a FacsCalibur (BD Biosiences, Oxford, UK). The 
instrument settings were chosen using unstained and, where necessary, single stained controls. Set 
up of instrument setting for each cell line was conducted independently to account for differences in 
autofluorescence due to different culture conditions. Flow cytometry data was analysed using 
FlowJo 7.6.5 (Freestar Inc., USA).
3.6 Confocal microsopy – instrumentation set-up
Confocal microscopy analysis was performed using an inverted Zeiss (Oberkochen, Germany) 
LSM510 Meta confocal microscope. Mounted cell samples were analysed using a plan apochromat 
63x/ 1.4 oil DIC objective with excitation provided by an argon laser. For FITC/Alexa 488 
excitation was at 488 nm and for Alexa 546 excitation was at 514 nm. Emission was collected for 
FITC/Alex 488 using a band pass 500-550 nm IR filter and for Alex 546 using a long pass 560 nm 
filter. All images were analysed using the Zeiss LSM Image Browser Version 4,2.0,121.
3.7 Actin labelling
Actin was stained using Alexa 546 phalloidin (Molecular Probes, Paisley, UK). The freeze dried 
phalloidin was dissolved in methanol and the resulting stock solution (200 units/ml) was aliquoted 
and stored at -20°C.
3.7.1 Actin: flow cytometry staining
2 x 106 fixed cells were washed twice with PBS. 50 μl 0.1% Triton X-100 (Molecular Biology 
tested, Sigma Aldrich, Gillingham, UK) was added to the pellet and incubated at room temperature 
for 3 minutes. Cells were washed twice with PBS (200 g, 5minutes). 200 μl 1% Bovine Serum 
Albumin (BSA; microbiological grade, Fisher Scientific, Loughborough, UK) in PBS with 5 μl  of 
the prepared phalloidin stock solution was added. The cells were incubated for 20 minutes at room 
temperature and washed once with PBS (200 g, 5minutes). Cells were stored for a maximum of 24 
hours in 500 μl of 1% BSA  in PBS  buffer.
 -33-
Analysing the surface of suspension growth adapted CHO cells                                                          
3.7.2 Actin: confocal microscopy staining
2 x 106 fixed cells or cells fixed on a cover glas were washed twice with PBS (200 g, 5 minutes). 
50 μl 0.1% Triton X-100 was added and cells were incubated at room temperature for 3 minutes. 
Cells were washed twice with PBS  and 200 μl 1% BSA in PBS with 5 μl  of the prepared 
phalloidin stock solution was added. The cells were incubated for 20 minutes at room temperature 
and washed twice with PBS. For suspension cells, cell pellets were dissolved in two drops of PBS 
and mounted on a glass slide; cells were mounted using approximately 50 μl ProLong Gold antifade 
(Invitrogen, Paisley, UK).
3.8 Integrin beta 1 labelling
The integrin beta 1 antibody used was clone 9EG7 (BD Biosciences, Oxford, UK). Isotype 
control was rat IgG2a, kappa, clone R35-95 (BD Biosciences, Oxford, UK).
3.8.1 Integrin beta 1: flow cytometry staining
Cells were stained for flow cytometry using 2 - 2.5 x 106 cells in 50 μl PBS/0.2 mM EDTA/0.5% 
BSA buffer. Antibody titer was 1 to 21, incubation time was 45 minutes at 4°C. Before secondary 
staining two washes with PBS/0.2 mM EDTA/0.5% BSA buffer were performed. As secondary 
antibody, mouse anti rat IgG2a PE, clone RG7/1.30 was used at a titer of 1 to 100, incubation time 
was 15 minutes at 4°C. Stained cells were stored for a maximum of 24 hours in 1ml of PBS/0.2mM 
EDTA/0.5% BSA buffer.
3.8.2 Integrin beta 1: confocal microscopy staining
Either a cover-slip with adherent cells or 2.5 x 106 suspension cells were washed twice with PBS 
and 50 μl 1 % BSA in PBS were added.  Integrin beta 1 antibody was used at a titer of 1 to 21 and 
incubation was for 45 minutes at 4°C. Samples were washed twice with PBS and 50 μl 1% BSA 
buffer added. Secondary antibody, Alexa Fluor 488 goat anti mouse IgG2b (Molecular Probes, 
Paisley, UK) was used at 1 to 100 and incubated for 15 minutes at 4°C. Cells were washed once, for 
suspension cells cell pellets were dissolved in two drops of PBS and mounting was done on glass 
slides using approximately 50 μl ProLong Gold antifade (Invitrogen, Paisely, UK). Samples were 
stored for a maximum of 10 days.
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3.9 Integrin alpha 1 labelling
The integrin alpha 1 antibody used was clone Ha31/8 (BD Biosciences, Oxford, UK).
3.9.1 Integrin alpha 1: flow cytometry staining
1 mg Sulfo-NHS-S-S-Biotin (Pierce, Thermo Fisher Scientific, Rockford, USA) was dissolved in 
200 μl PBS/EDTA. 20 μl integrin alpha 4 antibody were diluted 1 to 5. To the prepared antibody 
solution 2 μl of the prepared biotin solution was added and incubated over night at room 
temperature while mixing. The resulting biotinylated antibody was used for cell staining. Cells were 
stained for flow cytometry using 2 - 2.5 x 106 cells in 50 μl PBS/2mM EDTA/0.5%BSA buffer. 
Biotinylated antibody titer was 1 to 6, incubation time was 30 minutes at 4°C. Before secondary 
staining two washes were performed. Secondary staining was performed using Streptavidin-FITC at 
a titer of 1 to 25, incubation time was 15 minutes at 4°C. Cells were stored for a maximum of 24 
hours  in 1ml of PBS/2mM EDTA/0.5% BSA.
3.9.2 Integrin alpha 1: confocal microscopy staining
Either a cover-slip with fixed adherent cells or 2.5 x 106 fixed suspension cells were washed 
twice with PBS and 50 μl 1 % BSA in PBS were added.  Integrin alpha 1 antibody was used at a 
titer of 1 to 6 and incubation was for 45 minutes at 4°C. Samples were washed twice with PBS and 
50 μl 1% BSA buffer added. As secondary antibody, anti-Armenian and Syrian Hamster IgG FITC 
(BD Biosciences, Oxford, UK) was used at 1 to 100 and incubated for 15 minutes at 4°C. Cells 
were washed once, for suspension cells cell pellets were resuspended in two drops of PBS and 
mounted glass slides using approximately 50 μl ProLong Gold antifade (Invitrogen, Paisley, UK). 
Samples were stored for a maximum of 10 days.
3.10 Integrin alpha 4 labelling
The integrin alpha 4 antibody used was clone R1-2 (Miltenyi Biotec, Bergisch Gladbach, 
Germany).
3.10.1 Integrin alpha 4: flow cytometry staining
Cells were stained for flow cytometry using 2 - 2.5 x 106 cells in 50 μl PBS/2 mM EDTA/0.5% 
BSA buffer. Antibody titer was 1 to 6, incubation time 45 minutes at 4°C. The antibody used was a 
direct conjugate with the PE fluorochrome. Cells were stored for a maximum of 24 hours in 1 ml of 
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PBS/2  mM EDTA/0.5% BSA buffer before measuring at a BD Calibur (BD Biosciences, Oxford, 
UK).
3.10.2 Integrin alpha 4: confocal microscopy staining
Either a cover-slip with adherent cells or 2.5 x 106 suspension cells were washed twice with PBS 
and 50 μl 1 % BSA in PBS were added.  Integrin alpha 4 biotin (ready made)  was used at a titer of 
1 to 6 and incubation was for 45 minutes at 4°C. Samples were washed twice with PBS and 50 μl  
1% BSA buffer added. Secondary antibody, Streptavidin  FITC (BD Biosciences, Oxford, UK) was 
used at a titer of 1 to 25 and incubated for 15 minutes at 4°C. Cells were washed twice, for 
suspension cells pellets were dissolved in two drops of PBS and mounted on glass slides using 
approximately 50 μl ProLong Gold antifade (LifeTechnologies, Paisley, UK). Samples were stored 
for a maximum of 10 days.
3.11 Integrin alpha M – flow cytometry staining
The integrin alpha M antibody used was clone M1/70.15.11.5 (Miltenyi Biotec, Bergisch 
Gladbach, Germany). Cells were stained for flow cytometry using 2.5 - 5 x 106 fixed cells in 50 μl 
PBS/2mM EDTA/0.5%BSA buffer. Antibody titer was 1 to 6, incubation time was 45 minutes at 
4°C. The antibody used was a direct conjugate with the PE fluorochrome. Cells were stored for a 
maximum of 24 hours in 1 ml of PBS/2 mM EDTA/0.5% BSA buffer.
3.12 CD56 (neural cell adhesion molecule) – flow cytometry staining
The CD56 antibody used was clone AF12-7H3 (Miltenyi Biotec, Bergisch Gladbach, Germany). 
Cells were stained for flow cytometry using 2.5 - 5 x 106 fixed cells in 50 μl PBS/2 mM 
EDTA/0.5% BSA buffer. Antibody titer was 1 to 6, incubation time was 45 minutes at 4°C. The 
antibody used was a direct conjugate with the PE fluorochrome. Cells were stored for a maximum 
of 24 hours in 1 ml of PBS/2 mM EDTA/0.5% BSA buffer.
3.13 E-cadherin staining – flow cytometry staining
The CD324 antibody used was clone 67A4 (Miltenyi Biotec, Bergisch Gladbach, Germany). 
Isotype control was mouse IgG1-APC clone IS5-21F5 (Miltenyi Biotec, Bergisch Gladbach, 
Germany). Cells were stained for flow cytometry using 2.5 - 5 x 106 fixed cells in 50 μl PBS/2 mM 
EDTA/0.5% BSA buffer. Antibody titer was 1 to 6, incubation time was 45 minutes at 4°C. The 
antibody used was a direct conjugate with the APC fluorochrome. Cells were stored for a maximum 
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of 24 hours in 1 ml of PBS/2 mM EDTA/0.5% BSA.
3.14 CD44 staining – flow cytometry staining
The CD44 antibody used was clone DB105 (Miltenyi Biotec, Bergisch Gladbach, Germany). 
Isotype control was mouse IgG1-FITC clone IS5-21F5 (Miltenyi Biotec, Bergisch Gladbach, 
Germany). Cells were stained for flow cytometry using 2.5 - 5 x 106 fixed cells in 50 μl PBS/2 mM 
EDTA/0.5% BSA buffer. Antibody titer was 1 to 6, incubation time was 45 minutes at 4°C. The 
antibody used was a direct conjugate with the FITC fluorochrome. Cells were stored for a 
maximum of 24 hours in 1 ml of PBS/2 mM EDTA/0.5% BSA .
3.15 Biotinylation of cells
The cell biotinylation protocol used was based on a membrane proteomics approach by Peirce et 
al. (2004). The buffer used for biotinylation (BBS buffer) consisted of 10 mM boric acid, 2.3 mM 
sodium tetraborate, 115 mM NaCl and the pH was adjusted to 8.1. For biotinylation of suspension 
cell 2.5 x 107 cells (or multiples of that) were washed twice with approximately 15 ml BBS buffer 
(200g, 5 minutes). Cells were re-suspended in 1 ml BBS buffer and 100 µl of  a freshly prepared 1 
mg/ml sulfo NHS-S-S biotin solution (dissolved in water) were added. Cells were incubated at 
room temperature for 20 minutes under mixing. Incubation was followed by two washes with BBS 
buffer. Cells were then re-suspended in PBS, either for counting or for preparation of cell lysis.
Adherent cells were grown until about 95% confluent in T75 flasks (CCL61 ~2 x 107  cells) and 
washed two times with approximately 15 ml BBS buffer. To each flask 3 ml BBS buffer was added, 
together with 300 µl of a freshly prepared 1 mg/ml sulfo NHS-S-S biotin solution. Cells were 
incubated for 20 minutes at room temperature on a shaking platform. The supernatant was emptied 
into waste before carefully washing cells twice with approximately 10 ml BBS buffer. Cells were 
then incubated with 1 ml of PBS/2 mM EDTA solution and pooled in PBS in preparation for cell 
lysis or other analysis.
3.16 Lysis of cells – final version
1 x 107 cells were centrifuged (200g, 5min) and 1 ml lysis buffer containing 1% Igepal CA630 
(Sigma Aldrich) in PBS  with protease inhibitors (Sigma Aldrich, Gillingham, UK)  was added to 
the pellet. Cells were vortexed for 1 minute and sonicated in a water bath on ice for 15 minutes. The 
lysis solution was centrifugated at  22,000 g for 20 minutes at 4°C and the resulting supernatant 
stored at -20°C.
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3.17 Cell surface protein enrichment with affinity chromatography – final 
version
Degassed wash buffer 1 (500 mM KCl with 1% Igepal C30 and protease inhibitors) and wash 
buffer 2 (PBS with protease inhibitors) were prepared. Snap cap spin columns (Thermo Fisher 
Scientific, Rockford, USA ) were filled with 500 µl of Streptavidin Agarose resin (Thermo Fisher 
Scientific, Rockford, USA); columns were centrifuged for 1 minute at 1,000 g. This was followed 
by three washes with lysis buffer (PBS with 1% detergent) using centrifugation (1 minute at 1,000 
g).
The washed resin was added to the thawed and pooled cell lysates and incubated under over-
head mixing for 45 minutes at room temperature. The tubes containing the resin and the cell lysates 
were spun down for 1 minute at 1,000 g and the supernatant discarded. The resin was transferred 
back into the column using wash buffer 1. The columns with the resin were washed twice with 0.5 
ml wash buffer 1, followed by another two washes with wash buffer 2; each centrifugation step was 
1 minute at 1,000 g. For the elution step a stopper was used to close the column. The resin was 
mixed well with 300 µl of a 50 mM DTT (Fluka, Sigma Aldrich, Steinheim, Germany) solution and 
incubated for 30 minutes at 37°C. This was allowed to run through by gravity. 100 µl of ready-made 
4x NuPage LDS buffer (Invitrogen, Paisley, UK) was added, the column was vortexed and 
centrifugated for 1 minute at 1,000 g. The elutions were pooled and analysed on an SDS gel.
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4.   Chapter 
Growth characteristics of model cell lines used
In this chapter the relationship between the different cell lines are explained. Growth 
characteristics of the cell lines are given and their phenotype with regard to growth in either 
suspension or adherent conditions is explained in detail.
4.1 Introduction of cell lines and culture conditions used 
To gain insight into the changes of the cell surface due to adaptation to a serum-free suspension 
environment four cell lines were chosen as model cell lines to be used in this study. As a starting 
point an adherent CHO cell line from ATCC, clone CCL61, was chosen; this cell line is the parental 
cell line for all other cell lines used. The clone CCL61 has been used at Pfizer, Andover, USA to 
generate a number of CHO production cell lines. This study is concentrated on cell lines that have 
not been screened for production purpose but simply adapted to suspension growth, to avoid the 
phenotype in question to be due to additional selection pressure. The cell line chosen is called S-
cells in this study and grows well in chemically defined serum free suspension culture based on 
proprietary suspension media. At Pfizer the S-cell line was used to create another CHO clone, 
characterised by growing very well in adherent conditions using proprietary adherent media, this 
clone is called AML cells in this study.  To ensure that the characterised phenotype is not biased by 
the study being based on proprietary media with unknown components the CHO clone CHO-S from 
Invitrogen, as another cell line growing in  chemically defined serum-free suspension culture based 
on an entirely different media, was added to the model cell lines to be analysed in this study at a 
later stage. The relationship of the model cell lines is also explained in figure 4.1. 
To analyse if the cell lines chosen were able to grow in either adherent and/or suspension mode 
two different culture conditions (see also chapter 3.2) have been used in combination with different 
media. The aim was to characterise the model cell lines with regard to their growth phenotypes. For 
adherent growth, culturing in mF12 with 10% FBS was chosen as a standard condition for the 
suspension cell lines CHO-S and S cells, as the parental CCL61 is adapted to this media. For 
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suspension growth culturing in proprietary suspension media (PSM) from Pfizer under shaking 
conditions was chosen as standard conditions for the adherent cell lines AML and CCL61, as the 
focus of this study was on the Pfizer cell lines.  For an overview of the different conditions used and 
the cell lines they were applied to, see table 4.1
l
Figure 4.1 Flow diagram showing the relationship between the cell lines used in this study.
Black boxes denote the cell lines actually used. All three suspension adapted cell lines, S cells, 
AML cells and CHO-S are closely related to the adherent CHOK1 clone CCL61.
Table  4.1 The  combination  of  media,  cell  culture  conditions  and  cell  lines  used  to 
characterise the growth phenotype of the model cell lines. 
Bold indicates standard growth conditions for particular cell line,  italics indicates reversed conditions.
media culture conditions cell lines 
Ham's modified F-12K medium
 + 10 % FBS
adherent (static) CCL61, S cells, CHO-S 
proprietary adherent media 
(PAM)
from Pfizer + 10 % FBS
adherent (static) AML cells
CD-CHO medium from 
Invitrogen + 
8 mM glutamine
suspension (shaking) CHO-S
proprietary suspension media 
(PSM)
from Pfizer
suspension (shaking) S cells, AML cells, CCL61
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4.2 Cell growth characteristics in standard and reversed conditions
4.2.1 Methodology
To analyse the growth characteristics of  model cell lines cells were seeded at the 4 day split 
seeding density and cultured in the appropriate medium and cell culture environment for seven 
days. Viability and viable cell density (VCD) were measured for each cell line in their standard and 
in the reversed condition, either adherent or suspension.  
The generated growth data was used to calculate the growth rate constant µ as a parameter to 
describe the growth phenotype in addition to viability and viable cell density. The growth rate 
constant µ  gives the logarithm of the rate of cell number increase in proportion to the number of 
cells present during a given period. µ was determined based on the following equation: 
ln Nt – ln N0 = µ (t–t0)
where:            Nt is the number of cells at the time-point t, 
N0 is number of cells at time-point 0 (t0)
µ is the specific growth rate.
This can also be expressed as: 
µ = ((2.303 × (log Nt – log N0))/ (t–t0)
4.3 Growth results
Figure 4.2 A) shows the viable cell density in suspension is highest for the CHO-S cell line and 
lowest for the CCL61 cells; for the CCL61 there is nearly no increase in VCD after seeding. 
Viability remains above 95% for all four cell lines until day 4 and drops afterwards for CCL61, S 
cells and AML cells. For adherent conditions (figure 4.2 B) the highest VCD is reached by AML 
cells, with the three other cell lines showing a very similar VCD. The difference here might be due 
to the difference between the media. 
Figure 4.3 shows the results of the growth rate calculations. In suspension growth conditions the 
maximum growth rate of  0.06 h-1 is reached by S cells at day 2. CHO-S cells reach their maximum 
growth rate which is close to 0.06 h-1 a day later. AML cells and CCL61, the two cell lines growing 
in adherent mode as a standard condition, show a similar growth rate curve which peaks on day two 
and drops down quickly afterwards. CCL61 shows the lowest growth rate of all four cell lines in 
this condition with approximatively 0.03 h-1 on day two , which shows clearly that this cell line is 
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not adapted to suspension growth. There are fewer differences between the growth rate curves in 
adherent conditions. CHO-S peaks on day 2 before S cells on day 3, both reaching a similar 
maximum growth rate of around  0.06 h-1. CCL61 and AML cells show a very similar growth rate 
curve, again with a peak at around 0.06 h-1  at day 3.
 In suspension growth conditions from day 4 onwards the formation of small visible cell clumps 
was seen in all four cell lines; clumping was most pronounced in CCL61 and CHO-S and increased 
until the end of the cell culturing period. 
As can be seen in table 4.2 the average cell size of the four cell lines shows only small 
differences, with CHO-S being slightly larger; the average cell size is around 14 micron when 
measured in suspension; it can be assumed that cells in adherent conditions show a different surface 
area to the one calculated here due to their stretched-out morphology, nevertheless the data given in 
table 4.2 is of importance when analysing cell surface expression of proteins using flow cytometry 
as for flow cytometric analysis all cells are measured in suspension.
Table 4.2 Cell sizes and surface areas of cell lines in standard growth conditions.
All cell lines were grown in standard growth conditions. Adherent cells were harvested with PBS/ 
2 mM ETDA for 10 minutes before re-suspending them in media. Diameter was determined using 
the ViaCell cell counter on day four of culture. Diameter with standard deviation (number of repeats 
>= 11) is given. The diameter was used to calculate the cell surface area assuming a round cell.
cell line diameter / µm surface area / µm2
CCL61 14.47 ± 0.31 658  ± 29
S- cells 14.39 ± 0.72 654 ± 66
CHO-S 16.05 ± 1.12 816  ± 103
AML 13.73 ± 0.3 592 ± 26
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Figure 4.2: Growth results of suspension adapted cell lines S cells, AML cells, 
CHO-S and the non suspension adapted  model cell line CCL61.   
A) shows viable cell density and viability over the course of 7 days when cell lines are 
grown in suspension using PSM plus for CCL61, S cells and AML cells and supplemented 
CD CHO  media for CHO-S. Dashed lines give results for non standard conditions. B) 
shows results when cell lines are grown in adherent mode using mF12 plus 10% FBS for 
CCL61, S cells and CHO-S and PAM plus 10% FBS for AML cells. Dashed lines give re-
sults for non standard conditions. Number of independent samples is 3 in all measurements.  
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Figure 4.3: Growth rates of the suspension adapted cell lines S cells, AML cells, 
CHO-S and non suspension adapted cell line CCL61.                                                 
A) shows the differences in growth rate over the course of 7 days when cell lines are 
grown in suspension using PSM plus for CCL61, S cells and AML cells and supplemented 
CD CHO  media for CHO-S. B) shows results when cell lines are grown in adherent mode 
using mF12 plus 10% FBS for CCL61, S cells and CHO-S and PAM plus 10% FBS for 
AML cells. Repeats of calculations based on independent samples: n= 3. 
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4.4 Stability of growth characteristics over time 
To ensure that the growth characteristics analysed above were maintained by the cell lines during 
the cell culture period, two different vials of each cell line were thawed with an appropriate time 
gap were cultured. This allowed parallel analysis of different passages of the cell lines based on the 
same cell bank using the same batch of media.  For CHO-S, S cells and CCL61 cultures differing by 
more than 20 passages were compared whereas for AML cells the comparison was done for cells 
differing by only 10 passages due to difficulties with media delivery. 
Results of the comparison are shown in figure 4.4. For the cell lines CCL61, S cells and AML in 
standard growth conditions no variation in viable cell densities was seen in the comparison of 
passages. For CHO-S cells a difference in the maximal attainable viable cell densities is seen 
between the different passages: over passages the maximal viable cell density achieved decreases 
and a clear difference in viable cell density can already be seen on day four of culture between 
different early and late passages. Due to this, CHO-S cells were only used in this study when the 
passage number was below 20. For growth in reversed conditions all four cell lines show a similar 
maximal viable cell density, independent of the passage number. The larger variation seen for the 
CCL61 cells needs to be seen in relation to the low viable cell density reached and the high standard 
deviation between triplicates; both are due to the fact that these cells are not adapted to suspension 
growth. This data is indicative of the fact that the ability to grow successfully in reversed conditions 
remains stable for the chosen cell lines under the settings chosen. Hence, this ability can be seen as 
a characteristic of the phenotype of the four cell lines investigated.
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Figure 4.4: Stability of growth characteristics — comparison of viable cell density 
(VCD) in early and late passages of the model cell lines.   
VCD of two different passages was analysed for early (solid line) and late (dashed line) 
passages as described in figure 4.2 at the same time point.  For  all measurements three in-
dependent samples were measured. 
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4.5 Development of adherence and confluence in adherent conditions
Further analysis of the four cell lines with regard to their growth characteristics was carried out  
in adherent conditions.  The aim was to analyse if the four cell lines become adherent in the same 
time span and if they differ in the degree of confluence, i.e. the coverage of the cell culture surface 
reached after a period of four days; at this time point cell viability has not started to drop (see figure 
4.2) and hence one can assume only a low amount of dead cells exists in each culture. 
4.5.1 Methodology of adherence and confluence study
For the study of the development of adherence all four cell lines were seeded at 6500 cells/cm2 in 
6 well plates and the speed of attachment to the 6 well plate in serum containing media was 
documented.  The confluence levels reached by the four cell lines after being cultured for four days 
in adherent growth conditions were also analysed.
4.5.2 Results of adherence and confluence study
As can be seen in figure 4.5, both adherent cell lines, CCL61 and AML cells, were attached after 
one hour in culture, with nearly all cells showing the beginning of pseudopodia formation even as 
early as after 30 minutes of culture, but the clearly stretched-out morphology typically seen at later 
stages of culture was only recognisable after 3 hours of culture and then only for some of the cells. 
S cells were partially attached after one hour with a number of cells showing a clear stretched-out 
adherent morphology and others still showing a rounded up morphology with no pseudopodia 
formation. CHO-S cells were not adherent after one hour of culture and did not show any proper 
pseudopodia formation. Even after 7 hours only a few CHO-S cells showed the typical fibroblast 
morphology whereas this phenotype was developed in full by CCL61 and AML cells after 3 hours. 
All S cells showed pseudopodia formation after 7 hours, with a large variation in the spreading of 
the cells. It has to be noted that due to the experimental set-up and the microscope available it was 
not possible to analyse the same area of culture during the time of this experiment, which accounts 
for the large variation in cell distribution over the field of view. 
The confluence levels reached by the four cell lines after having been cultured for four days in 
adherent growth conditions also varied. As can be seen in figure 4.6, only AML cells become 100% 
confluent. CCL61 and S cells do not reach the same high degree of confluence and the culture of 
CHO-S cells actually shows a number of non-adherent cells which would not be accounted for in 
the viable cell density data due to the harvesting procedure. CCL61 cells might be contact inhibited 
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Figure 4.5:  Differences in adherence development of the different CHO cell lines  
Cells were cultured in 6 well plates and images were taken with a Nikon Eclipse TS100 mi-
croscope with an attached camera and a 40x objective using the NIS Elements F2.30 soft-
ware at the time points indicated. The different development of the morphology after trans-
fer into the corresponding adherent growth medium over the period of 7 hours can be seen. 
Cells were treated with trypsin for 10 minutes before seeding. Scale bars in top row images 
equal 20µm.  
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Figure 4.6:  Confluence levels reached by the model cell lines after a 4 days cul-
ture period 
Confluence levels reached in the respective adherent media after a period of 4 days are 
shown for the four cell lines in the given medium under static culture conditions. Some 
of the differences regarding confluence have been marked by arrows. Scale bars are 
40µm long. 
CCL61  
mF12 + 10 % FBS 
AML cells  
PAM + 10 % FBS 
CHO-S  
mF12 + 10 % FBS 
S cells 
mF12 + 10 % FBS 
Free area 
Free area 
Unattached cells 
Analysing the surface of suspension growth adapted CHO cells                                                          
and hence not reach the same level of confluence as the AML cells. This difference between CCL61 
and AML is also seen in the viable cell densities reached by those cell lines (see figure 4.2) and 
could also be related to the different media used.
4.6 Discussion of growth characteristics results
The growth data in figures 4.2 and 4.3 shows clearly that all four cell lines can proliferate in 
adherent growth conditions whereas only CHO-S, S cells and AML cells proliferate successfully in 
suspension conditions but show different maximal achievable viable cell densities in the respective 
growth conditions. Maximal growth rates for suspension adapted CHO cells in serum free 
conditions have been shown to be as low as 0.015 h-1  (LeFloch et al., 2006); this is clearly exceeded 
by the suspension cell lines CHO-S, S cells and AML used in this study. The maximal growth rate 
of S cells, AML cells and CHO-S shows hardly any difference between suspension and adherent 
culture conditions, in contrast to CCL61 that show a lower maximal growth rate in suspension 
conditions compared to adherent conditions. The data gained for the S cells and AML cells shows 
similar growth characteristics as seen before at Pfizer in the cell culture conditions described, 
though it should be noted that the optimal CO2 concentration for PSM and PAM would have been 
7%, which could not be used in this study due to limitations in incubator availability. 
The difference between CHO-S and S cells in maximal viable cell density reached might be 
based on the different media used in addition to their adaptation status, but AML and S cells have 
been cultured in the same suspensions media PSM; hence, any difference with respect to growth 
characteristics should indicate that those cells differ in their adaptation to suspension growth which 
might lead to phenotypic differences between these cell lines, as demonstrated by the confluence 
levels reached (see figure 4.6).
It can be summarised that CHO-S, S cells and AML cells have been adapted to suspension 
growth conditions, but not CCL61. Hence, differences in the surface between the two identified 
groups (suspension-adapted cells/ non-suspension-adapted cells) could be due to the process of 
suspension adaptation and hence be a reaction of the cell lines to the adaptation pressure and the 
new suspension environment. 
 Apart from the similarity in growth rates in adherent conditions, the speed of adherence 
development and the morphologies the four cell lines develop when becoming adherent differ. This 
is an indication that those cell lines are different in the way they interact with their environment and 
hence might indicate differences between the suspension-adapted cell lines with regard to their 
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surface proteins and cell signalling processes. For a summary of the results see table 4.3.
Table 4.3 Summary of cell line characteristics showing the phenotype differences between 
the suspension adapted cell lines and the non suspension-adapted cell line CCL61.
Each of the four cell lines shows a different phenotype for the characteristics analysed. The ability 
to  grow successfully in  suspension varies  to  a  large  degree,  with  viable  cell  densities  reached 
between 20 x 106/ml (CHO-S) and 2 x 106/ml (CCL61, a non suspension adapted cell line). * For 
CHO-S cells confluence cannot be determined properly due to the appearance of non-adherent cells.
Suspension 
growth
Adherent 
growth
Adherent 
after 1 hour
100% 
confluence 
after 4 days
CCL61 no yes yes no
AML cells yes yes yes yes
CH0-S yes yes no  no*
S cells yes yes yes no
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5.  Chapter  
Analysing the cell surface proteome using a 
combined biochemistry/ mass spectrometry 
approach 
In this chapter the role and structure of the proteins in the plasma membrane are summarised. 
Membrane proteome approaches based on mass spectrometry as a tool to study membrane proteins 
will be explained and different approaches of previous studies relevant to inform the strategy 
chosen in this project will be introduced.
5.1 Cell surface membrane proteins 
Proteins can be found in all lipid bilayers that exist in cells. Cell surface membrane proteins are 
important in the development and physiology of cells; for example, changes in cell membrane 
proteins have been found to be specific for the development of a cancer cell from a healthy cell 
(Pontier and Muller, 2009).  The lipids of the cell membrane can be seen as the backbone of the 
membrane structure, forming a barrier between the cytosol and cell environment, with the proteins 
being responsible for specific membrane functions, for instance for nutrient transport, signal 
transduction, adherence or as environmental sensors (Cooper and Hausmann, 2006). This multitude 
of functions explains why the membrane protein composition of different cell types differs to a 
large degree as this enables the cells to function properly in their own environment. This further 
strengthens our hypothesis that suspension adapted CHO cells might have a different surface 
protein complement compared to adherent CHO cells.
Proteins can either be attached to the membrane (intra- and extra-cellular peripheral membrane 
proteins) or inserted into the lipid bi-layer, in which case they are called integral membrane proteins 
(Macher and Yen, 2007). To allow interaction with the lipid bi-layer, integral membrane proteins 
usually have hydrophobic regions within their structure consisting mainly of hydrophobic amino-
acids as for example phenylalanine, valine and tryptophan; therefore most integral membrane 
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proteins are transmembrane proteins. Transmembrane proteins are grouped into different categories 
depending upon their orientation with regard to the N and C termini: type 1 proteins have a 
cytosolic C terminus, type 2 proteins have a cytosolic N terminus and multi-pass proteins possess 
several membrane spanning domains with either N or C terminus or both on the cytosolic 
membrane side (Tan et al., 2008). The membrane-spanning portion of proteins usually shows a 
structure of alpha helices containing about 25 hydrophobic amino acids, with the number of 
transmembrane domains varying between 1 and 14 (as, for example, in the band 3 protein found in 
red blood cells) or even higher (Copper and Hausmann, 2006). In mammals, very often the 
extracellular face of the membrane proteins contains carbohydrates due to post-translational 
modifications of the proteins – hence, a high percentage of plasma membrane proteins are 
glycoproteins. Another group of integral membrane proteins is anchored to the lipid bi-layer with 
the help of glycolipids. One typical example of such an anchor is glycosylphospatidylinositol (GPI); 
the GPI anchor is bound to proteins in the endoplasmatic reticulum in exchange for the 
transmembrane domain.
Further to their structure, membrane proteins can be defined by their role, such as inter-cellular 
communications, vesicle trafficking, ion transport and propagation of signalling cascades (Speers 
and Wu, 2007). Proteins on the cell surface act as receptors, allowing cells to sense and react to 
their environment  (Copper and Hausmann, 2006). For mammalian cells this includes interaction 
with the proteins of the extracellular matrix in tissue or interaction between cells. In tissue the cells 
are embedded in an extracellular matrix built from secreted proteins and polysaccharides. The 
plasma membrane interacts with the extracellular matrix. This interaction is found in particular 
between the so-called adhesion proteins of the cell membrane and the extracellular matrix. Those 
interactions are necessary to create a functional structure within the tissue and allow linkage of the 
cells to the extracellular matrix. A typical protein of the extracellular matrix is fibronectin, which is 
able to build up structures on its own or connect with other parts of the extracellular matrix such as 
collagen. Fibronectin has specific areas in its molecular structure which interact with proteins on the 
cell surface, for example integrins (Copper and Hausmann, 2006). Specific membrane proteins that 
can be classed into four groups mediate selective cell-cell adhesion: selectins, integrins, the 
immunoglobulin (Ig) superfamily and cadherins. The interaction between these membrane proteins 
is thought to occur in the culturing process of adherent cell lines. Selectins mediate transient 
interactions; the different selectins are expressed on different cell types, with E-selectin found on 
endothelial cells such as CHO cells. Selectins are cell surface receptors capable of interacting with 
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carbohydrates found in the form of glycoproteins on the cell surface. Cadherins are responsible for 
so-called stable adhesions junctions, which also involve the cytoskeleton of the cells connected. 
There are different sub-types of cadherins, which differ in their transmembrane and cytosolic 
structures. The most common structure of cadherins is a single-pass transmembrane domain and 
usually cadherins are glycoproteins with around 700-750 amino acids. The cadherin protein family 
shares a conserved extracellular domain, which is responsible for interactions between the same 
types of cells (homophilic actions) and shows a folding structure similar to that of the 
immunoglobulin (Ig) superfamily (Alberts et al., 2002). Membrane proteins can also act as an 
anchoring point for the cytoskeletal proteins and hence help define cell shape (Tan et al., 2008). 
Another group of membrane proteins is the class of transporter proteins, which is divided into 
channel and carrier proteins. Channel proteins are passive transporters that do not interact directly 
with the transported molecule, whereas carrier proteins bind the molecule in question and undergo 
conformational changes during the transport process. Transporter proteins can be found, for 
example, to a large extent in cells lining the intestine where uptake of nutrients occurs. Hence, 
membrane proteins allow cells to fulfil their specific functions in the context of their environment 
(Wu and Yates, 2003).
5.2 Analysis and identification of membrane proteins
To analyse the diverse set of membrane proteins found in mammalian cells, membrane 
proteomics has developed numerous techniques over the last ten years, mainly driven by the 
importance of cell membrane proteins in drug discovery (Wu and Yates, 2003). Proteomic studies 
usually rely on the use of mass spectrometry as the best tool to analyse complex protein samples. 
This approach has been used successfully to address specific questions in small protein sets 
(Aebersold and Mann, 2003). A mass spectrometer measures the mass-to-charge ratio (m/z) of ions 
(Biemann, 1992). Mass spectrometry allows accurate measurements of the mass of a peptide and to 
obtain further information on the peptide, e.g. its amino acid sequence or posttranslational 
modifications. With the help of bioinformatics mass spectrometry enables identification of proteins 
using the data obtained with the mass spectrometer (Aebersold and Mann, 2003). A basic mass 
spectrometer usually consists of an ion source, a mass analyser and a detector. More complex 
systems combine two mass spectrometers allowing tandem MS; in-between the two mass analysers 
a so-called collusion cell allows fragmentation of the peptides; this process is called collusion 
induced dissociation (CID). The identification of peptides using the tandem MS or MS/MS method 
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is possible due the facts that a) the peptide bond breaks in the collusion cell and b) the resulting 
fragmentation follows a general pattern (Kraj and Silberring, 2008). With the help of search 
engines, such as Mascot, together with MS/MS data sets containing parent ion mass, set of resulting 
fragment masses and an idea of the accuracy of those masses an identification of the protein in 
question is possible (Thomas, 2009). As the peptides resulting from the enzymatic digest, which is 
part of the sample preparation, can be calculated for each protein found in the bioinformatics 
databases the theoretical mass of those peptides and their possible fragmentation patterns can also 
be calculated. Hence, by comparing the theoretical data with the data obtained in the experiment an 
identification of the proteins is possible (Bantscheff et al., 2007). 
Due to the membrane protein structure which is determined by the transmembrane domain that 
needs to be hydrophobic to be embedded into the lipid bilayer, the standard proteomic approaches 
based on separation by 2D gel electrophoresis followed by mass spectrometry have failed (Ferro et 
al., 2000; Blonder et al., 2002). Furthermore, membrane proteins have a low abundance compared 
to intracellular proteins and their expression is highly dynamic (Macher and Yen, 2007), making 
their analysis even more difficult; integral membrane proteins are often under-represented in mass 
spectrometry studies of proteins as their large number of post translational modifications, the 
heterogeneity arising from this (Josic and Clifton, 2007) and their amphipathic nature (as they 
contain hydrophobic and hydrophilic regions) make them difficult to study (Wu and Yates, 2003). 
The standard procedure for a mass spectrometry proteomics study includes the following steps: 
protein isolation, SDS gel electrophoresis, enzymatic digest of proteins, high pressure liquid 
chromatography and mass spectrometry, with the last two usually being coupled into one instrument 
(HPLC -MS) (Aebersold and Mann, 2003). The amphipathic nature of the membrane proteins 
renders the classical proteomics approach based on two-dimensional gel electrophoresis useless as 
membrane proteins tend to be insoluble in the buffers used for iso-electric focusing (Santoni et al., 
2000). Using one-dimensional gel electrophoresis brings the problem of increased sample 
complexity and does not solve the problem of insufficient enzyme digest often encountered with the 
membrane-spanning segment of the protein. Different approaches have been used to help the 
analysis of membrane proteins, such as selective stepwise dissolving of lipid membranes and using 
different detergents and salts.  These methods, in addition to one-dimensional gel electrophoresis, 
have been used to reduce the complexity of the samples (Josic and Clifton, 2007). Significant 
advances have been made in non-gel based shot gun methods using liquid chromatography in 
combination with mass spectrometry (LC-MS) (Griffin and Aebersold, 2001). For this method 
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proteins are digested with proteases yielding a complex peptides mixture using a suitable enzyme, 
as for example trypsin, that is then separated by liquid chromatography and directly analysed by 
mass spectrometry.  The liquid chromatography system used most frequently for this kind of 
approach is typically a nano-liquid chromatography system with a reversed phase (RP) column 
(Kraj and Silberring, 2008). One advantage of the shotgun proteomic approach in comparison to 2D 
gel-electrophoresis is that the shotgun approach has a wider dynamic range, making low abundance 
and highly dynamic expressed proteins more detectable with this method. Furthermore the shotgun 
approach allows the use of a wider range of buffer components, such as detergents in the sample 
preparation; nevertheless detergents usually used in the preparation of membrane proteins have to 
be removed for LC-MS analysis (Blonder et al., 2002). The reagents that can be used in the sample 
preparation also depend on the type of instrument used for mass spectrometry; for example the 
different ion sources tolerate different reagents. Solubility of membrane proteins remains a major 
challenge in this approach and a great variety of methods trying to solve this problem can be found 
in the literature (Wu and Yates, 2003). A variety of treatments has been tested, for example, 
detergent containing buffer or buffers based on organic solvents.  Blonder et al. (2002) developed a 
organic solvent based membrane protein preparation for proteomic analysis showing an 
improvement in detection of hydrophobic peptides typical for integral membrane proteins but this 
method was developed for prokaryotes. The method was further developed for mammalian cells 
avoiding the previously necessary high pH fractionating and thermal denaturation, but the protocol 
involves a  lyophilisation step before two step fractionating is followed by mass spectrometric 
analysis (Blonder et al., 2006). An organic solvent based method has also been used to analyse 
integral membrane proteins of chloroplasts (Ferro et al., 2000); a variety of extraction conditions 
were tested to find the optimal condition but the coverage with regards to different parts of 
membranes of the chloroplasts changed with the extraction mixture used. Mirza et al. (2007) 
demonstrated that chloroform based extraction is also possible for epithelial cells; this method also 
involved protein precipitation and ultracentrifugation. Not all of those methods are compatible with 
a subsequent quantification of the proteins but all have been shown to improve identification of 
plasma membrane proteins (Wu and Yates, 2003; Josic and Clifton, 2007). 
Another approach to enhance identification of membrane proteins has been to remove the 
required detergent such as SDS before downstream analysis as shown by Wiśniewski et al. (2009) 
who used 8 molar urea together with size exclusion chromatography to deplete SDS combining this 
with the enzymatic digest on a filter; this method is called FASP for filter aided sample preparation.
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Furthermore, biochemical enrichment has proved to be an option for improved mass 
spectrometry based analysis of membrane proteins (Wu and Yates, 2003). For example, cationic 
silica micro-beads have been used to label and isolate proteins found in the apical membrane region 
of adherent epithelial cells (Josic and Clifton, 2007) but this method would not be useful for 
suspension cells.  Another method that has been used in membrane proteomic analysis is cell 
surface biotinylation. Peirce et al. (2004) used this method to investigate differential membrane 
protein expression on lymphocytes. Biochemical enrichment based on protein biotinylation has 
been successfully used for other quantitative mass spectrometry approaches (Elia, 2008) as for 
example by Berro et al. (2007) for comparative proteomic analysis of T cells, which are also 
suspension cells, which makes cell surface biotinylation an attractive option for this project. In the 
study by Berro et al. (2007) the proteomics analysis was followed up by analysis of the identified 
proteins with flow cytometry and western blotting. Flow cytometry and western blotting has also 
been used by Peirce et al. (2004) for conformation of results. 
The enrichment of biotinylated proteins is based on the strong affinity of biotin to avidin and 
streptavidin which can be used for affinity chromatography. A number of membrane protein studies 
are based on biotin derivatives such as N-hydroxysuccinimide (NHS) biotin; the reactive ester 
group of NHS reacts as the functional group in a nucleophilic substitution reaction with primary 
amines, such as found in lysine, and hence allows covalent binding of the biotin to the proteins that 
are to be enriched. In addition, lysine residues are numerous in proteins and their modification 
usually has non-detrimental effect on the protein function (Elia, 2008). Care has to be taken to avoid 
uptake of the chosen biotin derivative by the cells when preparing samples for membrane 
proteomics to avoid contamination of the samples with cytosolic proteins (Gauthier et al., 2004).  
Five different proteomic studies that are based on membrane biotinylation followed by 
enrichment were compared and used to develop a methodology for this study (see also chapter 3.15 
Biotinylation of cells). Zhao et al. (2004) analysed adherent cells which were biotinylated with 
sulfo-NHS-S-S-biotin, a biotin cleavable due to its disulfide group (structure is shown in figure 
10.1). Enrichment was based on a magnetic system and included harsh washes with high salt and 
high pH buffers. None of the agarose based enrichment steps in other studies included such a 
combination of washing steps. DDT, which reduces disulfide bonds, was used to elute biotinylated 
proteins from the streptavidin beads. After elution a precipitation step was added to reach higher 
protein concentrations. Zhang et al. (2003) used a similar approach of biotinylation and enrichment 
but give no details of elution conditions. The study demonstrated enhanced results for mass 
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spectrometry analysis of the plasma membrane proteins due to an decrease of contamination of the 
enriched protein fraction with proteins from cell organelles. Zhang et al. (2003) stress in their paper 
that sulfo-NHS-SS-biotin cannot cross the membrane. Peirce et al. (2004) also used biotinylation 
followed by  non-magnetic enrichment to compare stimulated against non-stimulated cell samples. 
The sample preparation was monitored using confocal microscopy and western blotting; the use of 
the biotin label for this purpose was also noted in some of the other studies. Peirce et al. (2004) 
demonstrated that labelling with water-soluble sulfo-NHS-SS-biotin was not completely restricted 
to the cell surface but also included some small sub-cellular structures, in contrast to another biotin 
derivative that gave significant intracellular signals. To enhance the quality of the enriched 
membrane fraction a pre-enrichment centrifugation step was included. The affinity enrichment used 
streptavidin agarose beads. The overall study used a very complex sample preparation, including 
two-dimensional gel electrophoresis based on a non standard isoelectric focusing approach, which 
does not lend itself to be used in conjunction with quantification strategies on the mass 
spectrometry level: the actual quantification was performed by gel staining. Another study by Yu et 
al. (2006) based on biotinylation compared cleavable and non-cleavable biotin. This included a pre-
enrichment step by centrifugation before the affinity chromatography step based on avidin agarose 
beads. For the cleavable biotin, elution from the agarose beads included DTT. Protein identification 
was achieved by reversed phase liquid chromatography coupled to a mass spectrometer, as with the 
studies mentioned before. It was noted that with this approach not only integral membrane proteins 
but also GPI linked proteins will be labelled. The results of the LC-MS  identification were cross-
checked with immuno-fluorescence microscopy for four proteins. Sostaric et al. (2006) used tissue 
as a starting material; cells from the tissue were cultured for a defined period. Adherent cultures 
were biotinylated using a non-cleavable biotin. After biotinylation viability of the cells was 
checked.  In this study, as is in several of the studies mentioned earlier, IgePal CA630 (NP-40) was 
used in the lysis buffer as a detergent to increase solubility of the hydrophobic membrane proteins. 
Enrichment was based on an avidin resin and followed by different approaches for mass 
spectrometry analysis: one route used two-dimensional gel electrophoresis, the other one-
dimensional gel electrophoresis. The latter allowed identification of a larger number of proteins. 
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5.3    Biotinylation of cell lines and subsequent analysis by flow 
cytometry
The protocol for biotinylation was developed based on the above studies and the successful 
biotinylation of the different cell lines was controlled by staining the cells with Streptavidin FITC. 
Another factor controlled during the protocol development was cell viability by measuring the cells 
after biotinylation on the ViCellXR cell viability analyser. The developed biotinylation approach  
showed successful biotinylation of more than 95% of the cells in one sample, independent of the 
cell line, while keeping the viability above 90%. As a next step the Streptavidin FITC  staining was 
used to compare the amount of biotin bound to the surface of the different cell lines . 
5.3.1 Methodology: Streptavidin staining of biotinylated cells
Cells were stained for flow cytometry using 5 x 106 cells in 50 μl PBS / 2 mM EDTA / 0.5 %BSA 
buffer. Staining was performed using Streptavidin FITC at a titer of 1 to 25, incubation time was 10 
minutes at 4°C. Cells were washed twice with PBS, fixed with 125 μl 4% PFA (15 minutes at 4°C) 
and re-suspended in PBS. Storage was for a maximum of 24 hours  in 1ml of PBS/2mM 
EDTA/0.5%BSA. Analysis of the cells was undertaken on a FacsCalibur. 
5.3.2 Biotinylated cells analysed with flow cytometry: differences in 
staining intensity
The results of staining after biotinylation with the final biotinylation protocol (described in 
chapter 3.15  Biotinylation of cells) of the different cell lines allow a comparison  of the surfaces of 
the different cell lines. Differences in the staining intensities, measured as median fluorescence 
intensities (MFI), indicate differences in the amount of biotin bound to the cell surface; this can also 
be described as different levels of biotinylation reached due to differences in the cell surface protein 
complement available for biotinylation. To avoid influence by instrumentation set-up, the shift in 
median fluorescence intensity has been calculated between unstained and stained biotinylated cells. 
The resulting change in median fluorescence intensity (Δ MFI) can be compared; a smaller Δ MFI 
indicates that less biotin has bound to the cell surface, which can be due to: 
• a lower amount of protein expressed on the cell surface, 
• a different subset of proteins expressed on the cell surface or
• a different accessibility of the proteins to biotinylation. 
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All of these indicate differences in the cell surface proteome.
As can be seen seen in figure 5.1 the percentage of cells that become labelled with the biotin is 
very similar when the different cell lines are compared. The ΔMFI  values clearly indicate (see also 
table 5.1) that there is a difference between the four model cell lines chosen for this study with 
respect to their cell surface.
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MFI FL1: 1.62 MFI FL1: 1.69 MFI FL1: 573 
Fig. 5.1: Differences in biotinylation levels of the different cell lines analysed by flow 
cytometry.  
Cell lines were grown in their standard growth conditions before biotinylation. Control sam-
ples with non-biotinylated cells were stained to check for unspecific staining of the fluoro-
chrome. Unstained biotinylated cells were used for instrument set-up. MFI (median fluores-
cence intensity) FL1 gives the median for the y-axis calculated for the cells in the FL1 re-
gion. A forward/ side scatter gate (not shown) was used. 
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Table 5.1 ΔMFI values for CHO cell lines calculated using the results shown in figure  5.1. 
The arrow indicates the increase of biotinylation levels reached. 
Cell line Δ MFI
CCL61 331.5
AML cells 571.3
CHO-S 1635.2
 S cells 1643.7
5.3.3 Discussion of biotinylation – staining results
The difference in biotinylation levels between the four cell lines is nearly a factor of 5, 
comparing CCL61 with S cells. The two cell lines AML cells and CCL61, which were grown in 
adherent conditions for this set-up, show a low biotinylation level compared to the two cell lines 
CHO-S and S cells grown in suspension. This might indicate that more proteins are expressed on 
the surface of suspension cells. But the difference in biotinylation levels could also be due to the 
cell surface proteins of the adherent cell lines being less accessible for biotinylation; this could be 
due to binding of fibronectin and other serum components to the cell surface proteins as this could 
reduce the number of lysine residues available for biotinylation due to a shielding effect of the 
extracellular matrix proteins.
5.4 Comparison of different lysis and enrichment strategies 
After the biotinylation protocol was shown to be stable a larger number of cells was labelled and 
lysed. Initially the adherent and the suspension cells were lysed differently; lysing the adherent cells 
directly on the T75 flasks was performed to avoid treating the cells with an additional buffer. Lysed 
S cells and CCL61 were then used to establish an enrichment strategy based on the articles 
discussed above. For economic reasons an agarose resin based approach was used and due to 
availability no ultra-centrifugation step was included. The result of the affinity chromatography 
enrichment was controlled with SDS gel electrophoresis stained with Coomassie Blue (pre-made 
solution and protocol from suppliers Pierce or Invitrogen, depending on the gel system used) as this 
is the next step forward prior to mass spectrometry analysis. 
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5.4.1 Methodology: lysis of cells
Lysis of adherent and suspension cells was done differently for the first enrichment experiments: 
suspension cells were treated as described in chapter 3.16 Lysis of cells. For adherent cells 1ml lysis 
buffer was added to a T75 flask after biotinylation and incubated for approximately 5 minutes on a 
shaking platform. Using vigorous pipetting the solution was then transferred into a vial and 
sonicated.  The resulting cell solution was centrifuged at 22,000 g for 20 minutes at 4°C and the 
resulting supernatant stored at -20°C.
Due to difficulties reaching comparable protein enrichment results with the CCL61 cells (see 
figure 5.3) the lysis protocol was changed and adherent cells were harvested after biotinylation 
using 1 ml PBS/2mM ETDA per T75 flask, incubating at 37°C for 5 minutes. The resulting cell 
solution was spun down, re-suspended in PBS and lysed as described for suspension cells. This 
change allowed better control of the cell count during lysis of the adherent cells; for lysis on the 
flask, cell count was determined by harvesting and counting an additional flask that had been 
biotinylated as well.
5.4.2 Methodology: Streptavidin affinity chromatography
The initially established enrichment protocol used was as follows: 2 ml centrifugation columns 
(Pierce) were filled with 500 µl PBS to clear out air bubbles. 1 ml agarose resin was applied and 
washed two times with 1 ml PBS (gravity flow). This was followed by sample application. In the 
first washing step 3 ml lysis buffer without protease inhibitors (1% detergent) were applied on top 
of the columns; wash step two used 3 ml 500 mM KCl (Sigma Aldrich) + 1% detergent and wash 
step three was a repeat of wash step one. To prepare the column for elution 3 ml 100 mM TRIS 
(pH7.6) with 2% SDS was applied. Elution was performed stepwise by applying 500 µl 100 mM 
TRIS (pH7.6), 4%SDS and 100 mM DTT, warmed up to to 37°C, onto the column which was 
closed with a stopper. After incubation for 10 minutes at 37°C the column was opened to let the 
elution buffer run through. This step was repeated and the resulting elution fractions were pooled. 
This pool, containing the enriched plasma membrane protein fraction, was acetone precipitated by 
adding 4 times the volume of acetone, cooled down to -20°C,   followed by overnight storage at 
-20°C. After centrifugation of the acetone protein mix at 16,000 g for 10 minutes at 4°C the protein 
pellet was air dried and dissolved in 100 µl elution buffer.
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Figure 5.2: Enrichment of plasma membrane proteins from CCL61 and S cells. 
1 x 108 biotinylated and lysed cells of each cell line were pooled and used in the Streptavi-
din affinity chromatography enrichment. Gel analysis of the resulting fractions was done 
by SDS PAGE using a 8-16% tris-glycine gel (150V for 40 minutes) and the Coomassie 
solution recommended by the gel supplier (Pierce). The flow through fractions (1/10 of 
the volume, equal to 1 x 107 cells) of the sample application onto the agarose resin were 
also run on the gel. From the elution fractions one quarter (enriched protein from 2.5 x 107 
cells) were analysed. Proteins can be seen in the elution fraction.  
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5.4.3 Results of enrichment by Streptavidin affinity chromatography
A side-by-side comparison of CCL61 and S cells was performed based on the described 
protocol,with the adherent cells lysed on the T75 flasks. From figure 5.2 one can learn that similar 
amounts of proteins were detected in the first flow-through fraction; further wash fractions were not 
analysed as they were too diluted to give a signal. Proteins were detected in the elution fraction;  for 
the CCL61 the amount of protein yielded by this enrichment was lower compared to the S cells.
This result correlates with the results from the biotinylation, where higher biotinylation levels 
were reached for the S cells compared to the CCL61. To check if the proposed protocol has actually 
worked and plasma membrane proteins had been enriched, the samples were used for an MS 
analysis. The enrichment protocol did not yield a well defined banding pattern in the gel, which is 
assumed to be due to the high detergent and SDS concentration in the samples as the protein pellet 
had been dissolved in the elution buffer after precipitation, but the blurred protein staining might 
also indicate degraded proteins due to proteolysis; also there were technical problems due to 
laboratory rearrangements with the imaging system. As the results from the mass spectrometric 
analysis were not satisfactory ( see chapter 5.5) the enrichment step was modified to the one 
described in chapter 3.17 Cell surface protein enrichment with affinity chromatography; the 
modification avoids the precipitation step and at the same time the samples were eluted in the 
correct SDS sample buffer for gel analysis; furthermore, protein-inhibitors were added to the 
washing steps to counter proteolysis taking place during the enrichment.
Using the same biotinylation as before, the new enrichment strategy was tested on CCL61 and  
on S cells in standard (suspension) and in reversed (adherent) conditions. This was done as the 
previous  enrichment showed a difference in the amount of proteins eluted for adherent and 
suspension cells.
For this enrichment adherent cells were again lysed on the flask. This enrichment method proved 
successful (see figure 5.3) even with fewer cells in the start sample. The fact that lower amounts of 
cells (less than 1/3) yielded an easily visible signal on the gel indicates that the previous protocol 
was not optimised with regard to elution efficiency or that extensive proteolysis had taken place 
during enrichment.
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Figure 5.3: Enrichment of plasma membrane proteins from CCL61 in standard 
and S cells in standard and reversed conditions. 
3 x 107 biotinylated and lysed cells of each cell line were used in the Streptavidin affinity 
chromatography based on the improved protocol. Gel analysis of the resulting elution frac-
tions (1/16 of the elution fraction, equivalent to 1.8 x 106 cells) was done using a 4-12% 
Bis TRIS gel with MOPS running buffer (Invitrogen) under reducing conditions and 
stained using the Coomassie solution recommended by the gel supplier. In all three elution 
fractions proteins can be observed. Differences seen in the protein bands between the 
CCL61 adherent and S cells adherent, indicating a loss of protein expression in either of 
those cell lines, have been marked by arrows. 
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  The latter assumption is supported by the observation that the protein bands are much clearer in 
figure 5.3 and it is possible to determine differences in the protein bands of the enriched membrane 
protein fraction between the CCL61 and the S cells, for example around 260 kDa and around 50 
kDa.  Although the lane for the S cells grown in suspension is somewhat overloaded, it is possible 
to say that the bands seen for adherent S cells (and not for CCL61) are also visible for suspension S 
cells. Again, even more clearly than before, the elution fraction of the suspension cells contains 
more protein than the elution fractions from the adherently grown cells. This might be due to the 
fact that the number of suspension cells was determined differently to the number of adherent cells, 
which was only be determined by an approximate method. Hence, as described in chapter 5.3.1  a 
new approach with regard to lysis of adherent cells was chosen. In addition, all four cell lines were 
now subject to analysis using the final protocol for biotinylation, lysis and affinity chromatography 
enrichment. Figure 5.4 shows that enrichment of proteins was successful for all four cell lines using 
the described method. There is a difference between the protein bands seen in total lysate and 
elution fraction, indicating a shift in protein composition within the sample. This indicates that 
some proteins, e.g. non-biotinylated non-membrane proteins, have been successfully removed from 
the enriched fraction, as would be expected. Furthermore, the eluted protein fraction shows large 
differences between the four cell lines; this is in line with the assumption that the four cell lines 
have a different membrane protein complement and the fact that the membrane protein complement 
is supposed to make up most of the proteins in the eluted fraction.
 -67-
Analysing the surface of suspension growth adapted CHO cells                                                          
 -68-
260 
160 
110 
80 
60 
50 
40 
30 
20 
15 
260 
160 
110 
80 
60 
50 
40 
30 
20 
15 
S cells 
 tl ef 
CHO-S 
 tl    ef 
AML 
tl    ef 
CCL61 
tl    ef 
 
  S cells 
suspension 
A) 
B) 
  CHO-S 
suspension 
  AML  
adherent 
CCL61 
adherent 
Figure 5.4: Enrichment of plasma membrane proteins from CCL61, S cells, AML 
cells  and CHO-S. 
Culture conditions: standard conditions. 3 x 107 biotinylated  and lysed cells of each cell line 
were pooled, fractionated with Streptavidin affinity chromatography based on the new lysis 
& the improved enrichment protocol. Gel analysis of the resulting fractions was done using a 
4-12% Bis TRIS gel. A) shows total lysate (tl, 1.5 x 104 cells) and 1/16 of the elution fraction 
(ef). Rectangles indicate differences in bands between tl and ef. B) only shows elution frac-
tion. Arrows in B) denote differences in bands in comparison to S cells. 
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5.5 Mass spectrometry analysis
The enriched protein fractions shown in figure 5.2 (Enrichment of plasma membrane proteins 
from CCL61 and S cells) were subjected to a mass spectrometry analysis to allow a verification of 
the successful enrichment of cell surface membrane proteins with the established method. A gel 
digest was performed as part of the sample preparation as described in chapter 5.4.1, followed by a 
mass spectrometry run and data analysis (described in chapter 5.4.2).
5.5.1 In-gel digest of Coomassie stained proteins
Each lane from an elution fraction was cut into small pieces, resulting in  9 pieces (halved again 
for treatment) over the entire gel length of a 4-20% SDS page gel, and transferred into 1 ml tubes 
(protein low binding tubes). 500 µl de-staining solution, made of 200 mM ammonium bicarbonate 
with 40% acetonitrile, were added to each piece and the tubes were incubated for 30 minutes at 
37°C, followed by a wash step with 200 µl  acetonitrile (HPLC grade, Fisher Scientific). Both times 
the supernatant was carefully discarded. A trypsin stock solution was made up from 20 µg trypsin 
(Sigma Aldrich) in 100 µl  0.1 mM HCl. To each gel piece 50 µl of 500 mM ammonium 
bicarbonate with 10% acetonitrile containing 0.2 µg trypsin from the stock solution  were added. 
The trypsin digest was performed at 37°C overnight in a shaking incubator. The resulting 
supernatant containing the digested proteins was transferred into fresh tubes. 200 µl acetonitrile 
were added and the gel pieces were again incubated at 37°C for 10 minutes. The resulting 
supernatant was pooled with the one gained before. Samples were dried in a vacuum concentrator 
5301 (Eppendorf, UK) overnight and re-suspended in buffer containing 3% acteonitrile and 0.1% 
formic acid.  As polymer contaminations were found in a trial mass spectrometry run, dried peptide 
samples were re-suspended in 20% acteonitrile and 0.1% formic acid (pH below 3) and cleaned 
using an in-house strong cation exchange protocol based on filter tips with porous beads resin. 
Samples were eluted in 20% acetonitrile, 500 mM KCl with 0.1% formic acid and dried again. 
5.5.2 Mass spectrometry analysis
 The tryptic peptides  were reconstituted in 5 µl 3% acetonitrile with 0.1% trifluoroacetic acid 
and analysed using an UltiMate 3000 capillary liquid chromatography system (Dionex, Camberley, 
UK) coupled to an HCT Ultra ion-trap mass spectrometer (Discovery System,  Bruker Daltonics, 
Coventry, UK). The peptides were injected onto a 5mm x 300 µm PepMap C reverse-phase trapping 
column (Dionex) in sample solvent at 30 µL/min, then separated on a 150mm x 300 µm  Atlantis 
 -69-
Analysing the surface of suspension growth adapted CHO cells                                                          
C18 analytical column (Waters, Elstree, UK) at a flow rate of 3 µL/min. Elution was performed 
with a linear gradient using buffer A (3% acetonitrile and 0.1% formic acid) and buffer B (97% 
acetonitrile and 0.1% formic acid), starting with 3% buffer A up to 40% buffer B over 40 minutes. 
Data acquisition was set in the positive ion mode with a mass range of 300 – 2000 m/z. Automatic 
dependent tandem mass spectrometry was performed on peptides with +2, +3, and +4 charge states 
by collisionally-induced dissociation.
The resulting mass spectra from the peptides and the peptide fragmentations were submitted to 
Mascot Daemon v.2.1.3 running with Mascot Server v.2.2.01 (Matrix Science, London, UK) to 
conduct a search to identify the proteins present in the samples. The mgf files from the subsequent 
runs were merged for this search. At the time of analysis the genome of the Chinese hamster had not 
been sequenced (Baycin-Hizal et al., 2012), hence the Mascot Daemon search was performed using 
the protein database for rodents (Hayduk et al., 2004) provided by SwissProt (8 and 9 of February 
2011).  At the same time an automatic decoy database search was performed within MASCOT. 
Search parameters were set at a mass tolerance of 0.8 Da for both MS and MS/MS data, one missed 
cleavage of trypsin, oxidation of methionine. The resulting list of protein accession numbers was 
then used in the Uniprot database to search for proteins annotated with 'membrane' as sub-cellular 
location.
5.5.3 Mass spectrometry results
For the CCL61 cell line the total number of proteins identified was 119, with 34 being classed 
within the Uniprot database as membrane proteins. Hence, 29% of the proteins identified for 
CCL61 where either membrane proteins or associated with the plasma membrane. For the S cells 
the total number of proteins identified was 1216, with 390 being classed in Uniprot as membrane 
proteins. This means that 32% of the  proteins identified for S cells were membrane proteins. The 
false discovery rate above the homology threshold and the identity threshold respectively (based on 
the decoy database search) were 13.5% /  6.9% for the samples from CCL61 and 9.63% / 4.62%  for 
the samples from S cells, which indicates that the amount of sample was insufficient for both mass 
spectrometer runs (Mirza et al., 2007). A list of the identified membrane proteins is included in 
chapter 10.1 Mass spectrometry: protein identification results. Unexpectedly, for the CCL61 cells 
no integrins, cadherins and growth factor receptors were identified; this is also in contrast to 
previous results by Ahram et al. (2005) who analysed the shedded proteome of adherent CHO cells 
and identified  a few integrins such as integrin alpha 11; this again indicates that the chosen sample 
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preparation is not suitable for the adherent CHO cells. In contrast to this, for the S cells two 
unexpected groups of membrane proteins were identified, inter-cellular adhesion molecules such as 
several cadherins, e.g. otocadherin and protocadherin, and nine different integrins including integrin 
alpha 4, integrin alpha 3, integrin alpha 5 and integrin beta 1. Other proteins involved in adhesion, 
such as CD166 and neural cell adhesion molecule 2, have been found, in addition also receptors for 
growth factor, including those for insulin, were identified. The later is in line with the fact that the 
PSM media contains insulin. Several channel proteins, for example members of the potassium 
voltage gated channel proteins and the sodium channel proteins, have been found; this can be seen 
as a clear indication that the analysed protein fraction was enriched for plasma membrane proteins 
as those proteins are integral membrane proteins. However, also signalling related molecules such 
as Focal adhesion kinase 1, a protein related to integrin signalling, has been identified in the S cells. 
Later re-analysis of the mass spectrometry data generated for the S cells using a CHO proteome 
database confirmed the expression of integrin beta 1 and CD166 on the S cells. 
Due to the use of the rodents database, proteins have been identified twice in some cases, usually 
based on the proteins listed for Mus musculus and Rattus norvegicus. For CCL61 one membrane 
proteins was identified twice and for S cells 52 membrane proteins were identified twice; 
nevertheless, the use of the rodent data base yielded a better protein identification than using only 
the mouse database, as can be seen from the tables presented.  The percentage of identified 
membrane proteins, which for both sample preparations is around 30% of the total proteins 
identified,  can be seen as an indication that the enrichment for membrane proteins has been equally 
successful for both cell lines. Unfortunately, the number of total proteins identified differs largely 
between the suspension and adherent cell line, which is probably due to the lower protein content in 
the elution fraction of the adherent CCL61 cells. To overcome these problems, changes in the 
method  were tried (no precipitation step, different cell lysis for adherent cells) but the difference 
between suspension and adherent cell lines with respect to total protein content in elution fraction 
could not be minimised,  as can be seen in figure 5.4 where for the CCL61 cells small proteins are 
not visible, indicating that the amount is below the detection limit of the Coomassie staining.
5.6 Discussion – biochemical and mass spectrometry analysis
A successful enrichment protocol was established based on biotinylation of cell membrane 
proteins, followed by affinity chromatography enrichment. Biotinylation of cells and subsequent 
flow cytometric analysis revealed that the four cell lines differ with respect to their cell surface 
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proteome. This confirmed that the choice of the model cell lines for this study should allow analysis 
of differences in the cell surface proteome of suspension and adherent CHO cell lines. The variation 
in biotinylation, as seen by analysing the fluorescent staining intensities, can either be due to a 
difference in the amount of cell surface proteins, with the suspension CHO cells expressing more 
cell surface proteins compared to the adherent CHO cell lines, or due to sterical hindrance of 
biotinylation of cell surface proteins on the adherent cell lines. The latter could either be due to a 
different protein set being expressed that might be less accessible to biotinylation or due to binding 
of extracellular matrix proteins to the cell surface proteins. The binding of extracellular matrix 
proteins may have a shielding effect on the cell surface proteins or itself bind large amounts of 
biotin which is then not available for cell surface protein biotinylation. The latter had been taken 
into account in the biotinylation protocol by keeping the biotin concentration constant compared to 
the set-up for suspension cells while using a higher total amount of biotin, and washing steps before 
the biotinylation should have ensured depletion of serum proteins. In line with the flow cytometry 
results the enrichment for the suspension cells also yielded a higher protein content in the enriched 
protein fraction, independent of the method used for enrichment and cell lysis.  The low protein 
yield after the enrichment for the adherent cells might be the reason for the lower success in protein 
identification with mass spectrometry analysis for the adherent cell line CCL61. 
It was originally planned to use a quantitative mass spectrometry approach  based on SILAC 
labelling (stable isotope labelling by amino acids in cell culture) to analyse the differences between 
the cell surface protein complement of the four different cell lines; however, the difference in 
enrichment efficiency yielding less sufficient proteome coverage for the adherent cells made it 
improbable that a quantitative comparison would be achievable. Also, the high number of sample 
preparation steps necessary to prepare samples for the mass spectrometry induced the risk of 
introducing bias into the quantification; this might also be another reason for the lower quality data 
gained for the CCL61 cell line. Due to these problems the mass spectrometry approach was not 
followed further. Instead, a more detailed analysis of the groups of proteins on S cells, as identified 
by mass spectrometry such as cell to cell adhesion proteins and extracellular matrix adhesion 
proteins, using flow cytometry was proposed to yield insight into the differences between the cell 
surfaces of suspension and adherent CHO cell lines.
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6.   Chapter 
Cell-to-cell adhesion and related molecules 
In this chapter the role cell-to-cell adhesion molecules might play in adaptation of adherent cells 
to successful suspension growth is briefly analysed. Furthermore, flow cytometry as a method to 
analyse cell surface protein expression is explained. Antibodies against those cell-to-cell antigens 
tested on CCL61 and S cells in this study are listed and results of flow cytometry staining of these 
antibodies that showed staining of CHO cells are given. 
6.1 Cell-to-cell adhesion molecules and their role in suspension 
adaptation
Transition to suspension from adherent growth can be compared to the development of a 
phenotype similar to the one found in metastatic cancer cells. Metastatic cells loose contact with the 
original tumour and are capable of moving within the body using the blood and lymph system, 
which will lead to metastatic cancer development (Yilmaz and Christofoir, 2010). This process has 
been described to include up- and down-regulation of molecules involved in cell-to-cell 
interactions, as loss of cell-to-cell contact plays a major role in this process (Yilmaz and Christofoir, 
2010). The major group of adhesion molecules in adherent junctions between cells as found in 
tissue are cadherins, including N-cadherin and E-cadherin (Niessen and Gumbier, 2002). E-cadherin 
has been shown to be involved in signalling process in anoikis (Geng et al., 2012). These so called 
classic cadherins are homophilic adhesion molecules that are characterised by five extra-cellular 
protein domain repeats and linked via their cytoplasmic tail to the cytoskeleton of the cells (Yagi 
and Takeichi, 2000; Yap et al., 2007). Some cadherins have been identified in this study, using mass 
spectrometry analysis, to be expressed on the cell surface of suspension adapted CHO cells (see 
chapter 5.4). Other molecules that show a change in expression level on metastatic tumour cells 
compared to healthy cells include tetraspanins such as CD81, CD44 and neural cell adhesion 
molecule (NCAM).
Tetraspanins have been associated with the polarisation of epithelial cells and are thought to 
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interact with integrins and cadherins to allow up-keep of cell polarisation (Yanez-Mo et al., 2000). 
CD44 is the receptor for hyaluran, a component of the extra-cellular matrix in tissue, playing a role 
in cell-to-cell and cell-matrix interaction (Thorne et al., 2004); CD44 has also been shown to be 
relevant to cell morphology (Shi et al., 2001). As well as being expressed on neural cells, NCAM 
has also been found on a variety of tissues and cells, including a subgroup of lymphocytes, the 
natural killer cells (Carter et al., 1999) and has been shown to be involved in cell motility (Prag et 
al., 2002).
6.2 Flow cytometry as a tool: protein expression level on the cell 
surface 
The expression level of proteins on the cell surface can be analysed by antibodies conjugated to 
fluorochromes. As antibodies recognise specific protein antigens, fluorochrome labelled antibodies 
allow 'tagging' of proteins. These labels can then be used in flow cytometry, where single cell 
solutions flow through a flow cell and are exposed to a laser light, which leads to excitation of the 
fluorochromes bound to the antibodies (Nolan and Yang, 2007).  With the help of flow cytometry it 
is therefore possible to analyse a population of cells with regard to their antigen and protein 
expression (Ritchie et al., 2000). Depending on the staining conditions used, either cell surface 
proteins are stained with the antibody or intracellular antigens can be labelled; the latter require a 
permeabilisation step to allow the antibody to enter the cell (Knowles and McCulloch, 1992). In 
flow cytometry analysis the percentage of cells which express the antigen in question can be 
calculated in relation to the total population measured in one sample (Herzenberger et al., 2006). 
Furthermore it is possible to analyse the 'brightness' of the stained population. In flow cytometry, 
'brightness' is given as fluorescence intensity, usually measured on a logarithmic scale 
(Herzenberger et al., 2006).  As fluorochromes are bound to the antigen recognising antibodies, 
fluorescence intensity is also a measure of the amount of antibody bound to the cell and therefore of 
the actual expression level of the antigen on the cell surface. This has been used to develop assays 
measuring absolute units of molecules per cell (Nolan and Yang, 2007) or antibody molecules 
bound per cell (Arun et al., 2010).
Flow cytometric analysis is usually done using specialised software; in this study FlowJo version 
7.6.5 (Treestar Inc., Ashland, USA) was used. Figure 6.1 shows a successful staining result. An 
example of a flow cytometric analysis showing the analysis methods used in this study  is given. 
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Figure 6.1: Example of flow cytometry analysis and explanation of terms used 
A typical result for an antibody staining with a direct fluorochrome conjugate for a surface 
marker is shown. This sample shows a bi-modal staining distribution as can clearly be seen 
in the histogram. The most important terms used in the flow cytometry part of this study 
are explained. 
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In addition, the major terms used in this study with respect to flow cytometric analysis are 
explained.
6.3 Antibodies for flow cytometry analysis of CHO cells
Flow cytometry antibody conjugates are usually available for use on human, mouse or rat cells, 
as the main application for flow cytometry is in the area of immunology. For this study antibodies 
against human and mouse cells from different suppliers were tested for reaction of the antibody on 
CHO cells. The use of antibodies based on their cross-reactivity (antibody binding to proteins other 
than that of the original species) is possible due to the homology known to exist between proteins of 
different species (Ahram et al., 2005). 
The following antibody fluorochrome conjugates recognising cell-to-cell adhesion proteins were 
tested: 
• anti mouse CD81 PE, clone Eat2, BD Biosciences, 
• anti mouse CD44 FITC, clone IM7, BD Biosciences, 
• anti human E cadherin antibody, polyclonal Goat IgG, R&D systems (Minneapolis, USA), 
• anti mouse CD 62l FITC, clone  MEL-14-H2.100, Miltenyi Biotec, 
• anti human CD324 APC (E-cadherin), clone 67A4,  Miltenyi Biotec,
• anti human CD44 FITC, clone DB105, Miltenyi Biotec 
• anti human CD56 APC (NCAM), clone  AF12-7H3,  Miltenyi Biotec
Only the last three antibodies (bold) gave a visible shift in the staining intensities between 
unstained and stained cells, for both cell lines, S-cells and CCL61. 
For CD44 and E-cadherin so-called isotype controls (ITC) were available. Those are antibodies 
of the same isotype labelled with the same fluorochrome and supplied at the same concentration as 
the corresponding antibody, however, the isotype antibody will not react with any cell type. Isotype 
controls can hence be used to identify if the antigen specific antibody has been bound non-
specifically, e.g. by binding of the Fc region of the antibody to the cell, as the isotype control would 
be bound as well and hence give a similar signal with regard to staining intensities. As can be seen 
in figure 6.2 the CD44 and the E-cadherin (CD324) antibodies recognise a specific antigen on the 
cell surface of the S cells, as the staining with the specific antibody is brighter than for the isotype 
control. Unfortunately, for the CD56 clone an isotype control was not available. 
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Figure 6.2: Isotype control staining for CD44 FITC and E-cadherin APC 
Histograms show one set of results from staining fixed S cells. Overlays compare unstained 
(light grey), isotype control staining (ITC, mid grey, dashed) and antigen specific staining 
(dark grey, dotted). For CD44 FITC a positive and a negative population can bee seen (bi-
modal distribution), whereas for E-cadherin APC only one population exists. Median fluo-
rescence intensities have been calculated using the markers given. Data is based on a for-
ward/side scatter gate (not shown). Standard deviation was calculated from three samples 
for isotype control and specific antibody. 
Median fluorescence intensity 
FL1 pos FL1 neg 
ITC 6.05 ± 0.04 2.51 ± 0.13 
specific 10.63 ± 1.13 2.18 ± 0.02 
Median fluorescence intensity 
staining 
ITC 1.95 ± 0.06 
specific 2.95 ± 0.11 
CD44 
E-cadherin 
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As the antibody also revealed a positive and a negative population when used for staining S cells 
it was assumed that the CD56 antibody staining is also specific on the CHO cell lines.
6.4 Comparison of CD44, NCAM and E-cadherin expression on S cells 
and CCL61
While testing the antibodies for suitability of detection of cell-to-cell adhesion molecules it 
became obvious that in some cases variation of the results in the staining between different passages 
of suspension adapted CHO cells were relatively large. Hence, a comparison of the expression level 
between two passages of CCL61 and S cells was performed with the passage comparison for S cells 
being repeated due to the large variation seen in the first set of results. 
In figure 6.3 the results of the comparison for the CCL61 cell line is shown. CD44 and CD56 
show a single stained population in each passage, whereas a bimodal staining distribution with a 
brighter population with a size of below 50% of the total popluation is seen for E-cadherin. For 
CD44 the median fluorescence intensities (MFI) are quite stable, whereas a larger variation between 
the MFI of the two passages is seen for CD56 and E-cadherin. Overall, from these results it is 
concluded that the expression level of the three adhesion molecules on CCL61 cells only differs 
slightly between passages.
In figure 6.4 the results of the comparison of passages on S cells is shown. In the first 
comparison (left column) for the S cells a large variation was seen for the MFI, together with a 
bimodal distribution where the brighter population showed a significant difference in size between 
passages for all three adhesion molecules tested. When this experiment was repeated with a 
different set of passages the variation in the distribution pattern and MFI were even larger for CD56 
and CD44. For both adhesion molecules the bimodal distribution was only visible in one of the 
passages tested. E-cadherin did not show a bimodal distribution in the two passages tested in the 
repeat experiment and only a small variation with regard to MFI. It was hence concluded that the 
expression level of CD44, CD56 and E-cadherin varies to a great extent on S cells over the course 
of culture.
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Figure 6.3: Variation in expression level of CD44, CD56 and E-cadherin on the cell 
surface of CCL61 
Two different passages were stained on the same day. Light grey lines in histograms show 
unstained samples, dark grey lines (dotted or solid) stained samples. Histograms show sin-
gle samples, representative of triplicates (unstained: duplicates) measured. Average of fluo-
rescence intensities of the population (FSC gate not shown) including standard deviation are 
given for each cell surface marker. Arrows denote bimodal distribution pattern.   
MFI 
Solid dark grey line: 2.68 ± 0.06 
Dotted dark grey line: 2.69 ± 0.09 
 
Median fluorescence intensity 
(MFI) 
Solid dark grey line: 7.32 ± 1.16 
Dotted dark grey line: 6.31 ± 0.43 
MFI 
Solid dark grey line: 4.03 ± 0.47 
Dotted dark grey line: 3.65 ± 0.28 
CD44 
CD56 
E–cadherin 
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Figure 6.4: Variation in expression level of CD44,E-cadherin and CD56 on the cell 
surface of S cells 
Left and right column denote independently repeated experiments; for each two different 
passages were stained on the same day. Light grey lines in histogram show unstained sam-
ples, dark grey lines stained samples. Histograms show single samples, representative of 
triplicates (duplicates for unstained) measured. Forward/ Side scatter gate (not shown) was 
applied. Average of median fluorescence intensities (MFI) for overall populations of stained 
samples are given. Arrows indicate bimodal staining distribution in sample.  
CD56 
1) 
CD44 
1) 
CD56 
2) 
CD44 
2) 
E-cadherin 
1) 
MFI 
solid: 
4.00 ± 0.44 
dotted: 
4.80 ± 0.08 
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2) 
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2.20 ± 0.10 
dotted: 
5.34 ± 0.21 
MFI 
solid: 
7.06 ± 0.28 
dotted: 
2.91 ± 0.13 
MFI 
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dotted: 
4.75 ± 0.33 
MFI 
solid: 
3.07 ± 0.17 
dotted: 
5.93 ± 1.28 
MFI 
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2.18 ± 0.07 
dotted: 
7.78 ±  2.19 
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6.5 Discussion: flow cytometric analysis of adhesion molecule 
expression levels
Ahram et al. (2005) have previously shown that CD44 and NCAM are expressed on adherent 
CHO cells, which is an accordance with the flow cytometric analysis of cell surface protein 
expression demonstrated here. Also, the expression of cadherins on CHO suspensions cells as 
suggested by the mass spectrometry results (see chapter 5) has been confirmed for E-cadherin by 
the flow cytometric analysis. 
As can be clearly seen in figure 6.3, there is a large variation in expression levels between 
different passages of S cells with respect to CD44, CD5 and E-cadherin expression. In contrast to 
the S cells, CCL61 cells show a bimodal expression pattern only for E-cadherin with a small, 
brighter stained population in both passages tested, whereas for the S cells for all adhesion 
molecules analysed bimodal distributions were found in at least two of the four passages tested. The 
difference in the protein expression can be regarded as a clear indication of a difference in the cell 
surface composition of the two CHO cell lines tested. The variation in protein expression seen here 
could not have been analysed using a quantitative mass spectrometry based approach, as the 
bimodal distribution would  have been seen as an overall lower expression of the proteins in 
question on the cell lines analysed. As the variation in expression is as large as shown between 
different passages of the S cells, it is not possible to perform a quantitative comparison of the 
expression levels between the suspension and adherent cell lines based on the fluorescence 
intensities. The fluctuation in expression on the S cells seen for the adhesion molecules tested is an 
indication that those proteins are not necessary for growth in suspension, as the variation in 
expression shows that the proteins are not conserved on the cell surface. This idea is strengthened 
by the data gained for S cell growth characteristics showing no difference in reachable viable cell 
density when comparing different passages (see figure 4.4), as the expression differs between 
passages while the growth characteristics remain stable over culture. It should be noted that the 
changes in expression seen for CD44 might be due to expression of different isoforms of this 
molecule (Liu and Jiang, 2006) as the antibody clone used might not recognise all possible 
isoforms. 
In conclusion, it can be said that CD44, NCAM and E-cadherin expression are neither necessary for 
growth in suspension nor counterproductive. As they are not a necessary part on the cell surface of 
suspension adapted CHO cells,  these adhesion molecules  play no major  part  in  the suspension 
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phenotype. It cannot be concluded whether these molecules play a role during the actual process of 
suspension adaptation as only the end points of the adaptation process have been analysed based on 
the two cell lines.
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7.   Chapter 
Integrins: cell to extra-cellular matrix 
interaction
In this chapter the structure, role and characteristics of integrins as cell surface molecules are 
described. The methodology  used to analyse integrin expression level and conformation are 
explained. Results on the expression level, differences in outside-in signalling and integrin 
conformation for the model CHO cell lines are given and their relevance for the CHO suspension 
phenotype is demonstrated.
7.1 Integrin structure and ligands
Integrins form a group of cell surface proteins that mainly interact with the extra-cellular matrix 
in tissue and serum components in cell culture. Integrins are heterodimers, consisting of an alpha 
and beta unit. The two units are non-covalently bound. Both units are transmembrane proteins 
(Etzioni, 1999) with a single hydrophobic transmembrane domain (Hynes, 1992), a large 
ectodomain and a short cytoplasmic tail (Regent et al., 2010). The alpha unit size varies between 
120 -180 kDa and the beta unit size between 90-110 kDa (Hynes, 1992). There are 8 known beta 
chains and around 20 alpha units have been identified so far (Regent et al., 2010). The subunits can 
be expressed in a variety of combinations; each of the known beta subunits can dimerize with 
different alpha units and some of the alpha subunits can also associate with different beta subunits 
(Ruoslathi, 1991). As the binding region is formed by the alpha and beta chain (Hynes, 1992) the 
different subunit combinations bind to different ligands, making the integrins a varied and complex 
family of cell surface receptor proteins, which allows them to play a role in cell adhesion, 
proliferation and differentiation (Streuli, 2009). So far, the largest known group of integrins 
comprises those containing the beta 1 subunit and most mammalian cells express one or more beta 1 
integrins constitutively (Hynes, 1992). Table 7.1 below shows the possible alpha subunits 
interacting with the beta 1 subunit and lists which ligands are recognised by the resulting integrin.
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Table 7.1 Integrin alpha units interacting with the integrin beta 1 chain and the resulting 
ligands.
(after Hynes (1992); Stupack and Cheresh (2002); reactome.org (2012))
* VCAM-1: vascular cell adhesion protein 1, expressed on activated endothelial cells
** requires magnesium ions
Integrin alpha unit Integrin beta unit Ligand
alpha 1 beta 1 fibrillar collagen domain, laminins 
**
alpha 2 beta 1 collagens, laminins **
alpha 3 beta 1 collagens, laminins 
(different epitops to Alpha 2)
alpha 4 beta 1 fibronectin, VCAM-1*
alpha 5 beta 1 fibronectin, fibrin
alpha 6 beta 1 laminins (laminin-5, laminin-1)
alpha 7 beta 1 laminins (laminin-2, laminin-1)
alpha 8 beta 1 fibronectin
alpha 9 beta 1 VCAM-1*
alpha 10 beta 1 collagen **
alpha 11 beta 1 collagen **
alpha V beta 1 vitronectin, fibronectin
Newer studies indicate that most integrins containing the integrin beta 1 subunit, e.g. integrin 
alpha 5 beta 1, integrin alpha 4 beta 1 and integrin alpha V beta 1, bind to the RGD tri-peptide motif 
that is found in most extra-cellular matrix components such as fibronectin (Wiesner et al., 2005; 
Regent et al., 2010; Stupack and Cheresh, 2002).
7.2 Integrin function, expression level and conformation
In contrast to the reversible growth arrest seen in fibroblasts when transferred into suspension, 
Francis and Frisch (1994) demonstrated that epithelial cells in suspension undergo anoikis and 
hence proved that the extra-cellular matrix is a survival factor for epithelial cells. Meredith et al. 
(1993)  showed that for epithelial cells attachment to integrin alpha antibodies offered protection 
from anoikis, indicating that integrin outside-in signalling (Legate et al., 2009) is necessary for cell 
survival. Extensive research by Ruoslathi (Giancotti and Ruoslathi, 1990;  Zhang et al., 1995; Lee 
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and Ruoslathi, 2005) links integrin alpha 5 beta 1 in different epithelial cells to apoptosis regulation 
via the protein Bcl-2. In the study by Giancotti and Rouslathi (1990) the integrin alpha 5 beta 1 
expression level was also linked to the capacity of the cells to adhere. Furthermore, increased  
integrin alpha 5 beta 1 expression correlated inversely with the maximal achievable cell density of 
the adherent cell line. As the above studies clearly link integrin expression level to adhesion 
capability and survival in suspension, the integrin expression level of three integrins (integrin beta 
1, integrin alpha 1 and integrin alpha 4) was analysed for the four model cell lines using flow 
cytometry.
The  different roles of integrins have been described in more detail by Stupack and Cheresh 
(2002) which describe integrins as important biosensors regulating the survival/ death response of 
cells as a function of the surrounding extra-cellular matrix. The complexity of this regulation is 
demonstrated by the fact that integrin alpha 5 beta 1 and integrin alpha V beta 3 outside-in 
signalling can provide resistance to serum withdrawal whereas integrin alpha V beta 1 cannot 
(Stupack and Cheresh, 2002). More recently, the integrin beta 1 cytoplasmic domain has been 
associated with the regulation of cell adhesion on fibronectin (Green et al., 2009). This study  
indicated that for constitutively expressed integrins different regulating mechanisms, such as 
modulation of interactions on the cytoplasmic tail, might play a role besides ligand binding and 
outside-in signalling. A similar idea is the concept of a bidirectional signalling process via integrins 
proposed by Regent et al. (2010).
Askari et al. (2009) suggest that this idea has to be extended as integrins have different 
conformational states of which they describe three in more detail: inactive (showing low affinity to 
ligand), primed (showing high affinity to ligand) and active (bound to ligand). Priming is described 
by them as either an inside-out signalling process, with the activation being controlled  by 
interaction between integrin beta 1 cytoplasmic domain and talin, or outside-in activation due to  
ligand binding; furthermore, they stress that integrin activity can be modulated by other factors such 
as divalent cations, mechanical force and monoclonal antibodies and that these different ways of 
activation might lead to different integrin conformations.  They explicitly mention that it might be 
possible to distinguish between integrins signalling inside-out and outside-in by conformation.  This 
idea has been developed further by Regent et al. (2010) which describe three conformations: bent 
closed conformation, intermediate extended with closed head piece (referring to the ligand binding 
site between alpha and beta sub-units) and extended open conformation. They linked these three 
different conformations to different activation and signalling stages: low-affinity, activated and 
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ligand occupied, respectively. They also describe integrin activation as insufficient to control cell 
adhesion processes. Studies of negative regulators of beta 1 integrins have strengthened the 
possibility that conformational changes triggered by proteins interacting with the cytoplasmic beta 1 
domain are the starting point of integrin activation but that  the full activation is a multi-step process 
requiring not only conformational changes but also clustering of integrins on the cell surface 
(Regent et al., 2010).
Figure 7.1 Model of integrin clustering in leukocytes.
How integrin clustering occurs in leukocytes and leads to activation of integrin alpha L beta 2: 
Extracellular signals from cell surface receptors, such as T-cell receptors (TCR), lead to Protein 
Kinase C activation and increased PI-3 activity resulting in dissociation of actin cytos-keleton from 
the integrin beta 2 cytoplasmic tail.  Ligand binding induces conformational changes of the integrin 
beta subunit which allows binding of helper proteins such as GTPases on the intracellular side, 
inducing clustering of the integrins. Clustering and ligand binding result in re-assembly of integrin 
beta 1 and actin interaction (van Kooyk and  Figdor (2000); Green et al. (1998)).
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The idea of activation through inside-out signalling events has been proposed earlier by van 
Kooyk and Figdor (2000)  for integrins involved in leukocyte adhesion. They proposed clustering as 
a major step in integrin activation and described release of cytoskeletal restrain as a necessary step 
for clustering. Their model stresses the importance of the intracellular interaction partners of the 
integrin. More details with respect to the process of clustering can be found in Figure 7.1.
The idea of clustering of integrin on lymphoctes was used in a study by Lub et al. (1997). They 
used confocal microscopy to study clustering of integrin alpha L beta 2 on a variety of cell lines and 
lymphocytes. Their results indicated a correlation between clustering of integrins and adhesion 
capability and demonstrated that cytochalasin D treatment induced clustering of integrins on the 
surface of resting lymphocytes. To analyse integrin conformation on the cell surface a confocal 
study has been conducted for the four model cell lines investigated in this study, analysing integrin 
beta 1, integrin alpha 1 and integrin alpha 4 conformation on the cell surfaces.
7.3 Anti-integrin antibodies and analysis methodology used
A number of antibodies were tested for use on CHO cells and their details are presented in table 7.2.
 Table 7.2 List of antibodies tested for analysis of integrin expression on CHO cells
Bold indicates the antibodies that have been found in this study to actually recognise a cell 
population in CHO cells.
integrin antibody clone supplier
integrin alpha 2 anti mouse CD49b DX5 Miltenyi Biotec
integrin alpha 4 anti human CD49d MZ18-24A9 Miltenyi Biotec
integrin alpha X anti mouse CD11c N418 Miltenyi Biotec
integrin alpha 5 anti mouse CD49e 5H10-27 (MFR5) BD Biosciences
integrin alpha 3 anti human CD49c C3 II.1 BD Biosciences
integrin alpha 4 anti mouse CD49d R1-2 Miltenyi Biotec
integrin alpha 1 anti rat/mouse CD49a Ha31/8 BD Biosciences
integrin beta 1 anti mouse CD29 9EG7 BD Biosciences
Only the last three antibodies gave a visible shift in the staining intensities between unstained 
and stained cells. For staining with integrin beta 1 and integrin alpha 4 the use of secondary 
antibodies was necessary as direct fluorochrome conjugates were not available (see also chapters 
3.8.1, 3.9.1 and 3.10.1). This made a modification in the analysis of the expression level necessary 
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as secondary antibodies introduce an increased background signal to the staining. As shown in 
Figure 7.2 this background signal was subtracted for the analysis from the expression levels and the 
resulting difference in fluorescence intensity(Δ FI ) was used for comparison of expression levels. 
For integrin beta 1 an isotype control (ITC) was available. The results of the isotype control 
staining are shown in Figure 7.3. As can be seen in this figure the integrin beta 1 antibody 
recognises a specific antigen on the cell surface of the S cells, as staining with the specific antibody 
is brighter than the staining from the isotype control.
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A) 
unstained 
C) 
integrin beta 1 staining 
B) 
secondary antibody only 
median FI 
A) unstained 2.49 
B) sec. ab only 3.04 
C) integrin beta 1 19.08 
Δ FI [C) - B)] 16.04 
Figure 7.2: Example of staining for integrin beta 1 with mouse anti rat IgG2a PE as 
secondary antibody. 
Histograms show one set of results for staining on fixed S cells. Data is based on FSC gate 
(not shown). A) shows results of unstained S cells, B) shows results of staining with second-
ary antibody only.  There is only a small shift in fluorescence intensity (FI) compared to un-
stained cells, indicating that no unspecific binding of the secondary antibody to the cells oc-
curs. C) shows results of complete staining for integrin beta 1. The single population is con-
siderably shifted. Δ FI  can be calculated based on median fluorescence intensity of B) and 
C). 
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FL2 stain 
unstained 2.22 ± 0.06 
sec. ab  only 4.31 ± 0.29 
FL2 stain 
ITC 3.97 ± 0.72 
CD29  11.33 ± 0.32 
median fluorescence intensity 
median fluorescence intensity 
Unstained cells (light grey) and                         
cells stained with secondary antibody only (black). 
Cells stained with ITC plus secondary antibody (dashed) 
and CD29 antibody plus secondary antibody  (dotted). 
Figure 7.3: Isotype control staining for integrin beta 1 with mouse anti rat IgG2a 
PE as secondary antibody. 
Histograms show one set of results for staining on fixed S cells. Upper overlay A) com-
pares unstained vs. secondary antibody only (SO). Lower overlay B) compares isotype 
control (ITC) vs. staining with CD29 antibody. Standard deviations were calculated from 
three different samples for each set up.  Data is based on FSC gate (not shown). Median 
fluorescence intensity of ITC and SO are comparable.   
A) 
B) 
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7.4 Stability of expression level of integrin beta 1, integrin alpha 1 and 
integrin alpha 4 over different passages of S cells and CCL61
As a large variation in the expression level was seen between passages in the analysis of the cell-
to-cell adhesion molecules, demonstrating an unstable heterogeneous bimodal distribution, the 
stability of the expression of the three integrins was analysed for S cells and CCL61. Figure 7.4 
shows the result of staining different passages of S cells and CCL61 with integrin alpha 4, which is 
a direct conjugate. The variation in expression as previously seen for cell-to-cell adhesion 
molecules with regard to the bimodal distribution pattern on S cells is not seen for integrin alpha 4. 
In all passages tested a single stained peak can be identified. This peak differs in shape between the 
passages of S cells, leading to a larger difference in median fluorescence intensity between the 
passages whereas peak form and median fluorescence intensities are very similar for the two 
passages of CCL61. This indicates a larger heterogeneity between cells in one passage in the 
suspension adapted S cells compared to cells in one passage of CCL61.
In figure 7.5 the results with respect to stability of expression between different passages for 
integrin alpha 1 are shown. As the staining with the recommended secondary antibody did not show 
a sufficient shift in staining intensities, the primary antibody had to be biotinylated and stained with 
Streptavidin FITC to reach measurable fluorescence intensity. The biotinylation introduced an 
additional variation into the set-up of the experiment because the biotinylation reaction had to be 
done for each staining experiment separately, as the biotinylated primary antibody was unstable 
when stored. The appearance of a small side peak in staining results for both cell lines is assumed to 
be due to a less efficient biotinylation of the primary antibody, as a slightly prolonged biotinylation 
reaction did not show this. The large variation seen in Δ FI for integrin alpha 1 when comparing 
passages is presumably due to the biotinylation step. 
In figure 7.6 the results of the passage comparison for integrin beta 1 are shown. Only a single 
stained peak is seen in both cell lines for both passages with less variation in peak size compared to 
integrin alpha 4. No variation in expression, such as a bimodal distribution pattern as previously 
found before on S cells when analysing cell-to-cell adhesion molecules, is seen. The variation in  
Δ FI between passages is smaller for the CCL61, as seen for integrin alpha 4.
Overall the above results show that integrin beta 1, integrin alpha 1 and integrin alpha 4 are 
constitutively expressed on the whole population of both cell lines, CCL61 and S cells. This allows 
detailed analysis of the expression level. In combination with a comparison of the three suspension 
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S cells 
integrin alpha 4 
median fluorescence intensity (MFI) 
solid dark grey line: 7.88 ± 0.76 
dashed dark grey line: 3.94 ± 0.54 
CCL61 
integrin alpha 4 
median fluorescence intensity (MFI) 
solid dark grey line: 4.01 ± 0.2 
dashed dark grey line: 5.12 ± 0.59 
Figure 7.4: Comparison of fluorescence intensities for integrin alpha 4 for two dif-
ferent passages of CCL61 and S cells. 
Histograms show staining results for integrin alpha 4 on two different passages. Light grey 
lines in histograms show unstained samples, dark grey lines (dotted or solid) stained sam-
ples. Histograms show single samples, representative of triplicates (unstained: duplicates) 
analysed. Average of fluorescence intensities of the population (FSC gate not shown) in-
cluding standard deviations are given. For both cell lines only single peaks, no bimodal 
distributions,  are seen. 
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Δ FI  
solid lines: 21.52 
dotted lines: 14.14 
Figure 7.5: Comparison of fluorescence intensities for integrin alpha 1 between dif-
ferent passages of CCL61 and S cells. 
Histograms show staining results for integrin alpha 1 on two (CCL61) or three (S cells) dif-
ferent passages. Secondary antibody staining (light grey) and specific staining (dark grey) 
are given and were used to calculate Δ FI based on median fluorescence intensities. For in-
tegrin alpha 1 the specific antibody needed to be biotinylated first; this could explain the 
small and less stained population seen in some passage (dotted lines) and the larger variance 
of the Δ FI  between the different passages.  
Δ FI 
solid lines: 28.01 
dotted lines: 47.16 
dashed lines: 13.87 
S cells 
integrin alpha 1 
CCL61 
integrin alpha 1 
Analysing the surface of suspension growth adapted CHO cells                                                          
 -94-
Δ FI 
solid lines: 7.44 ±1.6 
dashed lines: 4.48 ± 0.45 
Figure 7.6: Comparison of fluorescence intensities for integrin beta 1 between dif-
ferent passages of CCL61 and S cells. 
Histogram overlays show staining results for integrin beta 1 on two different passages. Top 
histograms show results for CCL61; lower histograms show result for S cells. Secondary 
antibody staining (light grey) and specific staining (dark grey) are given and were used to 
calculate Δ FI based on median fluorescence intensities.  Histograms show single samples, 
representative of triplicates analysed. Average of Δ FI of the populations (FSC gate not 
shown) including standard deviation are given. For both cell lines only single peaks, not 
bimodal distributions, are seen. 
Δ FI 
solid lines: 2.33 ± 1.14 
dashed lines: 2.73 ± 0.48 
CCL61 
integrin beta 1 
S cells 
integrin beta 1 
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adapted S cells, CHO-S and AML against the non-suspension adapted CCL61 it should be possible 
to test the hypothesis that integrins become down-regulated during suspension adaptation of CHO 
cells.
7.5 Comparison of expression level of integrin beta 1, integrin alpha 1 
and integrin alpha 4 on the model cell lines
After establishing that integrin beta 1, integrin alpha 1 and integrin alpha 4 are constitutively 
expressed on adherent and suspension CHO cells the next aim has been to compare expression 
levels of the three integrins on the four model cell lines. This analysis should test if integrin 
expression levels can be used to describe a suspension phenotype in CHO cells by verifying the 
hypothesis that integrin expression is down-regulated on suspension CHO cells in comparison to 
non-suspension adapted CHO cell lines.
7.5.1 Methodology: experimental set-up and analysis
As the integrin expression level showed some degree of variation between passages of the same 
cell line (see chapter 7.4) all four cell lines were stained on the same day using randomly chosen 
passages for the cell lines analysed. The experiment was repeated on different days: three times for 
integrin beta 1 and integrin alpha 4 and two times for integrin alpha 1, to minimise the influence of 
differences between passages on the results. For each experiment triplicates of the passages chosen 
were prepared. Expression levels were calculated as before using ΔFI, using the unstained samples 
as background control in the case of integrin alpha 4. The results of the experiment were normalised 
based on the ΔFI values of CCL61. Normalisation was used independently for each day to allow 
comparison of independent runs of this experiment on different days, as fluorescence intensities are 
also influenced by the day-to-day variation of the flow cytometer set-up.
7.5.2 Results: comparison of integrin expression levels
Apart from the variation between passages shown by the individual columns for each cell line in 
figure 7.7 there is a trend with regard to the expression level when comparing S cell and CCL61. In 
contrast to the hypothesis that integrins may be down-regulated on suspension adapted CHO cells, S 
cells show a  comparable or even higher expression (up to a factor of 2) of integrin beta 1 and 
integrin alpha 4 in relation to adherent CCL61. Only for integrin alpha 1 is a weak down-regulation 
of expression seen when comparing S cells to CCL61. Hence, the hypothesis that integrin in 
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Figure 7.7: Differences in expression level for integrin alpha 1, integrin alpha 4 and 
integrin beta 1 between the four model cell lines. 
Staining was done as described before. Stained samples were prepared as triplicates.  ΔFI 
was calculated as described before. For each experiment, the average of ΔFI of CCL61 was 
used for normalisation to allow better comparison between results from different days.     
No down-regulation of expression level is seen on both suspension cell lines for integrin 
alpha 4 compared to CCL61. S cells show also no down-regulation of expression level for 
integrin beta 1 compared to CCL61.  
AML show higher expression level for all three surface proteins compared to CCL61. 
A) 
B) 
C) 
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suspension-adapted CHO cells are generally down-regulated is invalid. For the other suspension 
adapted CHO cell line, CHO-S, there is a clear down-regulation of integrin beta 1 compared to 
CCL61, only a small degree of down-regulation for integrin alpha 1 and comparable or higher 
expression for integrin alpha 4. Again, this indicates that there is no general down-regulation of 
integrin expression on suspension adapted CHO cells. Interestingly, the AML cells as an adherently 
growing cell line cloned from a suspension CHO cell line (S cells) show up-regulation of 
expression for all three integrins tested. The heterogeneity of the cells within one passage, which is 
partially represented by the standard deviation calculated from the triplicates prepared, can be 
assumed to be the underlying reason for the variation observed between the passages. As the 
variance seen is different from experiment to experiment and varies also between the cell lines in 
one experiment a statistical analysis of the results gained for integrin expression levels, using for 
example an ANOVA  analysis, is not possible. These results indicate that integrins are not generally 
down-regulated on CHO cells growing in suspension; hence a further analysis of expression level 
for integrin beta 1 and integrin alpha 4 was done using AML cells grown in suspension. 
As can be seen in figure 7.8 the AML cells after growth in suspension over a period of four days 
developed yet another phenotype with regard to expression level of integrin beta 1 and integrin 
alpha 4. They revealed a slight up-regulation for integrin beta 1 but a clear down-regulation for 
integrin alpha 4 when compared to CCL61. The down-regulation of integrin alpha 4 is in contrast to 
what was seen before when comparing corresponding expression levels of S cells and CCL61, even 
though AML cells were cloned from S cells and grown in the same suspension medium (PSM) in 
this experiment.
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Figure 7.8: Expression level of integrin alpha 4 and integrin beta 1 on AML cells 
grown in suspension in comparison to CCL61. 
AML cells were grown for four days in suspension using PSM. Two different set-ups of 
the cell lines were stained on different days. Stained samples were prepared as triplicates.  
Δ FI was calculated as described before. For each experiment the average Δ FI of CCL61  
was again used for normalisation to allow better comparison between results from differ-
ent days. Integrin beta 1 is higher expressed on AML cells grown in suspension compared 
to adherent CCL61; integrin alpha 4 is much lower expressed on AML cells grown in sus-
pension compared to adherent CCL61.  
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7.6 Discussion: comparison of integrin expression levels 
It has been clearly demonstrated that suspension adapted CHO cells express integrin beta 1, 
integrin alpha 4 and integrin alpha 1 on the cell surface although no extra-cellular matrix proteins 
have been added to the culture.  The expression levels of these three integrins show no clear trend 
with respect to up- or down-regulation on suspension cells in comparison with adherent cells, as 
hypothesised: the three CHO cells lines capable of growing successfully in suspension (S cells, 
CHO-S and AML) all show a different phenotype with respect to the expression level of the three 
integrins in suspension culture. This might be due to the previously described phenotype differences 
(see chapter 4 and table 4.3) and the adaptation to a different media in the case of CHO-S cells. The 
result regarding the integrin expression levels is a clear indication that these cannot be used as 
criteria to describe a suspension CHO phenotype. 
There are also variations of the expression levels between different passages of the same cell line 
and differences in the variance seen in the analysis of single passages. This indicates that a certain 
degree of heterogeneity exists within each cell line with respect to integrin expression level, as 
previously seen for the cell-to-cell adhesion molecule variation, but those showed a larger 
heterogeneity than the integrins. The phenomenon of  heterogeneity in CHO cells has been shown 
to exist for various characteristics in CHO cells (Dahodwala et al., 2012; Davies et al., 2013).
As integrins are still expressed on CHO suspension cells, a further question is whether these 
surface proteins remain functionally active. As demonstrated in figure 4.5, all suspension adapted 
CHO cell lines used in this study are able to grow adherently, indicating that the expressed integrins 
could be functionally active. Adherent growth has been demonstrated to be related to integrin 
expression levels (Giancotti and Rouslathi, 1990), a result that is strengthened by the result of this 
study where CHO-S cells, with the lowest expression level of integrin beta 1, were the slowest to  
develop the adherent phenotype in comparison to the other suspension adapted CHO cell lines (see 
figure 4.5). To further study the functionality of the integrins found to be expressed on the surface 
of suspension adapted CHO cells it was analysed whether the integrin beta 1 antibody can block 
adherence of the cell lines as was previously demonstrated in other studies by Lenter et al. (1993) 
and Barkan et al. (2008) (see chapter 7.7). 
As mentioned before, another approach to analyse the integrins found to be expressed on the cell 
surface of suspension adapted CHO cells is the analysis of the integrin conformation using confocal 
microscopy, as clustering of integrins has been shown to play a major role in adhesion formation 
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(Altrock et al., 2012) and has been proposed to be indicative of activated integrins on the cell 
surface of suspension cells (Askari et al., 2009; van Kooyk and Figdor, 2000) (see chapter 7.8).
7.7 Development of adherent phenotype – blocking with integrin beta 1 
antibody (clone 9EG7)
To investigate if the integrin beta 1 found to be expressed on the suspension adapted CHO cell 
lines, S cells, AML cells and CHO-S, is functionally active it was tested if adherence development 
could be blocked with  the integrin beta 1 antibody clone 9EG7.
7.7.1 Epitope characterisation of clone 9EG7 and previous use in 
adherence blocking 
Lenter et al. (1993) used the integrin beta 1 clone 9EG7 to block adhesion of lymphocytes to 
endothelial cells and concluded that the integrin beta 1 epitope recognised by this clone was only 
accessible after integrin activation. Bazzoni et al. (1995) analysed the clone further and concluded 
that the epitope is inducible by fibronectin or depletion of calcium but is not a marker of integrin 
activation.  Green et al. (2009) described the integrin beta 1 epitope recognised by clone 9EG7 as a 
cation and ligand influenced binding site and showed that binding of the antibody was reduced in 
cells expressing integrin beta 1 mutants that were assumed to have different conformations of the 
integrin beta 1 and did not show fibrillar adhesion and reduced spreading in adherent growth. 
Barkan et al. (2008) used the integrin beta 1 clone 9EG7 to neutralise integrin beta 1 function on 
cancer cells in three dimensional cultures. In their study the inhibition of integrin beta 1 led to a 
change in down-stream signalling. It was hence assumed that integrin beta 1 clone can block 
integrin dependent adhesion but does not block ligand binding and that a reduced binding capability 
of integrin beta 1 indicates changes in intracellular signalling of integrin beta 1.
7.7.2 Methodology of blocking experiment
Using the same concentration (150 μg/ml) as used by Barkan et al. (2008) all four cell lines were 
cultured in 6 well plates. For CCL61, CHO-S and S cells, cells were cultured in mF12 plus 10% 
FBS. AML cells were cultured in PAM plus 10% FBS. All cells were treated with trypsin/EDTA for 
10 minutes before harvesting. To one set of each culture 150 μg/ml integrin beta 1 antibody was 
added and the difference in development of the adherent phenotypes documented.
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7.7.3 Influencing adherence with integrin beta 1 
As can be seen in figure 7.9,  CCL61 and AML, that are cell lines with adherent growth mode as 
standard, show no difference in the development of the adherence phenotype after 3 hours and 6.5 
hours, when cultures with and without integrin beta 1 antibody are compared; despite the cultures 
using different cell culture media, as described before.  The same is true for S cells: there is no 
difference in the development of adherence after 3 and 6.5 hours. Hence, although these cells are 
capable of binding the integrin beta 1 clone 9EG7, as demonstrated in the flow cytometric analysis 
previously, there is no sign of inhibition of adherence, indicating no difference in the intracellular 
signalling via integrin beta 1 when comparing those three cell lines. In contrast to this, for CHO-S 
there is a blocking effect of the integrin beta 1 phenotype on the development of adherence growth: 
CHO-S cells incubated with the integrin beta 1 antibody do not become adherent even after 6.5 
hours, despite being in the same media as S cells and AML cells in adherent culture. 
This can bee seen as an indication of changes in the intracellular signalling downstream of 
integrin beta 1 of CHO-S in comparison to CCL61, as the antibody shows reduced binding to 
integrin beta 1 mutants that result in reduced cell spreading (Green et al., 2009). CHO-S is the cell 
line showing the lowest expression of integrin beta 1 on the cell surface, as demonstrated before, 
but the largest effect of integrin beta 1 with regard to blocking adherence. CHO-S cells are hence 
noticeably different from the other suspension adapted cell lines (S cells and AML), as is also seen 
in the growth characterisation (see chapter 4).
The aim of this study was to define a CHO suspension surface phenotype in contrast to a CHO 
adherent surface phenotype; the above result can be seen as an indication that different suspension 
adapted CHO cells do not only show different integrin expression levels but these different 
expression levels might also be indicative of other differences, such as intracellular signalling, as 
previously indicated by Giancotti and Ruoslathi (1990) and Green et al. (2009).
Concentrating on the cell surface of suspension CHO cells, in the next step the conformation of 
the integrins on the cell surface was analysed with confocal microscopy; the aim is to identify if 
there is a specific distribution of integrins shared by the suspension adapted CHO cell lines (S cells, 
CHO-S and AML).
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Figure 7.9: Influence of integrin beta 1 clone 9EG7 on development of adherence 
phenotype in the four model cell lines.                                  
Blocking of development of adherence phenotype was tested by adding 150 µg/ml integrin 
beta 1 antibody. Cells were cultured in 6 well plates and images were taken with a Nikon 
Eclipse TS100 microscope with an attached camera and a 40x objective using the NIS Ele-
ments F2.30 software at the times indicated. Variation in development of the adherence 
morphology and the different influence of the integrin beta 1 antibody can be seen. Cells 
were treated with trypsin for 10 minutes before seeding. Scale bars in top rows equal 20 µm.  
time  
(hours) 
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7.8 Methodology for confocal analysis of integrin conformation
For the analysis of the integrin conformation by confocal microscopy the staining systems had to 
be changed as some of the fluorochromes used in flow cytometry could not be used for confocal 
analysis. The final methodology used is described in chapters 3.8.2, 3.9.2 and 3.10.2. Table 7.3 
shows a list of the secondary antibodies used  for the three integrins.
Table 7.3 List of secondary antibodies used for confocal microscopy 
isotype fluorochrome integrin used for
goat anti-mouse IgG2b Alexa 488 integrin beta 1
anti-Armenian and Syrian 
hamster IgG
FITC integrin alpha 1
Streptavidin FITC integrin alpha 4
A control experiment was done to ensure low background staining occurred with the secondary 
antibodies in the confocal set-up. Figure 7.10 confirms that all three secondary antibodies chosen 
give only a very weak background signal when imaged with the same set-up used for the specific 
staining, making the chosen antibodies suitable for confocal analysis of the integrin conformation.
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integrin alpha 1 
integrin alpha 4 
integrin beta 1 
Figure 7.10: Background control staining for integrin alpha 1, integrin alpha 4 and 
integrin beta 1 demonstrated on S cells. 
Set-up for SO and CS was identical.  Analysis was done using an inverted Zeiss LSM510 
Meta confocal microscope. Mounted cell samples were analysed using a plan apochromat 
63x/ 1.4 oil DIC objective. Excitation of fluorochrome was at 488 nm by an argon laser. 
Emission was collected using a band pass 500-550 IR filter. All scale bars equal 10 µm. 
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7.9 Analysing the conformation of integrins known to be expressed on 
the cell surface of CHO cells
Single staining and confocal analysis of integrin beta 1, integrin alpha 1 and integrin alpha 4 was 
performed twice on all four model cell lines grown in standard conditions. Single slides were 
prepared using the methodology described before and images taken with the instrumentation set-up 
described previously. For each image an optimisation process with respect to the laser transmission, 
detector gain and amplifier offset was performed to optimise signal and to avoid over- and 
underexposure of image pixels. The pinhole defining the optical slice imaged was set as close as 
possible to 1 Airy unit as the optimal size, while still reaching maximum signal intensities. Line 
averaging was set to either 1 or 2 for integrin beta 1 and to 2 or 4 for integrin alpha 1 and integrin 
alpha 4. Frame size and pixel dwell time were optimised automatically by the software after 
adjustment of the above parameters.
In figure 7.11 the results for the conformation analysis of integrin beta 1, integrin alpha 4 and 
integrin alpha 1 on the adherent cell lines CCL61 and AML, growing in mF12 plus 10% FBS and 
PAM plus 10% FBS respectively, are compared. Representative examples of images have been 
chosen. The signal intensities for all three integrin stainings were very weak, with integrin alpha 4 
and integrin alpha 1 requiring a laser transmission of above 35% and a detector gain around 1,000 
to allow imaging with a pinhole below 1.8 Airy units. This also increased the background signals 
for those two integrins and made it difficult to distinguish the adherent cells from the slide. From 
the images shown in figure 7.11 one can conclude that the conformation seen for the analysed 
integrins is very similar for the adherent cells CCL61 and AML. For integrin beta 1 in particular the 
distribution of the integrin is clearly regular over the entire cell surface, showing the stretched-out 
morphology of adherent cells for both cell lines. Only very small clusters of integrins are visible as 
green spots; slightly larger clusters show no distinctive distribution pattern. This is the typical 
conformation one would expect for focal adhesions (Wiesner et al., 2005).
In figure 7.12 the results for the conformation of the three integrins on the suspension cell lines  
CHO-S and S cells are shown. Both are grown in their standard growth conditions. For all three 
integrins a clear clustering of the signal on the cell surface can be seen; the dot-like clustering is 
most distinct for integrin beta 1 on the S cells but it is also visible for integrin beta 1 on CHO-S. 
This difference in signal intensity of the dot-like clusters might be due to the lower expression level 
of integrin beta 1 on CHO-S already demonstrated in the flow cytometric analysis of the expression 
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level. The integrin beta 1 signals are clustered evenly over the entire surface of the cells visible in 
the image. The clustering is less well defined for integrin alpha 4, and integrin alpha 1 shows less 
distinctive spots and some larger patches of clustering. Nevertheless, those integrins are regularly 
distributed over the entire cell surface of the suspension cells. 
The regular clustering over the cell surface of the entire cell was confirmed by taking so-called  
z-stacks of integrin beta 1 stained S cells, CHO-S and AML cells grown in suspension. With z-
stacks images in the z direction of the sample are taken with the exciting laser beam focusing on 
successive planes, creating a series of confocal single images with each slice representing a cross- 
section through the sample at a different depth. This allows visualisation of the integrin beta 1 over 
the complete surface of cells grown in suspension, enabling a three-dimensional model of the 
suspension cells in question to be gathered. 
In addition the three suspension adapted cell lines S cells, CHO-S and AML grown in suspension 
could be compared with respect to their integrin beta 1 conformation. Using integrin beta 1 
minimised problems with background in z-stack imaging due to the higher signal intensities 
compared to integrin alpha 1 and integrin alpha 4.  Z-stacks were set up using the interval 
optimisation offered by the program to ensure coverage of the entire cell. Representative results of 
z-stacks are shown in figures 7.13  for S cells, 7.14 for AML and 7.15  for CHO-S. For presentation 
in this report only every nth slice image from the z-stacks is shown. 
In figure 7.13 the clustering for integrin beta 1 on the S cells is easily visible. For all three cells 
imaged in the z-stack the even distribution of the clusters over the entire cell surface can be seen. In 
a three-dimensional reconstruction the integrin clusters form a sphere. This means that the cell 
surface of S cells is covered with regularly distributed integrin beta 1 clusters. A similar distribution 
is seen in figure 7.14 for the AML cells when they are grown in suspension; this is a large change of 
conformation compared to what was seen when AML cells were grown adherently, indicating an 
influence of the culture environment on the conformation of integrin beta 1. Both cell lines show 
the same specific conformation of evenly distributed integrin beta 1 clusters on the cell surface. 
In figure 7.15 the results for the integrin beta 1 conformation on CHO-S cells is shown. As 
expected from the flow cytometry results, the signal intensities are lower than those for S cells, 
requiring a higher laser transmission and leading to a higher background signal. Nevertheless, 
integrin clusters on the cell surface can be seen and are distributed over the entire surface of the 
cell. Hence, the sphere-like distribution of integrin beta 1 clusters as seen in S cells and AML is also 
present on the CHO-S cells.
 -106-
Analysing the surface of suspension growth adapted CHO cells                                                          
 -107-
CCL61 
integrin beta 1 integrin alpha 1 integrin alpha 4 
AML 
integrin beta 1 integrin alpha 1 integrin alpha 4 
Figure 7.11: Conformation of integrin beta 1, alpha 1 and alpha 4 on the adherent 
model CHO cell lines, CCL61 and AML. 
Cells were grown on cover-slips in 6 well plates and stained as described.  Imaging was 
performed using an inverted Zeiss LSM510 Meta confocal microscope. Mounted cell sam-
ples were analysed using a plan apochromat 63x/ 1.4 oil DIC objective. Excitation of the 
fluorochrome was at 488nm by an argon laser. Emission was collected using a band pass 
500-550 IR filter.  
For integrin alpha 1 and alpha 1 laser transmission had to be used at between 35% and 40%  
due to a very low staining signal. Laser transmission for integrin beta 1 was around 32%. 
Scale bars equal 10µm. 
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Figure 7.12: Conformation of integrin beta 1, alpha 1 and alpha 4 on S cells and 
CHO-S cells. 
Cells were grown in standard suspension conditions and stained as described before. Imag-
ing was performed using an inverted Zeiss LSM510 Meta confocal microscope. Mounted 
cell samples were analysed using a plan apochromat 63x/ 1.4 oil DIC objective. Excitation 
of fluorochrome was at 488nm by an argon laser. Emission was collected using a band pass 
500-550 IR filter. For integrin beta 1 a specific conformation with regularly distributed 
clusters of integrin beta 1 on the cell surface can be seen for both suspension cell lines. A 
similar but less distinct conformation is visible for integrin alpha 1 and integrin alpha 4. For 
integrin alpha 1 and alpha 4 laser transmission had to be used at between 35% and 40%  due 
to the very low staining signal. Laser transmission for integrin beta 1 was around 32%. 
Scale bars equal 10µm. 
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The conformation of integrin beta 1 on suspension CHO cells as seen in the confocal analysis in 
figures 7.13, 7.14 and 7.15 indicates sphere-like distribution of integrin clusters on the cell surface 
common to all three suspension adapted cell lines. In the next step the question to be addressed was 
whether this distribution is a common feature occurring for all cells, i.e. also for non-suspension 
adapted CCL61 when cultured in suspension, and whether the evenly distributed integrin beta 1 
clusters are a reaction to the media environment as suggested by the result for AML cells grown in 
suspension. 
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Figure 7.13: Three dimensional conformation of integrin beta 1 clusters on S cells  
Z-stacks were taken with an inverted Zeiss LSM510 Meta confocal microscope to analyse 
the three dimensional distribution of integrin beta 1 clusters on the cell surface. Every third 
image of the z-stack is presented. 
Set up:  image size: 512 x 512 pixels/ 58.4 µm x 58.4 µm  
  pixel time: 25.6 µs,  
  pinhole: 96 µm,  
  laser transmission : 29.6% 
scale bar: 10 µm 
A) scale 
B) z-stack 
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Figure 7.14: Three dimensional conformation of integrin beta 1 clusters on AML 
cells  grown in suspension 
Z-stacks were taken with an inverted Zeiss LSM510 Meta confocal microscope to analyse 
the three dimensional distribution of integrin beta 1 clusters on the cell surface. Every third 
image of the z-stack is presented. 
Set up:  image size: 228 x 228 pixels/ 22.6 µm x 22.6 µm  
  pixel time: 28.6 µs,  
  pinhole: 96 µm,  
  laser transmission : 35% 
   
scale bar: 10 µm 
A) scale 
B) z-stack 
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Figure 7.15: Three dimensional conformation of integrin beta 1 clusters on CHO-S 
Z-stacks were taken with an inverted Zeiss LSM510 Meta confocal microscope to analyse 
the three dimensional distribution of integrin beta 1 clusters on the cell surface. Every sec-
ond image of the z-stack is presented. 
Set up:  image size: 212 x 212 pixels/ 20.9 µm x 20.9 µm  
  pixel time: 15.4 µs,  
  pinhole: 121 µm,  
  laser transmission: 35% 
scale bar: 10 µm 
A) scale 
B) z-stack 
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7.10 Integrin beta 1 conformation as a reaction to the cell culture 
environment
To prove that the demonstrated integrin beta 1 conformation in suspension cells (figures 7.12 
-7.15)  is really due to the process of suspension adaptation it has to be verified that the 
conformation is a reaction of suspension adapted CHO cells to the cell culture environment. 
7.10.1 Methodology: conformation as reaction to cell culture 
environment
 S cells were cultured first in suspension growth conditions, then in adherent growth conditions 
and after that transferred back into suspension growth. AML cells were transferred from adherent 
into suspension growth conditions, and non-suspension adapted CCL61 were also transferred from 
adherent into suspension growth conditions. All three cell lines were treated in the same way when 
transferring them from adherent growth conditions into suspension growth conditions using a 
trypsin/EDTA harvest with a subsequent blocking of the trypsin using the adherent growth media. 
In all growth conditions the three cell lines were analysed for conformation of integrin beta 1 using 
confocal microscopy.
7.10.2 Result: conformation is a reaction to cell culture environment
As the results in figure 7.16 show, S cells change their conformation of integrin beta 1 when 
grown in adherent conditions. In adherent conditions the integrin conformation is comparable to 
what is seen for AML and CCL61 when these grow in their standard adherent mode, with smaller, 
less distinct cluster of integrin beta 1. Taking S cells back into suspension leads to re-formation of 
the integrin beta 1 conformation typical of suspension growth, with regularly distributed distinctive 
integrin beta 1 clusters on the cell surface. This conformation also develops when AML cells are 
grown in suspension. This is a clear indication that the demonstrated specific integrin beta 1 
conformation is a reaction of the two CHO cell lines to their growth environment, confirming that 
the conformation plays a role in the suspension phenotype. This result is strengthened by the fact 
that when transferring non-suspension adapted CCL61 cells into suspension growth the integrin 
beta 1 conformation changes to a different type of integrin beta 1 conformation, as shown in figure 
7.6. Large patches of integrin beta 1 clusters appear mainly on the connecting points where cells 
clump together. These cell clumps repeatedly appeared, to a varying degree, when CCL61 cells 
were cultured in suspension, for example during analysis of the cell growth characteristics. In 
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CCL61  cells grown in suspension, integrin beta 1 becomes concentrated at these contact points 
between the cells, indicating an interaction between cells and leaving the rest of the cell surface free 
of integrin beta 1 clusters. This conformation of CCL61 in suspension is apparently different from 
the conformation seen on S cells and AML cells growing in suspension. While the conformation of 
integrin beta 1 changes for all three cell lines in reaction to the environment, only the suspension 
adapted cell lines S cells and AML show the specific evenly clustered distribution of integrin beta 1 
on the cell surface when growing in suspension.
7.11 Discussion: role of integrin conformation in suspension adaptation
A specific conformation of integrins, in particular integrin beta 1, on the cell surfaces of the 
suspension adapted CHO cell lines (S cells, CHO-S and AML) has been found. This specific 
conformation is characterised by dot-like clusters of integrins that are evenly distributed over the 
entire cell surface, providing a sphere-like network of integrins on the cell surface similar to results 
seen for activated lymphocytes by Lub et al.(1997). The even distribution of integrin beta 1 clusters 
on leukocytes has also been demonstrated by Altrock et al. (2013).
It has been shown that this conformation is a reaction of the S cells and AML cells upon their 
cell culture environment and that both cell lines are capable of switching reversibly back and forth 
between the conformation seen in adherent growth and the one seen in suspension growth; similar 
processes of cell surface protein rearrangement have been shown for adherence of leukocytes by 
Shahal et al. (2012); in their study focal adhesion growth was influenced by RGD peptide density 
and EGF factor type (soluble, immobilised) and concentration. As S cells and AML cells in adherent 
conditions have been cultured in different media the conformation is clearly influenced by the 
suspension culture conditions seen, which for both cell lines used PSM media. The main factor for 
the demonstrated integrin conformation found can be assumed to be the suspension culture, 
independently of the media used, because CHO-S cells show a comparable integrin conformation in 
suspension, though being cultured in a different media. The switch seen between adherent and 
suspension confirms the importance of the integrin conformation for suspension growth. This idea 
is further strengthened by the fact that the non-suspension adapted CHO cell line CCL61 shows an 
entirely different conformation of integrin beta 1 when cultured in suspension using PSM media, 
lacking the evenly distributed dot-like clusters of integrin beta 1 on the cell surface and showing 
instead non-regularly distributed patches of integrin beta 1 that accumulate where the cells touch. 
Hence, it can be concluded that the non-suspension adapted cell line CCL61 lacks the capability to 
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change the integrin conformation to the dot-like clustering of integrins covering the entire cell 
surface, seen to exist for all three suspension adapted cell lines. Hence, CCL61 can be described as 
being less similar to leukocytes with regard to rearrangement capability of surface proteins 
compared to S cells, AML cells and CHO-S cells. Most studies (Lub et al., 1997, Bakker et al., 
2012) concentrated on the rearrangement of integrin beta 2 as the major beta chain involved in 
immune function, and not integrin beta 1; Altrock et al. (2012) showed a very similar integrin beta 1 
conformation as seen here for HSC cells.
Considering that integrins are constitutively expressed on suspension adapted CHO cells, 
although no ligand is provided by the cell culture environment, and the specific conformation type 
seen for integrins, it can be assumed that integrins, especially integrin beta 1,  play an important role 
in suspension CHO cells.  It is hence proposed that the described conformation of integrin beta 1 on 
the cell surface of suspension cells is part of a general suspension phenotype. The question remains 
what function the integrins have in the specific conformation demonstrated to exist on the surface of 
suspension adapted CHO cells.
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Figure 7.16: Conformation of integrin beta 1 clusters on the cell surfaces of S 
cells, AML cells and CCL61 as a reaction to cell culture environment. 
Top row shows conformation of integrin beta 1 on S cells in their standard growth condi-
tion (suspension). Middle row shows conformation of integrin beta 1 on: S cells grown in 
adherent conditions using mF12, AML cells grown in standard growth condition (PAM), 
CCL61 grown in standard growth condition (mF12). Bottom row shows integrin beta 1 
conformation on: S cells in suspension after having previously grown in adherent condi-
tions, AML cells growing in suspension and CCL61 growing in suspension. All imaging 
was done after three days in culture. All scale bars equal 10µm. 
Analysing the surface of suspension growth adapted CHO cells                                                          
8.   Chapter 
Intracellular interaction of integrins with the 
cytoskeleton
In this chapter the possible interactions between integrins and the actin cytoskeleton are 
described. Methods to analyse actin content and conformation are introduced. Then results on actin 
content and conformation for the model CHO cell lines are presented. The dependence of actin 
conformation on cell line and adaptation status is shown and the interplay between integrin and 
actin conformation is demonstrated as being relevant for suspension adaptation. 
8.1 Interaction between integrins and actin cytoskeleton – role of 
cytoplasmic beta tail and associated proteins
Studies concentrating on the intracellular signalling side of integrins stress the role the 
interaction between integrins and actin cytoskeleton plays. Wiesner et al. (2005) describe the actin 
cytoskeleton as one of the most important targets of integrin mediated cell signalling. Streuli (2009) 
describes the role integrins play in cell division and organisation of the mitotic spindle; both are 
processes where the rearrangement of the cytoskeleton is highly relevant. Regent et al. (2011) 
explain the connection between adhesion strength to ligands and the actin cytoskeleton as based on 
the integrin working as an interface between the two. The assembly of focal adhesions, points of 
attachment to the extracellular matrix, requires tension signals from the actin filaments which result 
in the binding of vinulin and talin to integrin cytoplasmic tails (Regent et al., 2011). Wiesner et al. 
(2005) describe the process of focal adhesion formation as a step-wise procedure that starts from 
focal complexes which are described as small dot-like dynamic structures (size around 100 nm) 
usually found in spreading cells. Focal adhesion, also called focal contact, is described as a mature 
focal complex with an elongated form  and a size of around 1 μm in resting cells. Integrin 
cytoplasmic tail binding proteins have been found to play a major role in focal adhesion 
development; talin and vinculin are seen as key players within the group of integrin cytoplasmic tail 
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binding proteins. Furthermore, the Arp2/3 complex, a nucleator for actin polymerisation that binds 
to vinculin, links actin polymerisation to integrins interacting with the extracellular matrix. The 
process of actin polymerisation is particularly active when integrins newly engage with the 
extracellular matrix, e.g. when integrins start to cluster (DeMali et al., 2003), and hence is more 
prominent in focal complexes. Delon and Brown (2007) describe the integrins as bidirectional 
acting proteins that on one hand act as classic receptors which allow the cell environment to 
influence the cell interior, while on the other hand the cell inside can also influence the integrins 
itself (concept of outside-in and inside-out signalling). Delon and Brown (2007) state that an active 
integrin conformation is required for integrin-actin interaction. They list several types of 
interaction: 
1) binding and capping of pre-existing actin filaments, which increases the stability of the cell, 
2) recruitment of proteins to polymerise new actin filaments (involving Arp2/3 complex),
 3) inhibition of actin dependent processes by intersecting with Rho GTPases (also described by 
Wiesner et al., 2005) and 
4) cytoskeleton contraction, amplifying integrin adhesion. 
Delon and Brown (2007) stress that the interaction between integrins and actin involves 
numerous (around 50) associated proteins and suggest that different integrins and different ligands 
might require different associated proteins and that adhesion site maturation might require a tightly 
regulated  sequence of associated proteins. They list a few of those associated proteins as essential 
for integrin function, including talin and integrin-linked kinase. Talin is known to bind direcly to 
integrins by a specific binding domain, thereby increasing the affinity of integrin to its ligand 
(Delon and Brown, 2007). Talin has been shown to have a second integrin binding domain which 
might play a role in integrin clustering. Talin anchors integrins in the membrane and provides the 
initial cytoskeleton connection. Integrin-linked kinase (ILK) is also able to bind directly to integrin 
beta 1 tails but might also interact indirectly. Phosphorylation of ILK regulates one of the down-
stream signalling pathways of integrin, protein kinase B/AKT3, and has also been indicated to 
phosphorylate integrins. ILK deficiency is linked to impaired adhesion to fibronectin (Wiesner et 
al., 2005). Other proteins that have been found to have an actin binding domain are parvin, filamin, 
α-actinin and tensin. The conformation of those proteins might also influence their role in the 
integrin-cytoskeleton interaction. Most of the data presented in the articles above is based on results 
gained from two-dimensional cell cultures using adherent cell lines such as fibroblasts, a model 
similar to the CCL61 cell line used in this study. Figure 8.1 summarizes the possible interaction 
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partners involved in the link between integrins and  cytoskeleton in cultured cells. Studies looking 
at the interaction between integrin and actin in tissue indicate differences in associated proteins and 
linkage between integrin and cytoskeleton in comparison to the two-dimensional models studied. 
Figure 8.1 Model of integrin-actin interaction and associated proteins.
Integrins predominantly interact with the actin cytoskeleton via the integrin beta 1 cytoplasmic tail. 
Proteins associated with this interaction (tensin, talin, filamin, ILK, paxillin, FAK, α-actinin) are 
shown. All are capable of binding to the cytoplasmic beta tail. Of these only filamin, tensin, talin 
and  α-actinin can bind to actin. Furthermore, those proteins can interact with each other either 
directly (solid blue line) or via other interaction proteins (dashed blue line). (Wiesner et al., 2005).
Different interactions might also play a role in suspension growing cells, as summarized by van 
Kooyk  and  Figdor  (2000)  and  shown  in  figure  7.1.  Several  studies  (Pedersen  et  al.,  1999; 
Humphries et al., 2007; Whitlock et al., 2000; Lub et al., 1997) have used cytoskeleton disrupting 
reagents  such  as  cytochalasin  D  to  study  actin  conformation,  focal  adhesion  formation  and 
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interaction  between  integrins  and  actin  cytoskeleton  in  adherent  and  suspension  cells.  Most 
interesting  in  this  context  is  the  study by Lub  et  al. (1997)  where  clustering  of  integrins  on 
lymphocytes  was induced by cytochalasin  D treatment.  Cytochalasin D has  been demonstrated 
frequently to disrupt the cytoskeleton of cells and this effect has been used to study the link between 
the actin cytoskeleton and numerous processes (Peterson and Mitchison, 2002; Mills et al., 2000). 
Hayduk and Lee (2004b) used cytochalasin D to improve protein production in adherent CHO cells.
8.2 Conformation of the actin cytoskeleton in the four model cell lines
As integrins were shown in this study to be expressed on the suspension adapted cells lines in a 
specific conformation, the conformation of actin as the main intracellular interaction partner of the 
integrins has also been analysed using confocal microscopy. The question is if there is also a 
specific conformation of actin for successfully suspension adapted CHO cell lines – as seen for the 
integrins – that could be used to described a CHO suspension phenotype.
In a first step the four cell lines S cells, CHO-S, AML and CCL61 were analysed with respect to 
their actin conformation when grown in their standard growth conditions. In figure 8.2  both 
adherent cell lines, AML and CCL61, show actin fibres across the cells and strong actin fibre 
formation (stronger staining signal) at the cell edges, a pattern one would expect for an adherent cell 
line grown in two-dimensional culture condition (Shahal et al., 2012). For the suspension cells no 
actin filaments can be seen across the intracellular part of the cells; instead, the actin cytoskeleton is 
concentrated in a sphere which from its diameter can be assumed to lie directly under the cell 
membrane; this is a conformation similar to what has been described to be found in activated T cells 
(Barda-Saad et al., 2004) and has also bee previously described for  lymphocytes (Mills et al., 
2000; Lub et al., 2007). The ruffling of the cytoskeleton might be due to the permeabilisation step 
that needs to be performed for actin staining, which can lead to cell shrinking. To determine 
whether the difference in the actin cytoskeleton conformation demonstrated to exist between 
adherent and suspension CHO cells is a reaction to the cell culture environment, AML and CCL61  
have also been cultured in suspension and their actin conformation was analysed.
In figure 8.3, both cell lines show a strong concentration of the actin cytoskeleton in a circle or 
sphere with no actin filaments across the inner area of the cells.  The non-suspension adapted cell 
line CCL61 shows only small clumps of cells with most cell clusters being around three cells in 
size, in contrast to the suspension adapted AML cells the cells of which grow in single cell mode 
(only few clusters of two cells). These cell clumps appeared repeatedly to a varying degree when 
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Figure 8.2: Conformation of actin in CCL61, AML, S cells and CHO-S in standard 
growth conditions. 
Cells were stained using phalloidin Alexa 546 and analysed by confocal microscopy. Im-
aging was performed using an inverted Zeiss LSM510 Meta confocal microscope. Mount-
ed cell samples were analysed using a plan apochromat 63x/ 1.4 oil DIC objective. Excita-
tion of fluorochrome was at 514 nm by an argon laser. Emission was collected using a long 
pass 560 nm filter. Pinhole was at 106 µm (111 µm for AML), laser transmission was 13%. 
All scale bars equal 10 µm.  
AML CCL61 
S cells CHO-S 
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Figure 8.3: Conformation of actin: S cells in comparison to CCL61 and AML, both 
grown in suspension. 
Cells were stained using phalloidin Alexa 546 and analysed by confocal microscopy. Im-
aging was performed using an inverted Zeiss LSM510 Meta confocal microscope. Mount-
ed cell samples were analysed using a plan apochromat 63x/ 1.4 oil DIC objective. Excita-
tion of fluorochrome was at 514 nm by an argon laser. Emission was collected using a long 
pass 560 nm filter. Pinhole was 106 µm  for S cells and 111 µm for CCL61 and AML and 
laser transmission was 13%. All scale bars equal 10 µm.  
S cells 
CCL61 susp 
CCL61 susp 
AML susp 
AML susp 
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CCL61 cells were cultured in suspension, for example during analysis of the cell growth 
characteristics. At the contact area of the CCL61 cell clumps the actin cytoskeleton is concentrated. 
This correlates with the result for the integrin beta 1 conformation seen in CCL61 cells grown in 
suspension where a concentration of the integrin beta 1 was also seen at the contact point of the 
clusters (compare figure 7.16). Hence, the conformations for actin and integrin beta 1 become 
similar when CCL61 are grown in suspension, indicating a strong linkage between integrin beta 1 
and actin, as suggested by previously mentioned studies. The actin conformation seen for the AML 
cells is the same as seen for the S cells. Therefore, suspension CHO cells seem to have a common 
distribution of the actin cytoskeleton that differs to a high degree from the conformation they show 
in adherent growth.  To further analyse the actin conformation z-stacks of S cells and AML grown in 
suspension were acquired to gain a three-dimensional model of the actin conformation.
Figure 8.4 clearly shows that the actin cytoskeleton of an S cell forms a strong sphere which is 1-
2 μm thick and completely encloses the intracellular area of the cell. The same conformation of a 
ball-like cytoskeleton is seen in AML cells when growing in suspension, whereas in adherent 
growth they show filaments across the cells and strong actin  fibre formation at the cell edges. The 
actin conformation seen is very similar for all four cell lines when grown in suspension, with the 
notable difference that CCL61 cells grown in suspension show a stronger signal for actin at the 
contact area of cells when small cell clumps are formed. The sphere-like actin conformation can be 
interpreted as a reaction of the cells lines to the culture conditions and seems to be linked to the 
integrin beta 1 conformation, as indicated by the comparable shift in distribution and conformation 
when switching AML and CCL61 from adherent to suspension growth. This is also in line with the 
literature where numerous studies have concentrated on the analysis of the integrin -cytoskeleton 
interaction (Pedersen et al., 1999; Humphires, 2007; Hayes et al., 2011, Bakker et al., 2012). One 
reason for the observed conformation can be assumed to be the shear stress that cells experience in 
suspension culture, leading to a strong sub-cortical actin cytoskeleton. Due to the weakness of the 
integrin signal, its imaging requiring a high laser transmission, it was not possible to analyse double 
stained cells to further investigate the interaction between integrin and actin, as the Alexa 546 
fluorochrome was also excited to a measurable extent by the 488 nm excitation wavelength at high 
laser transmission.
While imaging the actin in different cell lines it was noted that the signal intensity for the S cells 
seemed stronger compared to that of the other cell lines imaged. This may be an indication of a 
difference in actin content between the cell lines. The sphere-like actin conformation had shown to 
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be a feature seen not only for successfully suspension adapted CHO cell lines. As the confocal 
image intensities suggested a difference in actin content, the next question to address was if the 
successful suspension adapted CHO cell  lines  (S cells,  AML and CHO-S) show a higher actin 
content compared to the non-suspension adapted cell line CCL61.
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Figure 8.4: Three-dimensional conformation of actin in S cells.  
Cells were stained using phalloidin Alexa 546 and analysed. Z-stacks were taken with an 
inverted Zeiss LSM510 Meta confocal microscope to analyse the three-dimensional con-
formation of actin. Mounted cell samples were analysed using a plan apochromat 63x/ 1.4 
oil DIC objective. Excitation of fluorochrome was at 514nm by an argon laser. Emission 
was collected using a long pass 560 nm filter. Every second image of the z-stack is pre-
sented. 
Set up:  image size: 512 x 459 pixels/ 36.6 µm x 32.8 µm , 
  pixel time: 25.6 µs,  
  pinhole: 106 µm,  
  laser transmission : 13% 
A) scale 
scale bar: 10 µm 
B) z-stack 
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scale bar: 10 µm 
B) z-stack 
Figure 8.5: Three-dimensional conformation of actin in AML grown in suspension.  
Cells were stained using phalloidin Alexa 546 and analysed. Z-stacks were taken with an 
inverted Zeiss LSM510 Meta confocal microscope to analyse the three dimensional confor-
mation of actin. Mounted cell samples were analysed using a plan apochromat 63x/ 1.4 oil 
DIC objective. Excitation of fluorochrome was at 514nm by an argon laser. Emission was 
collected using a long pass 560 nm  filter. Every image of the z-stack is presented. 
Set up:  image size: 224 x 224 pixels/ 24.4 µm x 24.4 µm, 
  pixel time: 14.4 µs,  
  pinhole: 111 µm,  
  laser transmission : 13%  
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8.3 Comparison of the actin content of the four model cell lines by flow 
cytometry
The actin content of the four model cell lines was quantitatively measured by flow cytometry to 
address the question if, despite the four cell S cells, AML, CHO-S and CCL61 showing a 
comparable actin conformation when grown in suspension, the actin content could be used to 
distinguish a CHO suspension phenotype, as the conformation analysis had indicated a higher actin 
content in the S cells.
8.3.1 Methodology: analysis of actin content 
Flow cytometry in combination with phalloidin staining has been used previously to determine 
the actin content of cells (Rao et al., 1990; Knowles and McCulloch, 1992) and was adopted for this 
study as a reliable method to evaluate the actin content of the four model cell lines. 
The protocol used in this study was based on the same staining protocol as used for confocal 
analysis because the Alexa 546 fluorochrome could also be measured with the flow cytometer. A 
typical flow cytometry result for the actin staining of S cells and CCL61 cells is shown in figure 
8.6. As the actin staining yielded a clear and easily visible shift in both cell lines the staining results 
were analysed using two markers in histogram analysis, with one marker (no actin stain) defining 
the unstained (= negative) population and the other marker (actin staining) defining the stained (= 
positive) population. For an unstained sample more than 98% of the cells lay within the no-actin-
stain marker, whereas for a stained sample 98% of the cells lay within the actin-stain marker. The 
use of two markers within one histogram, possible due to the very bright staining signal, made a 
subtraction of the background staining, as done previously for integrin staining, unnecessary. 
Hence, median fluorescence intensities (MFI) as given by the analysis program could be used to 
evaluate the actin content of the cell lines. To allow comparison of data sets measured on different 
days the MFI values were normalised using the MFI of S cells as reference. MFI of S cells was 
chosen as the reference point as those samples were expected  to give the highest MFI values from 
the result in the confocal microscopy analysis.
8.3.2 Differences in actin content when comparing suspension adapted 
CHO cells lines to a non-suspension adapted CHO cell line
The actin content was analysed using the method described above. In the first set-up the cell 
lines were compared when grown in their standard growth conditions, i.e. S cells and CHO-S in 
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Figure 8.6: Staining examples and analysis method for actin content analysis. 
Cells were stained using phalloidin Alexa 546 and analysed by flow cytometry. Staining 
resulted in a single peak for the stained population with a well defined shift between un-
stained (light grey) and stained (dark grey) samples. Analysis was performed using two 
markers defining unstained and stained samples (no stain actin/ actin staining). Markers 
were kept constant for analysis of one experiment. Markers were set to include > 98% of 
the population within the FCS gate (not shown). Median fluorescence intensity of the pop-
ulation within the markers was used for analysis. Triplicates of stained samples were ana-
lysed. Calculated median fluorescence intensity was used for further analysis and normali-
sation. 
A) example of actin staining for S cells 
B) example of actin staining for CCL61 
unstained percentage MFI 
no actin 
stain 
99.8 2.51 
actin    
staining 
0.2 22.3 
stained percentage MFI 
no actin 
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0.1 ± 0.0  4.2 ± 1.5 
actin   
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99.9 ± 0.1 1470 ± 735.4 
 
unstained percentage MFI 
no actin 
stain 
99.8 2.6 
actin    
staining 
0.2 28.0 
stained percentage MFI 
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98.4 ± 0.2 85.8 ± 45.3 
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Figure 8.7: Actin content in standard and reversed growth conditions. 
Actin content was determined with flow cytometry. For each experiment median fluores-
cence intensity of  randomly chosen passages was determined and normalized against MFI 
of S cells. Standard deviation of MFI was calculated from triplicates of samples. Upper 
diagram A) shows results for cell lines grown in their standard growth conditions. Lower 
diagram B) compares cell lines grown in reversed growth conditions to S cells grown in 
standard conditions. Cells grown in suspension conditions have a higher actin content than 
cells grown in adherent conditions. 
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suspension, AML and CCL61 in adherent culture conditions. In the second set-up S cells, AML and 
CCL61 were grown in reversed growth conditions. The experiments were repeated twice; each time 
randomly chosen passages were analysed. As figure 8.7 A) clearly demonstrates, the actin content is 
higher in the suspension adapted cell lines CHO-S and S cells compared to adherently grown AML 
and CCL61. There is only a small degree of variation between different passages and the difference 
in actin content between S cells and CHO-S compared to CCL61 and AML is around a factor of 2, 
with CCL61 containing even less actin than AML cells. 
To examine if the increase in actin content is typical for CHO cells cultured and proliferating in 
suspension, AML and CCL61 were also cultured in suspension, with the expectation of an increase 
of the actin content if the actin content was purely a reaction to the cell environment; if only AML 
cells grown in suspension showed an increase in actin content this would indicate the actin content 
was an attribute related to successful suspension adaptation. In addition, S cells were grown in 
adherent mode with the expectation of a  decrease in actin content in the case the actin content was 
related to the cell culture environment.
As figure 8.6 B) demonstrates, CCL61  and the AML up-regulate their actin content although 
CCL61 are a non-suspension adapted cell lines, indicating that the actin content changes as a 
reaction to the cell culture environment. This is underlined by the fact that the S cells down-regulate 
the actin content when grown in adherent conditions. Nevertheless, the up-regulation for CCL61 
and the down-regulation for S cells is not as high as seen before where adherent CCL61 cells 
showed an actin content around a factor of 2 smaller than the S cells.
8.3.3 Discussion of the differences in actin content
 It was demonstrated that the amount of actin in the cytoskeleton is up-regulated when CHO cells 
are grown in suspension. Conformational analysis showed that the cytoskeleton is also rearranged to 
form a strong sub-cortical sheet of actin when CHO cells are grown in suspension. Hence, the actin 
cytoskeleton requires a complete rearrangement, from the actin fibre structures across the entire 
cells to a strong sphere-like actin cytoskeleton, when adherent CHO cells are transferred into 
suspension. The resulting sub-cortical actin sheet is stronger in the successfully suspension adapted 
cell lines, S cells, AML and CHO-S, than in CCL61 cells grown in suspension. Nevertheless, 
CCL61 show a conformation very similar to the described actin conformation when grown in 
suspension and show an increase in actin content. This indicates that both actin content and 
conformation are strongly influenced by the cell culture environment; it can be assumed that the 
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increase in shear stress cells experience in suspension growth conditions due to the continuous 
shaking plays a major role in this transformation. 
The actin content might be used as a measure of successful suspension adaptation when 
comparing different cell lines if the necessary control samples are included in the measurements. As 
previous studies have shown the importance of actin cytoskeleton and integrins expressed on the 
cell surface, and the confocal data for the CCL61 cells grown in suspension indicated a parallel re-
formation of the actin cytoskeleton with integrin beta 1 expressed on the cell surface, a further 
analysis to investigate this interaction has been performed. 
8.4 Interrogating the interaction between actin cytoskeleton and integrin 
beta 1 with cytochalasin D
Lub et al. (1997) have demonstrated that it is possible to induce clustering of integrins by 
cytochalasin D treatment. It has been concluded in this study that suspension adapted CHO cell 
lines show a specific integrin beta 1 conformation characterised by evenly distributed integrin 
clusters on the cell surface. Furthermore, the results of the actin analysis has shown that the 
cytoskeleton is up-regulated in CHO cells grown in suspension and that the actin conformation is 
linked to the integrin beta 1 conformation. It is hence proposed that it should be possible to 
introduce the specific integrin beta 1 clustering on non-suspension adapted CHO cells by treating 
those cells during suspension adaptation with cytochalasin D. This should also allow further 
analysis of the interplay between integrin  beta 1 conformation and actin conformation in 
suspension growing CHO cell lines.
8.4.1 Methodology: transfer into suspension growth with successive 
cytochalasin D treatment and recovery period
S cells and CCL61 cells were grown in adherent conditions for four days. Cells were then 
harvested using trypsin/EDTA followed by the blocking of the trypsin in adherent growth media 
with FBS and then transferred into PSM media at a seeding density of 0.4 x 106/ml (the required 
cell amount was spun down to avoid FBS supplementation). Cells were treated with 5 μM 
cytochalasin D (stock concentration 1 mg/ml  in ethanol), a concentration that had been tested to 
show breakdown of the actin cytoskeleton without having a directly negative effect on the viability 
(see appendix). A control sample was treated with the equivalent amount of ethanol (EtOH). Cells 
were incubated with cytochalasin D for 8 hours. Samples were stained for actin and integrin beta 1 
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Figure 8.8: Effect of cytochalasin D on integrin and actin conformation in suspen-
sion and non-suspension adapted CHO cells.  
CCL61 and S cells were transfered into PSM suspension culture with 5 µM cytochalasin D. 
After 8 hours of suspension culture, the cells were washed to remove cytochalasin D (CD) 
and cells were re-suspended in PSM and cultured for another 18 hours without CD. 
One set of cell samples was analysed for integrin beta 1 and actin conformation after CD 
treatment and another set was done after the 18 hour recovery period. Imaging was per-
formed using an inverted Zeiss LSM510 Meta confocal microscope. Mounted cell samples 
were analysed using a plan apochromat 63x/ 1.4 oil DIC objective. Excitation and emission 
was set as described before. All scale bars equal 10 µm. 
CCL61 grown in suspension 
cultured 8 hours with 5 µM cytochalasin D 
S cells grown in suspension 
cultured 8 hours with 5 µM cytochalasin D 
CCL61 grown in suspension 
18 hours after cytochalasin D withdrawal 
S cells grown in suspension 
18 hours after cytochalasin D withdrawal 
integrin 
beta 1 
integrin 
beta 1 
integrin 
beta 1 
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confocal analysis at this time point to prove disruption of the actin cytoskeleton by the drug. Cells 
were spun down to remove cytochalasin D and re-suspended in PSM, re-adjusting the seeding 
density to 0.4  x 106/ml again. Cells were cultured in suspension mode for 18 hours and analysed 
again with regard to integrin beta 1 and actin conformation.
8.4.2 Influence of cytochalasin D on integrin beta 1 and actin 
conformation
Figure 8.8 demonstrates clearly that cytochalasin D breaks down the actin conformation of the 
cells in suspension growth, leading to large irregularly distributed clusters of actin. Nevertheless, no 
actin filaments have formed across the intracellular parts of the cells. The integrin beta 1 
conformation shows irregularly distributed clusters for both cell lines, S cells and CCL61; and in 
the case of CCL61 also some diffuse, non-clustered expression on the cell surface is noticeable. 
Furthermore, both cell lines show membrane ruffles to some extent indicating that cells are 
undergoing an alteration of the properties of the actin network (Mills et al., 2000). After withdrawal 
of cytochalasin D and culture  in PSM media, the actin cytoskeleton conformation resembles very 
closely the conformation seen before in suspension cells, with a sphere-like sub-cortical sheet of 
actin, although there are a few areas showing a less even actin distribution than before. This is the 
case for both cell lines, S cells and CCL61 grown in suspension. The integrin beta 1 conformation 
after the recovery period shows small, quite regularly distributed clusters of integrins covering the 
entire cell surface for both cell lines. Hence, the previously seen sphere-like integrin beta 1 
conformation has been successfully induced in the non-suspension adapted CCL61 cell line. 
This conclusion is further strengthened by the data presented in figure 8.9 and 8.10 which show 
the three-dimensional conformation of integrin beta 1 on CCL61 cells after the recovery period, 
with figure 8.9 presenting the results after treatment with cytochalasin D and figure 8.10 presenting 
the results after treatment with the solvent control ethanol. While the treatment with cytochalasin D 
yields a z-stack for the CCL61 grown in suspension conditions similar to what was seen previously 
for S cells and AML grown in suspension (figures 7.13 and 7.14), the cells treated with the solvent 
control ethanol show concentration of the integrin beta 1 in form of large patches where two cells 
are in contact, as demonstrated previously for CCL61 cells grown in suspension without any 
treatment. The remaining cell surface is nearly entirely free of integrin beta 1 expression.
It has therefore been clearly demonstrated that integrin beta 1 clustering on CCL61 cells grown 
in suspension can be induced by treatment with cytochalasin D, resulting in a conformation that can 
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Figure 8.9: Three-dimensional integrin beta 1 conformation after cytochalasin D 
treatment in non-suspension adapted CCL61.  
CCL61 were transferred into PSM suspension culture with 5 µM cytochalasin D. After 8 
hours of culture, the cells were washed to remove cytochalasin D (CD) and cells were re-
suspended in PSM and cultured for another 18 hours without CD. After the recovery period 
z-stacks were taken with an inverted Zeiss LSM510 Meta confocal microscope to analyse 
the three-dimensional conformation of integrin beta 1.  Every second image of the z-stack is 
presented. 
Set up:  image size: 296 x 296 pixels; 29.3 µm x 29.3 µm, 
  pixel time: 11 µs 
  pinhole:  111 µm  
  laser transmission: 35% 
A) scale 
B) z-stack 
scale bar: 10 µm 
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scale bar: 10 µm 
B) z-stack 
Figure 8.10: Three-dimensional integrin beta 1 conformation after treatment with 
EtOH (control to cytochalasin D) in non-suspension adapted CCL61.  
CCL61 were transferred into PSM suspension culture adding 0.3%  EtOH (solvent con-
trol). After 8 hours of suspension culture, the cells were washed to remove EtOH and cells 
were re-suspended in PSM and cultured for another 18 hours. 
Z-stack was taken with an inverted Zeiss LSM510 Meta confocal microscope to analyse 
the three-dimensional conformation of integrin beta 1. Mounted cell samples were ana-
lysed using a plan apochromat 63x/ 1.4 oil DIC objective. 
Set up:  image size: 368 x 368 pixels, 36.6 µm  x 36.6 µm   
  pixel time: 17.8 µs 
  pinhole:  101 µm  
  laser transmission: 35% 
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be regarded as a common feature of suspension adapted CHO cell lines. The successful induction of 
the integrin beta 1 conformation in CCL61 grown in suspension by cytochalasin D treatment 
indicates that for suspension adaptation a controlled rearrangement of the actin cytoskeleton in 
conjunction with a specific change in integrin beta 1 conformation needs to occur. While suspension 
adapted cells such as S cells, AML and CHO-S can switch the actin and integrin beta 1 
conformation between the structures usually seen in adherent cells and the one described before for 
the suspension phenotype, non-suspension adapted CCL61 are only capable of doing so after 
breaking down the actin cytoskeleton with cytochalasin D. This difference between S cells, CHO-S 
and AML could indicate a difference in the proteins involved in the interplay between actin and 
integrin beta 1. 
8.5 Growth of non-suspension adapted CCL61 after cytochalasin D 
treatment
It was demonstrated that the specific integrin beta 1 clustering typical for suspension adapted 
CHO cells can be induced by treatment with cytochalasin D on CCL61 cells grown in suspension. 
The next question to address was whether this switch in conformation allows CCL61 to grow in 
suspension.
8.5.1 Methodology: suspension growth characteristics after treatment 
with cytochalasin D
CCL61 cells and S cells were treated with cytochalasin D as described before. After washing out 
of cytochalasin D, growth characteristics were determined for four days using the same method as 
in chapter 4. As a control set-up both cell lines were treated with ethanol. The aim was to find out if 
cytochalasin D treatment allows suspension growth of CCL61 cell comparable to the growth seen  
in treated S cells.
8.5.2 Influence of cytochalasin D treatment on suspension growth of S 
cells and CCL61
As figure 8.11 A) shows, CCL61 treated with cytochalasin D do not grow in suspension to a 
viable cell density comparable to that of S cells treated with cytochalasin D. The result 
demonstrates that the change of integrin beta 1 conformation induced by cytochalasin D is not 
sufficient to allow the CCL61 cells to grow in suspension suggesting that the conformational 
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Figure 8.11: Growth results of S cells and CCL61 grown in suspension after treat-
ment with cytochalasin D.   
Both cell lines, S cells and CCL61, were grown adherently first. After trypsin harvest and 
transfer into suspension culture with PSM, 5 µM cytochalasin D (CD) was added to the cul-
ture. Controls were treated with equivalent amounts of EtOH (solvent). After 8 hours of 
suspension culture, the cells were washed to remove CD/EtOH and cells were re-suspended 
in PSM. Cell growth was monitored for three consecutive days. Viable cell density and via-
bility are plotted. A) compares results of CD treated samples. B) compares effect of CD and 
EtOH in S cells (1, left)  and CCL61 (2, right). Number of independent samples is 3 in all 
measurements.  
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change is probably coupled to a change in either downstream signalling from the integrin and/ or a 
change in the signalling between actin cytoskeleton and integrin and the relevant associated proteins 
involved. It is noticeable that both cell lines show an early drop in viability after the treatment with 
cytochalasin D which is very unusual when compared to the viability data seen in the previous 
growth characterisation. The treatment with cytochalasin D shows an overall negative effect on the 
growth of the two cell lines, as can also be seen in figure 8.11 B) where the growth of cells treated 
with the solvent (ethanol) alone is compared to the growth results of the cytochalasin D treated 
samples. The viability remains above 95% for the ethanol treated samples and the S cells reach a 
viable cell density of close to 4.5 x 106/ml, however, for both cell lines the viability drops below 
80% on day 3 (around 60% for CCL61) and the cytochalasin D treated S cells only reach a viable 
cell density of maximal 1.5 x 106/ml. This indicates a loss of cell proliferation and survival 
signalling for the cytochalasin D treated cells.
8.6 Discussion: Interaction between integrins and actin cytoskeleton
From the specific integrin conformation found to exist on suspension adapted CHO cells as  
demonstrated in chapter 7 it was hypothesized that there might also be a specific actin conformation 
for suspension adapted CHO cells as integrins interact closely with the cytoskeleton via the help of 
numerous associated proteins (Wiesner et al., 2005; Regent et al., 2011). The analysis of the actin 
conformation with confocal microscopy revealed that all CHO cell lines, whether they were 
suspension-adapted or not, formed a sphere-like sub-cortical sheet of actin when grown in 
suspension, a conformation which has been demonstrated before for activated T cells (Barda-Saad 
et al., 2005) and suspension adapted CHO cells (Hayes et al., 2011). The change between the actin 
conformation from the adherent conformation characterised by actin fibres running across the entire 
cell to the sub-cortical sheet in suspension is influenced by the cell culture environment as 
demonstrated in figures 8.3 and 10.2. The conformational analysis also indicated an orchestrated 
rearrangement of integrin beta 1 and actin in the CCL61 grown in suspension, as the sphere-like 
sub-cortical actin sheet showed a higher concentration at the contact area between cells where, as 
previously demonstrated in figure 7.12, also integrin beta 1 occurs in larger patches. Further 
analysis of the actin content in the four model cell lines demonstrated that CHO cells grown in 
suspension up-regulate their actin content in comparison to adherent growth mode and that the actin 
content found in successfully suspension-adapted CHO cells as S cells, CHO-S and AML is higher 
than in the non-suspension adapted CCL61.
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When probing the degree of interplay between integrin beta 1 and actin by treatment of CCL61 
with cytochalasin D to induce integrin clustering as previously demonstrated for lymphocytes by 
Lub et al. (1997) it was found that the specific integrin beta 1 conformation previously seen on S 
cells, AML and CHO-S could indeed be induced with this treatment. Bakker et al. (2012) have also 
demonstrated an effect of cytochalasin D treatment on integrin clustering with respect to diffusion 
of integrin nano-clusters. 
Nevertheless, when tested for cell growth in suspension conditions using PSM media the CCL61 
cells with induced integrin beta 1 clustering were not capable of reaching viable cell densities 
comparable to those of S cells. One reason for this is clearly the detrimental effect of cytochalasin D 
on cell growth as seen by the reduced growth for S cells treated in the same way which did not 
reach their maximal viable cell density after the treatment. Furthermore, the results of the growth 
test after cytochalasin D treatment indicate that additional changes in, for example, the downstream 
signalling from integrins and/ or changes in the interaction between actin cytoskeleton and integrin 
and their associated proteins are necessary for successful suspension adaptation of CHO cells, 
involving for example MAP kinase and RhoA, which have been demonstrated by Hayes et al. 
(2011) to play a role in cytoskeletal remodelling in CHO cells. 
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9.   Chapter 
Conclusion and future work 
This study aims to provide a better understanding of the changes the cell surface of CHO cells, 
major production vehicles in bioprocessing, undergoes in the process of suspension adaptation. 
Suspension adaptation plays an important part in the biopharmaceutical industry, as state-of-the-art 
production of recombinant proteins, such as antibodies and cytokines, requires production cell lines 
to be adapted to suspension and serum-free culture conditions, ideally in a chemically defined 
media. The transition from a parental adherent cell line such as CCL61 studied here, to a CHO 
suspension cell line, such as S cells studied here, is hence underlined by a significant change in cell 
culture environment. Previous studies in this area concentrated on single aspects, such as the 
influence of specific integrins on adhesion strength. 
9.1 Conclusion: from cell characterisation to actin conformation
The four cell lines studied fall into two groups: the first one consisting of the non-suspension 
adapted CCL61 as the parental cell line, and the second group consisting of S cells, CHO-S and 
AML as suspension adapted cell lines. The second group can be further divided into two subgroups, 
with S cells and CHO-S usually cultured in suspension and AML usually being cultured in adherent 
conditions. It has been shown in this study that none of the suspension adapted cell lines has lost the 
capability to grow adherently but that adhesion strength varies, with CHO-S showing lowest 
adhesion capability.
 Studying the cell surface of the four model cell lines by biotinylation has indicated that cells 
growing in suspension differ in the amount of cell surface proteins from adherently grown cells. 
Enrichment of the cell surface proteins has shown differences in the composition of the cell surface 
proteome between adherent and suspension cells but also differences of the cell surface proteome 
between CHO-S and S cells, as one might expect from the different cell growth characteristics. No 
large variation was noticeable between S cells and AML, two very closely related cell lines. 
 -140-
Analysing the surface of suspension growth adapted CHO cells                                                          
Unfortunately, enrichment of cell surface proteins from adherent cells proved to be insufficient for 
analysis by LC-MS/MS  with a good proteome coverage. Although several approaches have been 
tested to yield comparable protein enrichment from suspension and adherent CHO cells, no 
sufficiently effective protocol could be established. Hence, the original plan of quantitative cell 
surface proteome analysis based on LC-MS/MS was not pursued further. Nevertheless, those results 
have established that there is indeed a difference in cell surface proteins between adherent and 
suspension cells. The results also confirmed that different suspension CHO cell lines differ in their 
surface proteome.
Flow cytometric analysis of cell-to-cell adhesion molecule expression has demonstrated that the 
three cell surface proteins CD44, CD56 and E-cadherin show a large variance with bimodal 
distribution patterns with respect to their expression level between different passages of S cells. 
This heterogeneity of expression is larger for the S cells than the variance of expression seen in 
CCL61 for these markers. The results demonstrated further that adaptation of cells to suspension 
growth conditions leads to a variety of changes in the cell surface proteome. The variable bimodal 
type of expression of the analysed markers seen for the S cells has had no influence on the growth 
characteristic of the cell lines as a comparison of different passages with respect to growth revealed 
no major change of viable cell density reached over time of culture. It has hence been concluded 
that the cell surface proteins CD44, CD56 and E-cadherin do not necessarily have to be expressed 
on successfully suspension adapted CHO cells, however, it is interesting to note that in this study 
the parental CCL61 cell line has shown only low (CD56 and E-cadherin) or non-existing expression 
(CD44) of these markers.
Integrins are cell surface proteins that on the extracellular side predominantly interact with the 
extracellular matrix in tissue and the serum proteins in two-dimensional cell culture. As suspension 
culture conditions exclude serum those cell surface proteins are of major interest in this study. It is 
known that integrins play a large role in apoptosis and anoikis regulation and that adherent cell lines 
with lower integrin expression levels are less adhesive in culture. In this study the expression level 
of integrin beta 1, integrin alpha 4 and integrin alpha 1 has been analysed. As the cell-to-cell 
adhesion marker expression proved too variable for a comparison of expression levels between cell 
lines, integrin expression was first studied with respect to expression stability of the three integrins 
on S cells and CCL61. It could be shown that there is some variation in expression level between 
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different passages of S cells and CCL61. The degree of variation was different for the three 
integrins analysed, with integrin beta 1 showing the smallest overall variation. The variation in 
expression level is larger for S cells than  for CCL61 for all three integrins. This is similar to the 
larger heterogeneity seen for cell-to-cell adhesion molecule expression on S cells when compared to 
variations between  cell-to-cell adhesion molecule expression on CCL61. Nevertheless, all three 
integrins analysed are expressed on both cell lines in all cells, a result that is underlined by the mass 
spectrometry results, which have shown expression of integrins on S cells. No bimodal expression 
pattern has been found for the three integrins, allowing analysis of the difference between the cell 
surface of suspension adapted cells and adherent cells with regard to integrin expression level using 
flow cytometry.
Table 9.1 Up- and down-regulation of the three integrins studied in suspension adapted 
CHO cells. 
Reference point is the expression level on adherently grown CCL61. Integrin alpha 1 was not 
measured in AML suspension. ↓ indicates down-regulation, ↑ up-regulation, ~ nearly constant 
expression.
cell line integrin alpha 1 integrin alpha 4 integrin beta 1
S cells ↓ ↑ ↑
CHO-S ~ ↑ ↓
AML suspension n/a ↓ ↑
As table 9.1 shows, the three integrins are expressed at different levels on suspension adapted CHO 
cell lines. No general trend of up- or down-regulation has been found in the data gathered. It is 
hence concluded that integrin expression levels cannot be used as a tool to describe successfully 
suspension-adapted CHO cell lines. To analyse if the integrins expressed on the cell surface are 
functionally active, the integrin beta 1 antibody was used in an adherence blocking experiment with 
S cells, CHO-S and AML. As mentioned before, these cell lines are all able to grow adherently 
(with some variation in adhesiveness).
The integrin beta 1 antibody used in this study has been shown to bind to an epitope which is 
induced by ligand binding or calcium depletion. Furthermore, reduced binding of the antibody has 
been found to be connected to a reduced adhesion capability of cells. Other studies have used the 
antibody to block adhesion. In this study the integrin beta 1 antibody only blocked adhesion of 
CHO-S to a noticeable degree. AML, S cells and CCL61 adhesion was not influenced by the 
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antibody. Hence, the CHO-S cell lines, which showed a reduced expression level of integrin beta 1 
and loss of adhesion in the blocking experiment with integrin beta 1 antibody, are noticeable 
different from the other suspension-adapted cell lines, S cells and AML. As reduced integrin beta 1 
binding has been described by Green et al. (2009) to be related to mutations in signalling down-
stream of integrin beta 1,  CHO-S might differ from S cells and AML not only in their integrin 
expression level but also in the signalling pathways down-stream of integrin - ligand binding. This 
is a further indication that different suspension CHO cells might react to suspension adaptation by 
changing cell surface proteins and intracellular signalling in different ways. Nevertheless, it can be 
assumed that some suspension-adapted CHO cells will show a decreased integrin beta 1 expression 
level (using clone 9EG7) combined with reduced adhesion capability,  however, this needs not to be 
true for all suspension adapted CHO cell lines, as shown for S cells. It might also be that a 
decreased integrin beta 1 expression level is correlated to higher reachable viable cell density, as 
CHO-S cells have shown much higher viable cell density in the growth characterisation. 
As no general trend for down-regulation of integrin across the CHO cell types tested has been 
found on suspension-adapted CHO cell lines and integrin conformation has been shown to be an 
important marker of integrin activation status, the integrin conformation was studied using confocal 
microscopy. The analysis of the three integrins alpha 1, alpha 4 and beta 1 has revealed a specific 
integrin conformation on CHO-S, S cells and AML in suspension. This conformation is 
characterised by dot-like clusters of integrins that are evenly distributed over the entire cell surface 
and hence form sphere-like nets on the cell surface. This conformation is most pronounced for 
integrin beta 1 on all suspension cell lines, however, the difference seen between integrin alpha 4 
and integrin alpha 1 as compared to integrin beta 1 might be due to the differences in signal 
intensities in confocal analysis of the three markers. It has been demonstrated that the described 
conformation is a reaction of the cells to their environment, as for S cells and AML this 
conformation could be induced by changing from adherent cell culture conditions to suspension 
conditions. In contrast to this, CCL61 grown in suspension do not show this type of conformation. 
It is hence concluded that dot-like integrin clusters covering the cell surface in an even network are 
a substantial necessary condition for suspension-adapted CHO cells and might hence be used in the 
development of suspension cell lines as an endpoint analysis.
One of the main interaction partners of integrins on the intracellular side is the actin 
cytoskeleton. Integrins do not interact directly with actin but through a larger set of associated 
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proteins; for example, focal adhesion kinase, tensin and vinculin can bind to the integrin beta tail 
and actin. The protein interaction complex is thought to depend, with respect to its composition, on 
the cell type and the integrins and ligands involved. To analyse the role of the integrins expressed 
on the cell surface of suspension-adapted CHO cells more closely the actin conformation has been 
studied using confocal microscopy. For adherent cells actin stress fibres running across the entire 
cell interior could be identified, as one expects for attached cells. In suspension,  the actin 
conformation is changed completely. Actin is then concentrated in sub-cortical ball-like structures 
enclosing the intracellular volume. This process of conformation change also occurs in CCL61 
grown in suspension; there is a small difference to suspension adapted CHO cells, as CCL61 form 
clumps in suspension culture (three  or more cells form groups) and actin is concentrated higher in 
the contact areas between the cells. This concentration of signal in the contact area of CCL61 
clumps was also seen in the integrin beta 1 conformational analysis. 
From a comparison of the signal intensity of the actin spheres seen in different cell lines it has 
been assumed that the actin content between different cell lines varies. Actin content analysis using 
flow cytometry has revealed that the amount of actin in cells increases when CHO cells are grown 
in suspension. The increase was strongest in CHO-S, but it was also measurable for S cells and 
AML grown in suspension. CCL61 grown in suspension also have shown an increase of actin 
content in comparison to adherent growth but have not reached values measured for fully 
suspension-adapted cells. The increase in actin content seen in suspension growing CHO cells can 
be assumed to be a reaction to the shear stress cells undergo by the constant shaking in suspension 
culture. Increase in actin content might hence be used as an indicator for suspension adaptation 
when using appropriate controls such as non-suspension adapted  cells and suspension-adapted 
cells, both grown in suspension. 
As results of integrin and actin conformation analyses have indicated a dependence between the 
conformational changes seen for both suspension and non-suspension adapted cells, this interplay 
has been analysed further with the help of cytochalasin D, an actin disrupting reagent. Cytochalasin 
D has been used here to induce integrin clustering in non-suspension adapted CCL61 by first 
breaking down the cytoskeleton with cytochalasin D, followed by a drug free recovery period of 18 
hours. Confocal analysis of the integrin beta 1 conformation has revealed that a clustered network 
of integrin beta 1 could indeed be induced in CCL61 grown in suspension after breakdown of the 
cytoskeleton with cytochalasin D; also no larger cell clumps have been found in the treated CCL61 
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cells. S cells treated in the same way regained the specific integrin actin conformation after the 
recovery period. Hence, integrin clustering in CCL61 grown in suspension could be induced, 
indicating the need for a structural transformation of integrin conformation in combination with a 
change or disruption of actin-integrin interaction to allow for this conformation to form.
The strong interaction observed between cytoskeleton and integrin beta 1 in CHO cells could be  
the reason why a specific integrin conformation has been observed on suspension-adapted CHO 
cells; integrins might be required to retain the enforced cytoskeleton for suspension cells. As 
successfully inducing the specific integrin beta 1 conformation in CCL61 grown in suspension 
reduced the appearance of cell clumps, the integrin conformation might also play a role in reducing 
cell-to-cell contact and/ or capability of clumping.
Analysing the cell growth of CCL61 cells treated with cytochalasin D has shown that the 
induced integrin beta 1 conformation is not sufficient  for successful growth in suspension. 
Although the rearrangement of conformation was demonstrated for the treated cells they were not 
able to grow in suspension and reached viable cell densities lower than those seen for S cells treated 
the same way. As a comparison with solvent-only treated samples has revealed that cytochalasin D 
has a negative effect on viable cell densities in S cells, perhaps a less toxic treatment inducing the 
transformation in conformation might be an alternative to yield better growth results. Nevertheless, 
as treated CCL61 have not shown growth comparable to treated S cells it can be assumed that 
additional changes apart from combined integrin/ actin conformation changes need to occur. As the 
results obtained reveal the importance of the integrin-actin interaction such additional changes 
might be found in the proteins linking actin and integrin. 
9.2 Future work
In this study the emphasis was on the changes the cell surfaces of CHO cells undergo in the 
adaptation from adherent to suspension growth. As numerous different protocols are applied in this 
process it would be worthwhile to quantitatively compare the cell surface proteome of different 
suspension adapted CHO cells using mass spectrometry to prove the hypothesis indicated by this 
study that the cell surfaces of different suspension-adapted  CHO cell lines varies in their cell 
surface proteome. This would allow using the same sample preparation process enabling 
comparable efficient cell surface protein enrichment. Data analysis would also be improved by the 
fact that the CHO genome has recently been sequenced (Baycin-Hizal et al., 2012), thereby 
allowing proteomic data analysis against Cricetulus griseus proteins instead of rodents, as 
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attempted in this study, hence improving the reliability of protein identification. The results could 
give an overview of the differences and the similarities between suspension adapted CHO cells and 
one could try to link those to certain other cell line characteristics, such as growth, capability of 
transfection or protein secretion by using cell lines differing in those capabilities.
With regards to cell-to-cell adhesion molecule expression, a possible further line of investigation 
would be to monitor molecules such as CD44, CD56 and E-cadherin during a cell suspension 
adaptation process to see how the change from low expression on adherent cells to a bimodal 
distribution on suspension cells occurs, e.g. if a positive population builds up slowly or if within a 
few passages most cells express these proteins and later-on lose their expression again. If the latter 
is the case this might indicate changes in intracellular processes, such as DNA transcription or 
mRNA translation regulation, to play a role in suspension adaptation. It would also be interesting to 
analyse if the expression of the three markers is in some way correlated, e.g. if cells expressing 
CD44 also express CD56 and E-cadherin, as this would indicate that different specific sub-
populations arise during suspension adaptation. Such an analysis was attempted in this study with 
the S cells but yielded unreliable data as the bimodal distribution at the time of analysis was 
predominantly shifted to non-expressing cells. 
It would be useful to establish a more stable integrin expression analysis to generate data with a 
comparable variance as this would allow the results to be tested more rigorously with statistical 
methods. One way would be to stain more samples of unfixed cells in one experiment and measure 
these against internal standards such as fluorescent beads, to compare expression levels between 
cell lines. This would reduce sample preparation steps and differences possibly induced due to 
storage duration. On the other hand, the differences observed between passages might well be a 
naturally occurring fluctuation in expression level due to the heterogeneity of CHO cell lines. 
Another route of investigation that would build on the results yielded in this study would be to 
investigate if integrin beta 1 expression and its down-regulation is generally correlated with higher 
viable cell density, as indicated by the results seen in this study for CHO-S. In conjunction with 
analysis of the integrin beta 1 conformation and actin content this approach might allow the 
establishment of threshold values for a suspension phenotype describing a CHO cell line with 
optimal growth characteristics. This analysis should also include fast growing suspension cell lines 
adapted to different media, e.g. with and without insulin or zinc, to allow a study of the influence of 
these factors on integrin expression and conformation. In addition, it would be important to analyse 
the influence of the integrin beta 1 conformation and expression level with regard to the 
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characteristic of clump formation in cell culture. This could yield a better understanding of the role 
of the cell surface protein expression and conformation of the process of cell clumping, which is a 
problem frequently encountered in bio-pharmaceutical industry.
As the treatment with cytochalasin D  has demonstrated the importance of the interaction 
between integrin and actin cytoskeleton in suspension adaptation, it would be important to study 
this process in more detail to gain a better understanding of the changes in intracellular processes 
that are possibly important in suspension adaptation. This could include a detailed study of the 
proteins involved in integrin-actin interaction such as vinculin, talin, focal adhesion kinase, with 
regard to their respective expression, activation and localisation in the cell. The results might 
indicate how one could directly influence the changes necessary for suspension adaptation. 
Furthermore, such a study could be extended to the signalling pathways downstream of the integrins 
as the appearance of the suspension specific integrin clusters also indicates that changes in 
intracellular signalling might occur in suspension adaptation as has been attempted in a parallel PhD 
project.
The results gained here with regard to integrin conformation and expression are based on 
suspension adapted but non-producing cell lines. As establishing production cell lines includes 
numerous steps, thereby applying additional selection pressure, it would be important to analyse if 
the specific integrin conformation and actin up-regulation found for suspension adapted cells in this 
study can be found in industrial production cell lines as well. If the results indicated the same 
integrin conformation and actin up-regulation for production cell lines, this would strengthen the 
concept that these characteristics are important for suspension adapted cells. Furthermore, one could 
analyse the influence of different transfection and selection procedures on those characteristics and 
eventually optimise the choice of a certain cell clone for production by using integrin and actin 
conformation as an additional selection step ensuring that the cell line chosen will show a stable 
suspension phenotype.
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10.   Chapter 
Appendix
10.1 Mass spectrometry: protein identification results
10.1.1 CCL61: List of proteins identified 
Table 10.1  Proteins identified for CCL61 and designated to be localised in 'membrane' 
Italics mark proteins identified more than once (in different organism).
Accession Entry name Protein names Subcellular locations Organism
Q5SSE9 ABCAD_MOUSE
ATP-binding cassette sub-family A member 
13
Membrane; Multi-
pass membrane 
protein; 
Mus musculus 
(Mouse)
Q99PA3 BASI_CRIGR Basigin (CD antigen CD147) (Fragment)
Cell membrane; 
Single-pass type I 
membrane protein; 
Melanosome; 
Cricetulus 
griseus 
(Chinese 
hamster)
P54290 CA2D1_RAT
Voltage-dependent calcium channel subunit 
alpha-2/delta-1 (Voltage-gated calcium 
channel subunit alpha-2/delta-1) 
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
P47934 CACP_MOUSE
Carnitine O-acetyltransferase (Carnitine 
acetylase) (EC 2;3;1;7) (Carnitine 
acetyltransferase) (CAT) (CrAT)
Endoplasmic 
reticulum; Peroxis-
ome; Mitochon-
drion inner mem-
brane; Peri-pheral 
membrane protein; 
Matrix side;
Mus musculus 
(Mouse)
Q704S8 CACP_RAT
Carnitine O-acetyltransferase (Carnitine 
acetylase) (EC 2;3;1;7) (Carnitine 
acetyltransferase) (CAT) (CrAT)
Endoplasmic re-
ticulum; Peroxi-
some; Mito-
chondrion inner 
membran; Peri-
pheal membrane 
protein; Matrix 
side; 
Rattus 
norvegicus 
(Rat)
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Accession Entry name Protein names Subcellular locations Organism
Q3TVA9 CC136_MOUSE Coiled-coil domain-containing protein 136
Membrane; Single-
pass membrane 
protein; 
Mus musculus 
(Mouse)
Q4V885 COL12_RAT
Collectin-12 (Collectin placenta protein 1) 
(CL-P1) (Nurse cell scavenger receptor 2)
Membrane; Single-
pass type II 
membrane protein; 
Rattus 
norvegicus 
(Rat)
P20816 CP4A2_RAT
Cytochrome P450 4A2 (CYPIVA2) 
(Cytochrome P-450 K-2) (Cytochrome P450 
K-5) (Cytochrome P450-LA-omega 2) 
(Lauric acid omega-hydroxylase) (EC 
1;14;15;3)
Endoplasmic 
reticulum 
membrane; 
Peripheral 
membrane protein; 
Microsome 
membrane; 
Peripheral 
membrane protein; 
Rattus 
norvegicus 
(Rat)
P59764 DOCK4_MOUSE Dedicator of cytokinesis protein 4
Endomembrane 
system; Peripheral 
membrane protein; 
Mus musculus 
(Mouse)
Q8K3H0 DP13A_MOUSE
DCC-interacting protein 13-alpha (Dip13-
alpha) (Adapter protein containing PH 
domain; PTB domain and leucine zipper 
motif 1)
Early endosome 
membrane; 
Peripheral 
membrane protein; 
Nucleus; 
Mus musculus 
(Mouse)
P17182 ENOA_MOUSE
Alpha-enolase (EC 4;2;1;11) (2-phospho-D-
glycerate hydro-lyase) (Enolase 1) (Non-
neural enolase) (NNE)
Cytoplasm; Cell 
membrane; 
Mus musculus 
(Mouse)
P39087 GRIK2_MOUSE
Glutamate receptor; ionotropic kainate 2 
(Glutamate receptor 6) (GluR-6) (GluR6) 
(Glutamate receptor beta-2) (GluR beta-2)
Cell membrane; 
Multi-pass 
membrane protein; 
Cell junction ; 
synapse ; 
postsynaptic cell 
membrane; Multi-
pass membrane 
protein; 
Mus musculus 
(Mouse)
Q61647 HAS1_MOUSE
Hyaluronan synthase 1 (EC 2;4;1;212) 
(Hyaluronate synthase 1) (Hyaluronic acid 
synthase 1) (HA synthase 1)
Membrane; Multi-
pass membrane 
protein; 
Mus musculus 
(Mouse)
Q920H8 HEPH_RAT Hephaestin (EC 1;-;-;-)
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
A2AAE1 K1109_MOUSE
Uncharacterized protein KIAA1109 (Fragile 
site-associated protein homolog)
Membrane; Single-
pass membrane 
protein; 
Mus musculus 
(Mouse)
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Accession Entry name Protein names Subcellular locations Organism
P04104 K2C1_MOUSE
Keratin; type II cytoskeletal 1 (67 kDa 
cytokeratin) (Cytokeratin-1) (CK-1) (Keratin-
1) (K1) (Type-II keratin Kb1)
Cell membrane; Mus musculus (Mouse)
Q60675 LAMA2_MOUSE
Laminin subunit alpha-2 (Laminin M chain) 
(Laminin-12 subunit alpha) (Laminin-2 
subunit alpha) (Laminin-4 subunit alpha) 
(Merosin heavy chain)
Secreted ; 
extracellular space; 
extracellular matrix; 
basement 
membrane; 
Mus musculus 
(Mouse)
Q61092 LAMC2_MOUSE
Laminin subunit gamma-2 (Epiligrin subunit 
gamma) (Kalinin subunit gamma) 
(Kalinin/nicein/epiligrin 100 kDa subunit) 
(Laminin B2t chain) (Laminin-5 subunit 
gamma) (Nicein subunit gamma)
Secreted ; 
extracellular space; 
extracellular matrix; 
basement 
membrane; 
Mus musculus 
(Mouse)
Q8BI84 MIA3_MOUSE
Melanoma inhibitory activity protein 3 
(Transport and Golgi organization protein 1) 
(TANGO1)
Endoplasmic 
reticulum 
membrane; Single-
pass type I 
membrane protein; 
Mus musculus 
(Mouse)
O55164 MPDZ_RAT
Multiple PDZ domain protein (Multi-PDZ 
domain protein 1)
Endomembrane 
system; Cell 
junction ; tight 
junction; Apical cell 
membrane; Cell 
junction; synapse; 
Apical cell 
membrane; Cell 
junction; synapse; 
postsynaptic cell 
membrane ; 
postsynaptic 
density; Cell 
projection; dendrite; 
Cell junction ; 
synapse; 
synaptosome; 
Rattus 
norvegicus 
(Rat)
Q9JLN9 MTOR_MOUSE
Serine/threonine-protein kinase mTOR (EC 
2;7;11;1) (FK506-binding protein 12-
rapamycin complex-associated protein 1) 
(FKBP12-rapamycin complex-associated 
protein) (Mammalian target of rapamycin) 
(mTOR) (Mechanistic target of rapamycin) 
(Rapamycin target protein 1) (RAPT1)
Endoplasmic 
reticulum 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Golgi apparatus 
membrane;  
Mitochondrion 
outer membrane;  
Lysosome; 
Mus musculus 
(Mouse)
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Accession Entry name Protein names Subcellular locations Organism
A2AQP0 MYH7B_MOUSE
Myosin-7B (Myosin cardiac muscle beta 
chain) (Myosin heavy chain 7B; cardiac 
muscle beta isoform)
Membrane; 
Peripheral 
membrane protein; 
Mus musculus 
(Mouse)
Q99MZ6 MYO7B_MOUSE Myosin-VIIb
Apical cell 
membrane; 
Mus musculus 
(Mouse)
Q7TN88 PK1L2_MOUSE
Polycystic kidney disease protein 1-like 2 
(PC1-like 2 protein) (Polycystin-1L2)
Membrane; Multi-
pass membrane 
protein; 
Mus musculus 
(Mouse)
O88488 PTPRQ_RAT
Phosphotidylinositol phosphatase PTPRQ 
(EC 3;1;3;-) (Protein-tyrosine phosphatase 
receptor-type expressed by glomerular 
mesangial cells protein 1) (rPTP-GMC1) 
(Receptor-type tyrosine-protein phosphatase 
Q) (PTP-RQ) (R-PTP-Q) (EC 3;1;3;48)
Cell membrane; 
Single-pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q9D620 RFIP1_MOUSE
Rab11 family-interacting protein 1 (Rab11-
FIP1) (Rab-coupling protein)
Recycling 
endosome; 
Cytoplasmic vesicle 
; phagosome 
membrane; 
Mus musculus 
(Mouse)
O89026 ROBO1_MOUSE Roundabout homolog 1
Membrane; Single-
pass type I 
membrane protein; 
Mus musculus 
(Mouse)
Q01887 RYK_MOUSE
Tyrosine-protein kinase RYK (EC 2;7;10;1) 
(Kinase VIK) (Met-related kinase) (NYK-R)
Membrane; Single-
pass type I 
membrane protein; 
Mus musculus 
(Mouse)
Q6QIY3 SCNAA_MOUSE
Sodium channel protein type 10 subunit alpha 
(Peripheral nerve sodium channel 3) (PN3) 
(Sensory neuron sodium channel) (Sodium 
channel protein type X subunit alpha) 
(Voltage-gated sodium channel subunit alpha 
Nav1;8)
Membrane; Multi-
pass membrane 
protein; 
Mus musculus 
(Mouse)
O35412 SI1L1_RAT
Signal-induced proliferation-associated 1-like 
protein 1 (SIPA1-like protein 1) (SPA-1-like 
protein p1294) (Spine-associated Rap 
GTPase-activating protein) (SPAR)
Cytoplasm; 
cytoskeleton; Cell 
junction ; synapse; 
postsynaptic cell 
membrane ; 
postsynaptic 
density; Cell 
junction; synapse ; 
synaptosome; 
Rattus 
norvegicus 
(Rat)
P23739 SUIS_RAT
Sucrase-isomaltase; intestinal [Cleaved into: 
Sucrase (EC 3;2;1;48); Isomaltase (EC 
3;2;1;10)]
Apical cell 
membrane; Single-
pass type II 
membrane protein; 
Rattus 
norvegicus 
(Rat)
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Accession Entry name Protein names Subcellular locations Organism
Q6ZWR6 SYNE1_MOUSE
Nesprin-1 (Enaptin) (Myocyte nuclear 
envelope protein 1) (Myne-1) (Nuclear 
envelope spectrin repeat protein 1) (Synaptic 
nuclear envelope protein 1) (Syne-1)
Nucleus outer 
membrane; Single-
pass type IV 
membrane protein; 
Cytoplasmic side; 
Cytoplasm; 
cytoskeleton; 
Cytoplasm ; 
myofibril; 
sarcomere; 
Mus musculus 
(Mouse)
Q9EQU3 TLR9_MOUSE Toll-like receptor 9 (CD antigen CD289)
Endoplasmic 
reticulum 
membrane; Single-
pass type I 
membrane protein; 
Endosome; 
Lysosome; 
Cytoplasmic vesicle 
; phagosome; 
Mus musculus 
(Mouse)
Q2QI47 USH2A_MOUSE
Usherin (Usher syndrome type IIa protein 
homolog) (Usher syndrome type-2A protein 
homolog)
Cell projection; 
stereocilium 
membrane; Single-
pass type I 
membrane protein;  
Secreted; 
Mus musculus 
(Mouse)
10.1.2 S cells: List of proteins identified
Table 10.2  Proteins identified for S cells and designated to be localised in 'membrane' 
Italics mark the proteins identified more than once (in different organism);
Accession Entry name Protein names Subcellular locations Organism
Q9Z1T6 FYV1_MOUSE
1-phosphatidylinositol-3-phosphate 5-kinase 
(Phosphatidylinositol-3-phosphate 5-kinase) 
(EC 2;7;1;150) (FYVE finger-containing 
phosphoinositide kinase) (PIKfyve) 
(Phosphatidylinositol-3-phosphate 5-kinase 
type III) (PIPkin-III) (Type III PIP kinase) 
(p235)
Cytoplasmic vesicle 
membrane; 
Peripheral 
membrane protein; 
Endosome 
membrane; 
Mus 
musculus 
(Mouse)
Q8K4S1 PLCE1_MOUSE
1-phosphatidylinositol-4;5-bisphosphate 
phosphodiesterase epsilon-1 (EC 3;1;4;11) 
(Phosphoinositide phospholipase C-epsilon-
1) (Phospholipase C-epsilon-1) (PLC-
epsilon-1)
Cytoplasm; cytosol; 
Cell membrane; 
Golgi apparatus 
membrane; 
Mus 
musculus 
(Mouse)
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Q99P84 PLCE1_RAT
1-phosphatidylinositol-4;5-bisphosphate 
phosphodiesterase epsilon-1 (EC 3;1;4;11) 
(Phosphoinositide phospholipase C-epsilon-
1) (Phospholipase C-epsilon-1) (PLC-
epsilon-1)
Cytoplasm ;cytosol;  
Cell membrane; 
Golgi apparatus 
membrane; 
Rattus 
norvegicus 
(Rat)
A2AP18 PLCH2_MOUSE
1-phosphatidylinositol-4;5-bisphosphate 
phosphodiesterase eta-2 (EC 3;1;4;11) 
(Phosphoinositide phospholipase C-eta-2) 
(Phosphoinositide phospholipase C-like 4) 
(PLC-L4) (Phospholipase C-like protein 4) 
(Phospholipase C-eta-2) (PLC-eta2)
Cytoplasm; Cell 
membrane; 
Mus 
musculus 
(Mouse)
Q60991 CP7B1_MOUSE
25-hydroxycholesterol 7-alpha-hydroxylase 
(Oxysterol 7-alpha-hydroxylase) (EC 
1;14;13;100) (Cytochrome P450 7B1) 
(Hippocampal transcript 1 protein) (HCT-1)
Endoplasmic 
reticulum 
membrane; 
Peripheral 
membrane protein; 
Microsome 
membrane; 
Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
Q01237 HMDH_MOUSE
3-hydroxy-3-methylglutaryl-coenzyme A 
reductase (HMG-CoA reductase) (EC 
1;1;1;34)
Endoplasmic 
reticulum 
membrane; Multi-
pass membrane 
protein; Peroxisome 
membrane;
Mus 
musculus 
(Mouse)
P51639 HMDH_RAT
3-hydroxy-3-methylglutaryl-coenzyme A 
reductase (HMG-CoA reductase) (EC 
1;1;1;34)
Endoplasmic 
reticulum 
membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
P10852 4F2_MOUSE
4F2 cell-surface antigen heavy chain (4F2hc) 
(CD antigen CD98)
Apical cell 
membrane; Single-
pass type II 
membrane protein; 
Melanosome; 
Mus 
musculus 
(Mouse)
Q99J27 ACATN_MOUSE
Acetyl-coenzyme A transporter 1 (AT-1) 
(Acetyl-CoA transporter 1) (Solute carrier 
family 33 member 1)
Endoplasmic 
reticulum 
membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
O54967 ACK1_MOUSE
Activated CDC42 kinase 1 (ACK-1) (EC 
2;7;10;2) (Non-receptor protein tyrosine 
kinase Ack) (Tyrosine kinase non-receptor 
protein 2)
Cell membrane; 
Cell 
junction;adherens 
junction; 
Mus 
musculus 
(Mouse)
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Q9Z1K7 APC2_MOUSE Adenomatous polyposis coli protein 2
Cytoplasm; Golgi 
apparatus 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cell membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cytoplasm 
;cytoskeleton; 
Mus 
musculus 
(Mouse)
Q8C0T9 ADCYA_MOUSE
Adenylate cyclase type 10 (EC 4;6;1;1) 
(Germ cell soluble adenylyl cyclase) (sAC) 
(Testicular soluble adenylyl cyclase)
Cell membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cytoplasm;cytoskel
eton; Cytoplasm 
;perinuclear region; 
Mus 
musculus 
(Mouse)
Q9Z286 ADCYA_RAT
Adenylate cyclase type 10 (EC 4;6;1;1) 
(Germ cell soluble adenylyl cyclase) (sAC) 
(Testicular soluble adenylyl cyclase)
Cell membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cytoplasm;cytoskel
eton; 
Mitochondrion;  
;perinuclear 
region; ;centrosome 
;centriole; 
Rattus 
norvegicus 
(Rat)
P17182 ENOA_MOUSE
Alpha-enolase (EC 4;2;1;11) (2-phospho-D-
glycerate hydro-lyase) (Enolase 1) (Non-
neural enolase) (NNE)
Cytoplasm; Cell 
membrane; 
Mus 
musculus 
(Mouse)
Q8C8R3 ANK2_MOUSE Ankyrin-2 (ANK-2) (Brain ankyrin)
Cytoplasm;cytoskel
eton; Membrane; 
Cyto-plasm; 
myofibril; 
sarcomere; M-band; 
Apical cell 
membrane; Cell 
membrane; 
Mus 
musculus 
(Mouse)
P21958 TAP1_MOUSE
Antigen peptide transporter 1 (APT1) (ATP-
binding cassette sub-family B member 2) 
(Histocompatibility antigen modifier 1) 
(Peptide transporter TAP1)
Endoplasmic 
reticulum 
membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
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P36370 TAP1_RAT
Antigen peptide transporter 1 (APT1) (ATP-
binding cassette sub-family B member 2) 
(Peptide transporter TAP1)
Endoplasmic 
reticulum mem-
brane; Multi-pass 
membrane protein; 
Rattus 
norvegicus 
(Rat)
O35643 AP1B1_MOUSE
AP-1 complex subunit beta-1 (Adapter-
related protein complex 1 subunit beta-1) 
(Adaptor protein complex AP-1 subunit beta-
1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin 
assembly protein complex 1 beta large chain) 
(Golgi adaptor HA1/AP1 adaptin beta 
subunit)
Golgi apparatus; 
Cytoplasmic vesicle 
;clathrin-coated 
vesicle membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side;  
Mus 
musculus 
(Mouse)
P17426 AP2A1_MOUSE
AP-2 complex subunit alpha-1 (100 kDa 
coated vesicle protein A) (Adapter-related 
protein complex 2 alpha-1 subunit) (Adaptor 
protein complex AP-2 subunit alpha-1) 
(Alpha-adaptin A) (Alpha1-adaptin) (Clathrin 
assembly protein complex 2 alpha-A large 
chain) (Plasma membrane adaptor HA2/AP2 
adaptin alpha A subunit)
Cell membrane; 
Membrane;coated 
pit; Peripheral 
membrane protein; 
Cytoplasmic side; 
Mus 
musculus 
(Mouse)
Q9Z1T1 AP3B1_MOUSE
AP-3 complex subunit beta-1 (Adapter-
related protein complex 3 subunit beta-1) 
(Adaptor protein complex AP-3 subunit beta-
1) (Beta-3A-adaptin) (Clathrin assembly 
protein complex 3 beta-1 large chain)
Golgi apparatus; 
Cytoplasmic vesicle 
;clathrin-coated 
vesicle membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Golgi apparatus; 
Mus 
musculus 
(Mouse)
Q9QWY8 ASAP1_MOUSE
Arf-GAP with SH3 domain; ANK repeat and 
PH domain-containing protein 1 (130 kDa 
phosphatidylinositol 4;5-biphosphate-
dependent ARF1 GTPase-activating protein) 
(ADP-ribosylation factor-directed GTPase-
activating protein 1) (ARF GTPase-activating 
protein 1) (Development and differentiation-
enhancing factor 1) (DEF-1) (Differentiation-
enhancing factor 1) (PIP2-dependent ARF1 
GAP)
Cytoplasm; 
Membrane; 
Mus 
musculus 
(Mouse)
Q1AAU6 ASAP1_RAT
Arf-GAP with SH3 domain; ANK repeat & 
PH domain-containing protein 1 (130 kDa 
phosphatidylinositol 4;5-biphosphate-
dependent ARF1 GTPase-activating protein) 
(ADP-ribosylation factor-directed GTPase-
activating protein 1) (ARF GTPase-
activating protein 1) (Development and 
differentiation-enhancing factor 1) (Diff-
erentiation-enhancing factor 1) 
Cytoplasm; 
Membrane; 
Rattus 
norvegicus 
(Rat)
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Q03265 ATPA_MOUSE ATP synthase subunit alpha; mitochondrial
Mitochondrion 
inner membrane; 
Mus 
musculus 
(Mouse)
P56480 ATPB_MOUSE
ATP synthase subunit beta; mitochondrial 
(EC 3;6;3;14)
Mitochondrion; 
Mitochondrion 
inner membrane; 
Mus 
musculus 
(Mouse)
Q5SSE9 ABCAD_MOUSE
ATP-binding cassette sub-family A member 
13
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q8K441 ABCA6_MOUSE ATP-binding cassette sub-family A member 6
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q91V24 ABCA7_MOUSE ATP-binding cassette sub-family A member 7
Cell membrane; 
Multi-pass 
membrane protein; 
Golgi apparatus 
membrane;  Endo-
some membrane; 
Mus 
musculus 
(Mouse)
Q63563 ABCC9_RAT
ATP-binding cassette sub-family C member 9 
(Sulfonylurea receptor 2)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
P16067 ANPRB_RAT
Atrial natriuretic peptide receptor 2 (EC 
4;6;1;2) (Atrial natriuretic peptide receptor 
type B) (ANP-B) (ANPR-B) (NPR-B) 
(Guanylate cyclase B) (GC-B)
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q80YW5 BSPRY_MOUSE B box and SPRY domain-containing protein
Cytoplasm; 
Membrane; 
Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
Q05793 PGBM_MOUSE
Basement membrane-specific heparan sulfate 
proteoglycan core protein (HSPG) [Cleaved 
into: Endorepellin; LG3 peptide]
Secreted;extracellul
ar space 
;extracellular 
matrix;basement 
membrane; 
Mus 
musculus 
(Mouse)
Q99PA3 BASI_CRIGR Basigin (CD antigen CD147) (Fragment)
Cell membrane; 
Single-pass type I 
membrane protein; 
Melanosome; 
Cricetulus 
griseus 
(Chinese 
hamster)
Q9ES38 S27A5_RAT
Bile acyl-CoA synthetase (BACS) (EC 
6;2;1;7) (Bile acid-CoA ligase) (BA-CoA 
ligase) (BAL) (Cholate--CoA ligase) (Fatty 
acid transport protein 5) (FATP-5) (Solute 
carrier family 27 member 5) (Very long-chain 
acyl-CoA synthetase-related protein) 
(VLACS-related) (VLACSR)
Endoplasmic 
reticulum 
membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
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Q9QY30 ABCBB_MOUSE
Bile salt export pump (ATP-binding cassette 
sub-family B member 11) (Sister of P-
glycoprotein)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q3UHD1 BAI1_MOUSE Brain-specific angiogenesis inhibitor 1
Cell membrane; 
Multi-pass 
membrane protein; 
Mus 
musculus 
(Mouse)
Q8CGM1 BAI2_MOUSE Brain-specific angiogenesis inhibitor 2
Cell membrane; 
Multi-pass 
membrane protein; 
Mus 
musculus 
(Mouse)
Q80ZF8 BAI3_MOUSE Brain-specific angiogenesis inhibitor 3
Cell membrane; 
Multi-pass 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9R0M0 CELR2_MOUSE
Cadherin EGF LAG seven-pass G-type 
receptor 2 (Flamingo homolog)
Cell membrane; 
Multi-pass 
membrane protein; 
Mus 
musculus 
(Mouse)
Q91ZI0 CELR3_MOUSE
Cadherin EGF LAG seven-pass G-type 
receptor 3
Cell membrane; 
Multi-pass 
membrane protein; 
Mus 
musculus 
(Mouse)
Q99PF4 CAD23_MOUSE Cadherin-23 (Otocadherin)
Cell membrane; 
Single-pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
P58365 CAD23_RAT Cadherin-23 (Otocadherin)
Cell membrane; 
Single-pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q08460 KCMA1_MOUSE
Calcium-activated potassium channel subunit 
alpha-1 (BK channel) (BKCA alpha) 
(Calcium-activated potassium channel; 
subfamily M subunit alpha-1) 
(K(VCA)alpha) (KCa1;1) (Maxi K channel) 
(MaxiK) (Slo-alpha) (Slo1) (mSlo1) 
(Slowpoke homolog) (Slo homolog) (mSlo)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q80TJ1 CAPS1_MOUSE
Calcium-dependent secretion activator 1 
(Calcium-dependent activator protein for 
secretion 1) (CAPS-1)
Cytoplasmic vesicle 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cell junction 
;synapse; 
Mus 
musculus 
(Mouse)
Q62717 CAPS1_RAT
Calcium-dependent secretion activator 1 
(Calcium-dependent activator protein for 
secretion 1) (CAPS-1) (rCAPS)
Cytoplasmic vesicle  
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cell 
junction;synapse; 
Rattus 
norvegicus 
(Rat)
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Q8BYR5 CAPS2_MOUSE
Calcium-dependent secretion activator 2 
(Calcium-dependent activator protein for 
secretion 2) (CAPS-2)
Cytoplasmic vesicle 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cell junction 
;synapse; 
Mus 
musculus 
(Mouse)
Q8VI47 MRP2_MOUSE
Canalicular multispecific organic anion 
transporter 1 (ATP-binding cassette sub-
family C member 2)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
P18886 CPT2_RAT
Carnitine O-palmitoyltransferase 2; 
mitochondrial (EC 2;3;1;21) (Carnitine 
palmitoyltransferase II) (CPT II)
Mitochondrion 
inner membrane; 
Peripheral 
membrane protein; 
Matrix side; 
Rattus 
norvegicus 
(Rat)
P26231 CTNA1_MOUSE
Catenin alpha-1 (102 kDa cadherin-
associated protein) (Alpha E-catenin) 
(CAP102)
Cytoplasm;cytoskel
eton; Cell 
junction ;adherens 
junction; Cell 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Mus 
musculus 
(Mouse)
Q07113 MPRI_MOUSE
Cation-independent mannose-6-phosphate 
receptor (CI Man-6-P receptor) (CI-MPR) 
(M6PR) (300 kDa mannose 6-phosphate 
receptor) (MPR 300) (Insulin-like growth 
factor 2 receptor) (Insulin-like growth factor 
II receptor) (IGF-II receptor) (M6P/IGF2 
receptor) (M6P/IGF2R) (CD antigen CD222)
Lysosome 
membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q61490 CD166_MOUSE
CD166 antigen (Activated leukocyte cell 
adhesion molecule) (Protein DM-GRASP) 
(CD antigen CD166)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q01062 PDE2A_RAT
cGMP-dependent 3';5'-cyclic 
phosphodiesterase (EC 3;1;4;17) (Cyclic 
GMP-stimulated phosphodiesterase) (CGS-
PDE) (cGSPDE)
Membrane; 
Peripheral 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q00657 CSPG4_RAT
Chondroitin sulfate proteoglycan 4 
(Chondroitin sulfate proteoglycan NG2) 
(HSN tumor-specific antigen)
Cell membrane; 
Single-pass type I 
membrane protein; 
Extracellular side; 
Apical cell mem-
brane;  Cell pro-
jection lamelli-
podium; membrane; 
Rattus 
norvegicus 
(Rat)
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Q8VHY0 CSPG4_MOUSE
Chondroitin sulfate proteoglycan 4 
(Chondroitin sulfate proteoglycan NG2) 
(Proteoglycan AN2)
Apical cell 
membrane; Single-
pass type I 
membrane protein; 
Extracellular side; 
Cell 
projection;lamellip
odium membrane; 
Single-pass type I 
membrane protein; 
Extracellular side; 
Mus musculus 
(Mouse)
Q9Z261 CLD7_MOUSE Claudin-7
Cell membrane; 
Multi-pass 
membrane protein; 
Lateral cell 
membrane; Cell 
junction ;tight 
junction; 
Mus 
musculus 
(Mouse)
Q9QZE5 COPG_MOUSE
Coatomer subunit gamma (Gamma-coat 
protein) (Gamma-COP)
Cytoplasm; Golgi 
apparatus 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cytoplasmic 
vesicle;COPI-
coated vesicle 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Mus 
musculus 
(Mouse)
Q3TVA9 CC136_MOUSE Coiled-coil domain-containing protein 136
Membrane; Single-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
P02463 CO4A1_MOUSE
Collagen alpha-1(IV) chain [Cleaved into: 
Arresten]
Secreted 
;extracellular 
space;extracellular 
matrix ;basement 
membrane; 
Mus 
musculus 
(Mouse)
Q63870 CO7A1_MOUSE
Collagen alpha-1(VII) chain (Long-chain 
collagen) (LC collagen)
Secreted;extracellul
ar space 
;extracellular 
matrix;basement 
membrane; 
Mus 
musculus 
(Mouse)
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Q07563 COHA1_MOUSE
Collagen alpha-1(XVII) chain (180 kDa 
bullous pemphigoid antigen 2) (Bullous 
pemphigoid antigen 2) [Cleaved into: 120 
kDa linear IgA disease antigen homolog]
Cell junction 
;hemidesmosome; 
Membrane; Single-
pass type II 
membrane protein;  
Secreted; extra-
cellular space extra-
cellular matrix base-
ment membrane; 
Mus 
musculus 
(Mouse)
Q99MQ5 COPA1_MOUSE
Collagen alpha-1(XXV) chain (CLAC-P) 
[Cleaved into: Collagen-like Alzheimer 
amyloid plaque component (CLAC)]
Membrane; Single-
pass type II 
membrane protein; 
Mus 
musculus 
(Mouse)
Q2UY11 COSA1_MOUSE Collagen alpha-1(XXVIII) chain
Secreted;extra-
cellular space extra-
cellular matrix base-
ment membrane; 
Mus 
musculus 
(Mouse)
P08122 CO4A2_MOUSE
Collagen alpha-2(IV) chain [Cleaved into: 
Canstatin]
Secreted 
;extracellular 
space;extracellular 
matrix ;basement 
membrane; 
Mus 
musculus 
(Mouse)
Q9QZS0 CO4A3_MOUSE
Collagen alpha-3(IV) chain [Cleaved into: 
Tumstatin]
Secreted;extracellul
ar space 
;extracellular 
matrix;basement 
membrane; 
Mus 
musculus 
(Mouse)
Q9QZR9 CO4A4_MOUSE Collagen alpha-4(IV) chain
Secreted ;extra-
cellular space 
extracellular matrix 
basement mem-
brane; 
Mus 
musculus 
(Mouse)
Q80YA9 CNKR2_MOUSE
Connector enhancer of kinase suppressor of 
ras 2 (Connector enhancer of KSR 2) (CNK 
homolog protein 2) (CNK2)
Cytoplasm; Mem-
brane; Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
Q61330 CNTN2_MOUSE
Contactin-2 (Axonal glycoprotein TAG-1) 
(Axonin-1) (Transient axonal glycoprotein 1) 
(TAX-1)
Cell membrane; 
Lipid-anchor;GPI-
anchor; 
Mus 
musculus 
(Mouse)
Q9JMB8 CNTN6_MOUSE
Contactin-6 (Neural recognition molecule 
NB-3) (mNB-3)
Cell membrane; 
Lipid-anchor ;GPI-
anchor; 
Mus 
musculus 
(Mouse)
Q64535 ATP7B_RAT
Copper-transporting ATPase 2 (EC 3;6;3;4) 
(Copper pump 2) (Pineal night-specific 
ATPase) (Wilson disease-associated protein 
homolog)
Golgi appa-
ratus;trans-Golgi 
net-work mem-
brane; Multi-pass 
membrane protein; 
Rattus 
norvegicus 
(Rat)
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Q64446 ATP7B_MOUSE
Copper-transporting ATPase 2 (EC 3;6;3;4) 
(Copper pump 2) (Wilson disease-associated 
protein homolog)
Golgi apparatus 
;trans-Golgi 
network membrane; 
Multi-pass 
membrane protein; 
Mus 
musculus 
(Mouse)
P09605 KCRS_RAT
Creatine kinase S-type; mitochondrial (EC 
2;7;3;2) (Basic-type mitochondrial creatine 
kinase) (Mib-CK) (Sarcomeric mitochondrial 
creatine kinase) (S-MtCK)
Mitochondrion 
inner membrane; 
Peripheral 
membrane protein; 
Intermembrane 
side; 
Rattus 
norvegicus 
(Rat)
Q923L3 CSMD1_MOUSE
CUB and sushi domain-containing protein 1 
(CUB and sushi multiple domains protein 1)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
O70244 CUBN_RAT
Cubilin (460 kDa receptor) (Glycoprotein 
280) (gp280) (Intrinsic factor-cobalamin 
receptor) (Intrinsic factor-vitamin B12 
receptor)
Endosome 
membrane; 
Peripheral 
membrane protein; 
Lysosome 
membrane; 
Peripheral 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q8CIM7 CP2DQ_MOUSE
Cytochrome P450 2D26 (EC 1;14;14;1) 
(CYPIID26)
Endoplasmic 
reticulum 
membrane; 
Peripheral 
membrane protein; 
Microsome 
membrane; 
Mus 
musculus 
(Mouse)
Q45VK7 DYHC2_MOUSE
Cytoplasmic dynein 2 heavy chain 1 
(Cytoplasmic dynein 2 heavy chain) (Dynein 
cytoplasmic heavy chain 2) (Dynein heavy 
chain 11) (mDHC11) (Dynein heavy chain 
isotype 1B)
Cytoplasm;cytoskel
eton ;cilium 
axoneme; Cell 
membrane; 
Peripheral 
membrane protein; 
Cytoplasm; 
Mus 
musculus 
(Mouse)
Q9JJ79 DYHC2_RAT
Cytoplasmic dynein 2 heavy chain 1 
(Cytoplasmic dynein 2 heavy chain) (Dynein 
cytoplasmic heavy chain 2) (Dynein heavy 
chain isotype 1B) (Dynein-like protein 4)
Cytoplasm;cytoskel
eton ;cilium 
axoneme; Cell 
membrane; 
Peripheral 
membrane protein; 
Cytoplasm; 
Rattus 
norvegicus 
(Rat)
Q8BUR4 DOCK1_MOUSE
Dedicator of cytokinesis protein 1 (180 kDa 
protein downstream of CRK) (DOCK180)
Cytoplasm; 
Membrane; 
Mus 
musculus 
(Mouse)
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Q8C3J5 DOCK2_MOUSE
Dedicator of cytokinesis protein 2 (Protein 
Hch)
Endomembrane 
system; Peripheral 
membrane protein; 
Cytoplasm;cytoskel
eton; 
Mus 
musculus 
(Mouse)
O55111 DSG2_MOUSE Desmoglein-2
Cell membrane; 
Single-pass type I 
membrane protein; 
Cell junction 
;desmosome; 
Mus 
musculus 
(Mouse)
Q80UP3 DGKZ_MOUSE
Diacylglycerol kinase zeta (DAG kinase zeta) 
(EC 2;7;1;107) (Diglyceride kinase zeta) 
(DGK-zeta)
Cytoplasm; 
Nucleus; Cell 
membrane; 
Mus 
musculus 
(Mouse)
Q91ZV2 DCBD2_RAT
Discoidin; CUB and LCCL domain-
containing protein 2 (Endothelial and smooth 
muscle cell-derived neuropilin-like protein)
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q61824 ADA12_MOUSE
Disintegrin and metalloproteinase domain-
containing protein 12 (ADAM 12) (EC 
3;4;24;-) (Meltrin-alpha)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9R1V6 ADA22_MOUSE
Disintegrin and metalloproteinase domain-
containing protein 22 (ADAM 22)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q8BPN8 DMXL2_MOUSE DmX-like protein 2 (Rabconnectin-3)
Cytoplasmic 
vesicle;secretory 
vesicle ;synaptic 
vesicle membrane; 
Peri-pheral 
membrane protein; 
Mus 
musculus 
(Mouse)
Q4VA61 DSCL1_MOUSE
Down syndrome cell adhesion molecule-like 
protein 1 homolog
Cell membrane; 
Single-pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
P11531 DMD_MOUSE Dystrophin
Cell membrane; 
Peripheral mem-
brane protein; 
Cytoplasmic side; 
Cytoplasm cyto-
skeleton; 
Mus 
musculus 
(Mouse)
Q5U430 UBR3_MOUSE
E3 ubiquitin-protein ligase UBR3 (EC 
6;3;2;-) (N-recognin-3) (Ubiquitin-protein 
ligase E3-alpha-3) (Zinc finger protein 650)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q2TL32 UBR4_RAT
E3 ubiquitin-protein ligase UBR4 (EC 
6;3;2;-) (N-recognin-4) (Zinc finger UBR1-
type protein 1)
Multi-pass mem-
brane protein; Cyto-
plasm; Cytoplasm 
;cytoskeleton; 
Nucleus; 
Rattus 
norvegicus 
(Rat)
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A2AN08 UBR4_MOUSE
E3 ubiquitin-protein ligase UBR4 (EC 
6;3;2;-) (N-recognin-4) (Zinc finger UBR1-
type protein 1) (p600)
Membrane; Multi-
pass membrane 
protein; Cytoplasm; 
Cytoplasm;cytoskel
eton; Nucleus; 
Mus musculus 
(Mouse)
Q8BL66 EEA1_MOUSE Early endosome antigen 1
Cytoplasm; Early 
endosome mem-
brane; Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
Q69ZW3 EHBP1_MOUSE EH domain-binding protein 1
Cytoplasm; 
Membrane; 
Mus 
musculus 
(Mouse)
Q6RI88 S4A5_RAT
Electrogenic sodium bicarbonate 
cotransporter 4 (Solute carrier family 4 
member 5)
Cell membrane; 
Multi-pass 
membrane protein; 
Basolateral cell 
membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q9JJ22 ERAP1_RAT
Endoplasmic reticulum aminopeptidase 1 (EC 
3;4;11;-) (ARTS-1) (Adipocyte-derived 
leucine aminopeptidase) (A-LAP) 
(Aminopeptidase PILS) (Puromycin-
insensitive leucyl-specific aminopeptidase) 
(PILS-AP)
Endoplasmic 
reticulum 
membrane; Single-
pass type II 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q9EQH2 ERAP1_MOUSE
Endoplasmic reticulum aminopeptidase 1 
(EC 3;4;11;-) (ARTS-1) (Adipocyte-derived 
leucine aminopeptidase) (A-LAP) 
(Aminopeptidase PILS) (Puromycin-
insensitive leucyl-specific aminopeptidase) 
(PILS-AP) (VEGF-induced aminopeptidase)
Endoplasmic 
reticulum 
membrane; Single-
pass type II 
membrane protein; 
Mus musculus 
(Mouse)
P54763 EPHB2_MOUSE
Ephrin type-B receptor 2 (EC 2;7;10;1) 
(Neural kinase) (Nuk receptor tyrosine 
kinase) (Tyrosine-protein kinase receptor 
EPH-3) (Tyrosine-protein kinase receptor 
SEK-3)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q60902 EP15R_MOUSE
Epidermal growth factor receptor substrate 
15-like 1 (Epidermal growth factor receptor 
pathway substrate 15-related sequence) 
(Eps15-rs) (Eps15-related protein) (Eps15R)
Cell membrane; 
Peripheral 
membrane protein; 
Nucleus; Membrane 
;coated pit; 
Mus 
musculus 
(Mouse)
Q6IE26 EPHX4_MOUSE
Epoxide hydrolase 4 (EC 3;3;-;-) 
(Abhydrolase domain-containing protein 7) 
(Epoxide hydrolase-related protein)
Membrane; Single-
pass type II 
membrane protein; 
Mus 
musculus 
(Mouse)
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Q9JIM1 S29A1_MOUSE
Equilibrative nucleoside transporter 1 
(Equilibrative nitrobenzylmercaptopurine 
riboside-sensitive nucleoside transporter) 
(Equilibrative NBMPR-sensitive nucleoside 
transporter) (Nucleoside transporter; es-type) 
(Solute carrier family 29 member 1)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
O70503 DHB12_MOUSE
Estradiol 17-beta-dehydrogenase 12 (EC 
1;1;1;62) (17-beta-hydroxysteroid 
dehydrogenase 12) (17-beta-HSD 12) (3-
ketoacyl-CoA reductase) (KAR) (EC 1;3;1;-) 
(KIK-I)
Endoplasmic 
reticulum 
membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q3TZZ7 ESYT2_MOUSE Extended synaptotagmin-2 (E-Syt2)
Cell membrane; 
Multi-pass 
membrane protein; 
Mus 
musculus 
(Mouse)
Q80T14 FRAS1_MOUSE Extracellular matrix protein FRAS1
Cell membrane; 
Single-pass type I 
membrane protein; 
Extracellular side; 
Mus 
musculus 
(Mouse)
A3KGK3 FR1L4_MOUSE Fer-1-like protein 4
Membrane; Single-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q6P6L0 FIL1L_MOUSE
Filamin A-interacting protein 1-like (Protein 
down-regulated in ovarian cancer 1 homolog) 
(DOC-1)
Cytoplasm; 
Membrane; 
Nucleus; 
Mus 
musculus 
(Mouse)
O35346 FAK1_RAT
Focal adhesion kinase 1 (FADK 1) (EC 
2;7;10;2) (Protein-tyrosine kinase 2) 
(pp125FAK)
Cell junction;focal 
adhesion; Cell 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Rattus 
norvegicus 
(Rat)
P35846 FOLR1_MOUSE
Folate receptor alpha (FR-alpha) (Folate 
receptor 1) (Folate-binding protein 1)
Cell membrane; 
Lipid-anchor ;GPI-
anchor; 
Mus 
musculus 
(Mouse)
Q6NVD0 FREM2_MOUSE
FRAS1-related extracellular matrix protein 2 
(ECM3 homolog) (NV domain-containing 
protein 1)
Cell membrane; 
Single-pass type I 
membrane protein; 
Extracellular side; 
Mus 
musculus 
(Mouse)
Q8BKG4 FZD10_MOUSE Frizzled-10 (Fz-10) (CD antigen CD350)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q8BWQ4 FTSJ1_MOUSE
FtsJ methyltransferase domain-containing 
protein 1 (EC 2;1;1;-)
Membrane; Single-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
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Q5SNZ0 GRDN_MOUSE
Girdin (Akt phosphorylation enhancer) (APE) 
(Coiled-coil domain-containing protein 88A) 
(G alpha-interacting vesicle-associated 
protein) (GIV) (Girders of actin filament) 
(Hook-related protein 1) (HkRP1)
Membrane; Cell 
membrane; 
Cytoplasm;cytosol; 
Cytoplasmic 
vesicle; Cell 
projection 
;lamellipodium; 
Mus 
musculus 
(Mouse)
Q8BMF8 GLDN_MOUSE
Gliomedin (Cancer-related gene liver 2 
protein) (CRG-L2)
Cell membrane; 
Single-pass type II 
membrane protein; 
Mus 
musculus 
(Mouse)
Q01097 NMDE2_MOUSE
Glutamate [NMDA] receptor subunit epsilon-
2 (N-methyl D-aspartate receptor subtype 2B) 
(NMDAR2B) (NR2B)
Cell membrane; 
Multi-pass 
membrane protein; 
Cell 
junction;synapse 
;postsynaptic cell 
membrane;
Mus 
musculus 
(Mouse)
Q01098 NMDE3_MOUSE
Glutamate [NMDA] receptor subunit epsilon-
3 (N-methyl D-aspartate receptor subtype 2C) 
(NMDAR2C) (NR2C)
Cell membrane; 
Multi-pass 
membrane protein; 
Cell 
junction;synapse 
;postsynaptic cell 
membrane;  
Mus 
musculus 
(Mouse)
P35438 NMDZ1_MOUSE
Glutamate [NMDA] receptor subunit zeta-1 
(N-methyl-D-aspartate receptor subunit NR1) 
(NMD-R1)
Cell membrane; 
Multi-pass 
membrane protein; 
Cell 
junction;synapse 
;postsynaptic cell 
membrane; Cell 
junction;synapse 
;postsynaptic cell 
membrane;postsyna
ptic density; 
Mus 
musculus 
(Mouse)
P42264 GRIK3_RAT
Glutamate receptor; ionotropic kainate 3 
(Glutamate receptor 7) (GluR-7) (GluR7)
Cell membrane; 
Multi-pass 
membrane protein; 
Cell junction 
;synapse;postsynapt
ic cell membrane;
Rattus 
norvegicus 
(Rat)
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Q925T6 GRIP1_MOUSE
Glutamate receptor-interacting protein 1 
(GRIP-1)
Cytoplasmic 
vesicle; 
Endoplasmic 
reticulum; Cell 
junction 
;synapse;postsynapt
ic cell membrane;  
Membrane; Lipid-
anchor; 
Mus 
musculus 
(Mouse)
Q9WU65 GLPK2_MOUSE
Glycerol kinase 2 (GK 2) (Glycerokinase 2) 
(EC 2;7;1;30) (ATP:glycerol 3-
phosphotransferase 2) (Glycerol kinase; testis 
specific 2)
Mitochondrion 
outer membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cytoplasm; 
Mus 
musculus 
(Mouse)
Q91VW5 GOGA4_MOUSE Golgin subfamily A member 4 (tGolgin-1)
Cytoplasm; Golgi 
apparatus 
membrane; 
Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9JJQ0 PIGB_MOUSE
GPI mannosyltransferase 3 (EC 2;4;1;-) (GPI 
mannosyltransferase III) (GPI-MT-III) 
(Phosphatidylinositol-glycan biosynthesis 
class B protein) (PIG-B)
Endoplasmic 
reticulum 
membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q8VHN7 GPR98_MOUSE
G-protein coupled receptor 98 (Monogenic 
audiogenic seizure susceptibility protein 1) 
(Neurepin) (Very large G-protein coupled 
receptor 1)
Cell membrane; 
Multi-pass 
membrane protein;  
Secreted; 
Mus 
musculus 
(Mouse)
Q8CHG3 GCC2_MOUSE
GRIP and coiled-coil domain-containing 
protein 2 (185 kDa Golgi coiled-coil protein) 
(GCC185)
Cytoplasm; Golgi 
apparatus ;trans-
Golgi network 
membrane; 
Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
O70443 GNAZ_MOUSE
Guanine nucleotide-binding protein G(z) 
subunit alpha (G(x) alpha chain) (Gz-alpha)
Membrane; Lipid-
anchor; 
Mus 
musculus 
(Mouse)
P55205 GUC2G_RAT
Guanylate cyclase 2G (EC 4;6;1;2) (Guanylyl 
cyclase receptor G) (GC-G) (Kinase-like 
domain-containing soluble guanylyl cyclase) 
(ksGC)
Cell membrane; 
Single-pass type I 
membrane protein;  
Cytoplasm; 
Rattus 
norvegicus 
(Rat)
Q6TL19 GUC2G_MOUSE
Guanylate cyclase 2G (EC 4;6;1;2) 
(Guanylyl cyclase receptor G) (mGC-G)
Membrane; Single-
pass type I 
membrane protein; 
Mus musculus 
(Mouse)
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P52785 GUC2E_MOUSE
Guanylyl cyclase GC-E (EC 4;6;1;2) 
(Guanylate cyclase 2E)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
P51840 GUC2E_RAT
Guanylyl cyclase GC-E (EC 4;6;1;2) 
(Guanylate cyclase 2E)
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
O35387 HAX1_MOUSE
HCLS1-associated protein X-1 (HS1-
associating protein X-1) (HAX-1) (HS1-
binding protein 1) (HSP1BP-1)
Mitochondrion; 
Endoplasmic 
reticulum; Nucleus 
membrane; Sarco-
plasmic reticulum; 
Cytoplasmic 
vesicle; 
Mus 
musculus 
(Mouse)
Q7TSE9 HAX1_RAT
HCLS1-associated protein X-1 (HS1-
associating protein X-1) (HAX-1) (HS1-
binding protein 1) (HSP1BP-1)
Endoplasmic 
reticulum; 
Sarcoplasmic 
reticulum; 
Cytoplasmic 
vesicle; 
Mitochondrion; 
Nucleus 
membrane; 
Rattus 
norvegicus 
(Rat)
Q8BKN6 HS3SA_MOUSE
Heparan sulfate glucosamine 3-O-
sulfotransferase 3A1 (EC 2;8;2;23) (Heparan 
sulfate D-glucosaminyl 3-O-sulfotransferase 
3A1) (Heparan sulfate 3-O-sulfotransferase 
3A1)
Golgi apparatus 
membrane; Single-
pass type II 
membrane protein; 
Mus 
musculus 
(Mouse)
Q3V1H3 HPHL1_MOUSE Hephaestin-like protein 1 (EC 1;-;-;-)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q6ZPR6 IBTK_MOUSE Inhibitor of Bruton tyrosine kinase (IBtk)
Cytoplasm; 
Membrane; 
Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
P11881 ITPR1_MOUSE
Inositol 1;4;5-trisphosphate receptor type 1 
(IP3 receptor isoform 1) (IP3R 1) (InsP3R1) 
(Inositol 1;4;5-trisphosphate-binding protein 
P400) (Protein PCD-6) (Purkinje cell protein 
1) (Type 1 inositol 1;4;5-trisphosphate 
receptor) (Type 1 InsP3 receptor)
Endoplasmic 
reticulum 
membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q9Z329 ITPR2_MOUSE
Inositol 1;4;5-trisphosphate receptor type 2 
(IP3 receptor isoform 2) (IP3R 2) (InsP3R2) 
(Inositol 1;4;5-trisphosphate type V receptor) 
(Type 2 inositol 1;4;5-trisphosphate receptor) 
(Type 2 InsP3 receptor)
Endoplasmic 
reticulum 
membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
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P29995 ITPR2_RAT
Inositol 1;4;5-trisphosphate receptor type 2 
(IP3 receptor isoform 2) (IP3R 2) (InsP3R2) 
(Type 2 inositol 1;4;5-trisphosphate receptor)  
(Type 2 InsP3 receptor)
Endoplasmic 
reticulum 
membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
P70227 ITPR3_MOUSE
Inositol 1;4;5-trisphosphate receptor type 3 
(IP3 receptor isoform 3) (IP3R 3) (InsP3R3) 
(Type 3 inositol 1;4;5-trisphosphate receptor) 
(Type 3 InsP3 receptor)
Endoplasmic 
reticulum 
membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q63269 ITPR3_RAT
Inositol 1;4;5-trisphosphate receptor type 3 
(IP3 receptor isoform 3) (IP3R 3) (InsP3R3) 
(Type 3 inositol 1;4;5-trisphosphate receptor)  
(Type 3 InsP3 receptor)
Endoplasmic 
reticulum 
membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q60751 IGF1R_MOUSE
Insulin-like growth factor 1 receptor (EC 
2;7;10;1) (Insulin-like growth factor I 
receptor) (IGF-I receptor) (CD antigen 
CD221) [Cleaved into: Insulin-like growth 
factor 1 receptor alpha chain; Insulin-like 
growth factor 1 receptor beta chain]
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
P24062 IGF1R_RAT
Insulin-like growth factor 1 receptor (EC 
2;7;10;1) (Insulin-like growth factor I 
receptor) (IGF-I receptor) (CD antigen 
CD221) [Cleaved into: Insulin-like growth 
factor 1 receptor alpha chain; Insulin-like 
growth factor 1 receptor beta chain]
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q80UK8 INT2_MOUSE Integrator complex subunit 2 (Int2)
Nucleus membrane; 
Single-pass 
membrane protein; 
Mus 
musculus 
(Mouse)
P17852 ITA3_CRIGR
Integrin alpha-3 (CD49 antigen-like family 
member C) (Galactoprotein B3) (GAPB3) 
(VLA-3 subunit alpha) (CD antigen CD49c) 
[Cleaved into: Integrin alpha-3 heavy chain; 
Integrin alpha-3 light chain]
Membrane; Single-
pass type I 
membrane protein; 
Cricetulus 
griseus 
(Chinese 
hamster)
Q62470 ITA3_MOUSE
Integrin alpha-3 (CD49 antigen-like family 
member C) (Galactoprotein B3) (GAPB3) 
(VLA-3 subunit alpha) (CD antigen CD49c) 
[Cleaved into: Integrin alpha-3 heavy chain; 
Integrin alpha-3 light chain]
Membrane; Single-
pass type I 
membrane protein; 
Mus musculus 
(Mouse)
Q00651 ITA4_MOUSE
Integrin alpha-4 (CD49 antigen-like family 
member D) (Integrin alpha-IV) (Lymphocyte 
Peyer patch adhesion molecules subunit 
alpha) (LPAM subunit alpha) (VLA-4 subunit 
alpha) (CD antigen CD49d)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
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P11688 ITA5_MOUSE
Integrin alpha-5 (CD49 antigen-like family 
member E) (Fibronectin receptor subunit 
alpha) (Integrin alpha-F) (VLA-5) (CD 
antigen CD49e) [Cleaved into: Integrin 
alpha-5 heavy chain; Integrin alpha-5 light 
chain]
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q61738 ITA7_MOUSE
Integrin alpha-7 [Cleaved into: Integrin 
alpha-7 heavy chain; Integrin alpha-7 light 
chain]
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q3V0T4 ITAD_MOUSE Integrin alpha-D (CD antigen CD11d)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
P43406 ITAV_MOUSE
Integrin alpha-V (Vitronectin receptor subunit 
alpha) (CD antigen CD51) [Cleaved into: 
Integrin alpha-V heavy chain; Integrin alpha-
V light chain]
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9QXH4 ITAX_MOUSE
Integrin alpha-X (CD11 antigen-like family 
member C) (Leukocyte adhesion receptor 
p150;95) (CD antigen CD11c)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
P09055 ITB1_MOUSE
Integrin beta-1 (Fibronectin receptor subunit 
beta) (VLA-4 subunit beta) (CD antigen 
CD29)
Cell membrane; 
Single-pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
A2A863 ITB4_MOUSE Integrin beta-4 (CD antigen CD104)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
P22273 IL6RA_RAT
Interleukin-6 receptor subunit alpha (IL-6 
receptor subunit alpha) (IL-6R subunit alpha) 
(IL-6R-alpha) (IL-6RA) (IL-6R 1) (CD 
antigen CD126)
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q02257 PLAK_MOUSE
Junction plakoglobin (Desmoplakin III) 
(Desmoplakin-3)
Cell junction; 
adherens junction; 
desmo-some; 
Cytoplasm cyto-
skeleton; peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
P04104 K2C1_MOUSE
Keratin; type II cytoskeletal 1 (67 kDa 
cytokeratin) (Cytokeratin-1) (CK-1) (Keratin-
1) (K1) (Type-II keratin Kb1)
Cell membrane; 
Mus 
musculus 
(Mouse)
Q6IMF3 K2C1_RAT
Keratin; type II cytoskeletal 1 (Cytokeratin-
1) (CK-1) (Keratin-1) (K1) (Type-II keratin 
Kb1)
Cell membrane; 
Rattus 
norvegicus 
(Rat)
Q9EQG6 KDIS_RAT
Kinase D-interacting substrate of 220 kDa 
(Ankyrin repeat-rich membrane-spanning 
protein)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
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Q61097 KSR1_MOUSE
Kinase suppressor of Ras 1 (mKSR1) 
(Protein Hb)
Cytoplasm; 
Membrane; 
Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
Q3UVC0 KSR2_MOUSE Kinase suppressor of Ras 2
Cytoplasm; 
Membrane; 
Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
Q8K1F9 LCTL_MOUSE
Lactase-like protein (Klotho/lactase-phlorizin 
hydrolase-related protein)
Endoplasmic 
reticulum 
membrane; Single-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
P19137 LAMA1_MOUSE
Laminin subunit alpha-1 (Laminin A chain) 
(Laminin-1 subunit alpha) (Laminin-3 
subunit alpha) (S-laminin subunit alpha) (S-
LAM alpha)
Secreted 
;extracellular 
space;extracellular 
matrix ;basement 
membrane; 
Mus 
musculus 
(Mouse)
Q60675 LAMA2_MOUSE
Laminin subunit alpha-2 (Laminin M chain) 
(Laminin-12 subunit alpha) (Laminin-2 
subunit alpha) (Laminin-4 subunit alpha) 
(Merosin heavy chain)
Secreted;extracellul
ar space 
;extracellular 
matrix;basement 
membrane; 
Mus 
musculus 
(Mouse)
Q61789 LAMA3_MOUSE
Laminin subunit alpha-3 (Epiligrin subunit 
alpha) (Kalinin subunit alpha) (Laminin-5 
subunit alpha) (Laminin-6 subunit alpha) 
(Laminin-7 subunit alpha) (Nicein subunit 
alpha)
Secreted 
;extracellular 
space;extracellular 
matrix ;basement 
membrane; 
Mus 
musculus 
(Mouse)
Q61001 LAMA5_MOUSE
Laminin subunit alpha-5 (Laminin-10 subunit 
alpha) (Laminin-11 subunit alpha) (Laminin-
15 subunit alpha)
Secreted;extracellul
ar space 
;extracellular 
matrix;basement 
membrane; 
Mus 
musculus 
(Mouse)
Q61087 LAMB3_MOUSE
Laminin subunit beta-3 (Epiligrin subunit 
bata) (Kalinin B1 chain) (Kalinin subunit 
beta) (Laminin-5 subunit beta) (Nicein 
subunit beta)
Secreted 
;extracellular 
space;extracellular 
matrix ;basement 
membrane; 
Mus 
musculus 
(Mouse)
O88917 LPHN1_RAT
Latrophilin-1 (Calcium-independent alpha-
latrotoxin receptor 1) (CIRL-1)
Cell membrane; 
Multi-pass 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q9Z173 LPHN3_RAT
Latrophilin-3 (Calcium-independent alpha-
latrotoxin receptor) (CIRL-3)
Cell membrane; 
Multi-pass 
membrane protein; 
Rattus 
norvegicus 
(Rat)
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Q5SGE0 LPPRC_RAT
Leucine-rich PPR motif-containing protein; 
mitochondrial (130 kDa leucine-rich protein) 
(LRP 130) (Leucine rich protein 157) 
(rLRP157)
Mitochondrion; 
Nucleus; 
Nucleus;nucleoplas
m; Nucleus inner 
membrane; Nucleus 
outer membrane; 
Rattus 
norvegicus 
(Rat)
Q8CBC6 LRRN3_MOUSE
Leucine-rich repeat neuronal protein 3 
(Neuronal leucine-rich repeat protein 3) 
(NLRR-3)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q8R502 LRC8C_MOUSE
Leucine-rich repeat-containing protein 8C 
(Protein AD158)
Endoplasmic 
reticulum mem-
brane; Multi-pass 
membrane protein; 
Mus 
musculus 
(Mouse)
P70193 LRIG1_MOUSE
Leucine-rich repeats and immunoglobulin-
like domains protein 1 (LIG-1)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
P97629 LCAP_RAT
Leucyl-cystinyl aminopeptidase (Cystinyl 
aminopeptidase) (EC 3;4;11;3) (GP160) 
(Insulin-regulated membrane 
aminopeptidase) (Insulin-responsive 
aminopeptidase) (IRAP) (Oxytocinase) 
(OTase) (Placental leucine aminopeptidase) 
(P-LAP) (Vesicle protein of 165 kDa) 
(Vp165)
Cell membrane; 
Single-pass type II 
membrane protein; 
Endomembrane 
system; Single-pass 
type II membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q8CIV3 LIPH_MOUSE Lipase member H (EC 3;1;1;-)
Secreted; Mem-
brane; Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9ESE1 LRBA_MOUSE
Lipopolysaccharide-responsive and beige-like 
anchor protein (Beige-like protein)
Cell membrane; 
Single-pass 
membrane protein; 
Endoplasmic 
reticulum; Golgi 
apparatus ;trans-
Golgi network; 
Lysosome; 
Mus 
musculus 
(Mouse)
Q9JI18 LRP1B_MOUSE
Low-density lipoprotein receptor-related 
protein 1B (LRP-1B) (Low-density 
lipoprotein receptor-related protein-deleted in 
tumor) (LRP-DIT)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
P98158 LRP2_RAT
Low-density lipoprotein receptor-related 
protein 2 (LRP-2) (Glycoprotein 330) 
(gp330) (Megalin)
Cell membrane; 
Single-pass type I 
membrane protein; 
Membrane;clathrin-
coated pit; 
Cytoplasm; 
Rattus 
norvegicus 
(Rat)
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Q8VI56 LRP4_MOUSE
Low-density lipoprotein receptor-related 
protein 4 (LRP-4) (LDLR dan)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9QYP1 LRP4_RAT
Low-density lipoprotein receptor-related 
protein 4 (LRP-4) (Multiple epidermal 
growth factor-like domains 7)
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q61830 MRC1_MOUSE
Macrophage mannose receptor 1 (MMR) (CD 
antigen CD206)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9WV57 MPEG1_RAT
Macrophage-expressed gene 1 protein 
(Macrophage gene 1 protein) (Mpg-1)
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q80U28 MADD_MOUSE
MAP kinase-activating death domain protein 
(Rab3 GDP/GTP exchange factor)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
O08873 MADD_RAT
MAP kinase-activating death domain protein 
(Rab3 GDP/GTP exchange factor)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q8BI84 MIA3_MOUSE
Melanoma inhibitory activity protein 3 
(Transport and Golgi organization protein 1) 
(TANGO1)
Endoplasmic 
reticulum mem-
brane; Single-pass 
type I membrane 
protein; 
Mus 
musculus 
(Mouse)
Q9WVQ1 MAGI2_MOUSE
Membrane-associated guanylate kinase; WW 
and PDZ domain-containing protein 2 
(Activin receptor-interacting protein 1) 
(Acvrip1) (Atrophin-1-interacting protein 1) 
(AIP-1) 
Cell junction sy-
napse synaptosome; 
Cell membrane; 
Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9EQJ9 MAGI3_MOUSE
Membrane-associated guanylate kinase; WW 
and PDZ domain-containing protein 3 
(Membrane-associated guanylate kinase 
inverted 3) (MAGI-3)
Cell membrane; 
Peripheral 
membrane protein; 
Cell junction ;tight 
junction; Nucleus; 
Mus 
musculus 
(Mouse)
Q9R1L5 MAST1_MOUSE
Microtubule-associated serine/threonine-
protein kinase 1 (EC 2;7;11;1) (Syntrophin-
associated serine/threonine-protein kinase)
Cell membrane; 
Peripheral mem-
brane protein; 
Cytoplasmic side; 
Cytoplasm;cytoskel
eton; 
Mus 
musculus 
(Mouse)
Q810W7 MAST1_RAT
Microtubule-associated serine/threonine-
protein kinase 1 (EC 2;7;11;1) (Syntrophin-
associated serine/threonine-protein kinase)
Cell membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cytoplasm 
;cytoskeleton;  
Rattus 
norvegicus 
(Rat)
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Q60592 MAST2_MOUSE
Microtubule-associated serine/threonine-
protein kinase 2 (EC 2;7;11;1)
Membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cytoplasm;cytoskel
eton; Cell junction; 
Mus 
musculus 
(Mouse)
P06795 MDR1_MOUSE
Multidrug resistance protein 1 (EC 3;6;3;44) 
(ATP-binding cassette sub-family B member 
1) (P-glycoprotein 1) (CD antigen CD243)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
P43245 MDR1_RAT
Multidrug resistance protein 1 (EC 3;6;3;44) 
(ATP-binding cassette sub-family B member 
1) (P-glycoprotein 1) (CD antigen CD243)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
P21449 MDR2_CRIGR
Multidrug resistance protein 2 (EC 3;6;3;44) 
(P-glycoprotein 2)
Membrane; Multi-
pass membrane 
protein; 
Cricetulus 
griseus 
(Chinese 
hamster)
Q8CG09 MRP1_RAT
Multidrug resistance-associated protein 1 
(ATP-binding cassette sub-family C member 
1) (Leukotriene C(4) transporter) (LTC4 
transporter)
Cell membrane; 
Multi-pass 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q69ZN7 MYOF_MOUSE Myoferlin (Fer-1-like protein 3)
Cell membrane; 
Single-pass type II 
membrane protein; 
Nucleus membrane; 
Single-pass type II 
membrane protein; 
Cytoplasmic vesicle 
membrane; 
Mus 
musculus 
(Mouse)
A2AQP0 MYH7B_MOUSE
Myosin-7B (Myosin cardiac muscle beta 
chain) (Myosin heavy chain 7B; cardiac 
muscle beta isoform)
Membrane; 
Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9Z1N3 MYO9A_RAT
Myosin-IXa (Myr 7) (Unconventional 
myosin-9a)
Membrane; Single-
pass membrane 
protein; Cytoplasm; 
Rattus 
norvegicus 
(Rat)
Q8C170 MYO9A_MOUSE Myosin-IXa (Unconventional myosin-9a)
Membrane; Single-
pass membrane 
protein; 
Mus musculus 
(Mouse)
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Q64331 MYO6_MOUSE Myosin-VI (Unconventional myosin-6)
Golgi apparatus 
;trans-Golgi 
network membrane; 
Peripheral 
membrane protein; 
Nucleus; 
Cytoplasm;perinucl
ear region; 
Membrane 
;clathrin-coated pit; 
Cell 
projection;ruffle; 
Cytoplasmic 
vesicle; 
Mus 
musculus 
(Mouse)
Q99MZ6 MYO7B_MOUSE Myosin-VIIb
Apical cell 
membrane; 
Mus 
musculus 
(Mouse)
P28660 NCKP1_MOUSE
Nck-associated protein 1 (NAP 1) (Brain 
protein H19) (MH19) (Membrane-associated 
protein HEM-2) (p125Nap1)
Cell membrane; 
Single-pass 
membrane protein; 
Cytoplasmic side; 
Cell projection 
;lamellipodium 
membrane; 
Cytoplasmic side;
Mus 
musculus 
(Mouse)
P55161 NCKP1_RAT
Nck-associated protein 1 (NAP 1) 
(Membrane-associated protein HEM-2) 
(p125Nap1)
Cell membrane; 
Single-pass 
membrane protein; 
Cytoplasmic side; 
Cell 
projection;lamellip
odium membrane; 
Cytoplasmic side; 
Rattus 
norvegicus 
(Rat)
Q6ZWR6 SYNE1_MOUSE
Nesprin-1 (Enaptin) (Myocyte nuclear 
envelope protein 1) (Myne-1) (Nuclear 
envelope spectrin repeat protein 1) (Synaptic 
nuclear envelope protein 1) (Syne-1)
Nucleus outer 
membrane; Single-
pass type IV mem-
brane protein; Cyto-
plasmic side; Cyto-
plasm 
;cytoskeleton; 
myofibril; 
sarcomere; 
Mus 
musculus 
(Mouse)
 -174-
Analysing the surface of suspension growth adapted CHO cells                                                          
Accession Entry name Protein names Subcellular locations Organism
Q6ZWQ0 SYNE2_MOUSE
Nesprin-2 (Nuclear envelope spectrin repeat 
protein 2) (Nucleus and actin connecting 
element protein) (Protein NUANCE) 
(Synaptic nuclear envelope protein 2) (Syne-
2)
Nucleus outer 
membrane; Single-
pass type IV 
membrane protein; 
Cytoplasmic side; 
Sarcoplasmic 
reticulum mem-
brane;  Cell 
membrane;  Cyto-
plasm; cytoske-
leton; Mitochon-
drion;; nucleo-
plasm; 
Mus 
musculus 
(Mouse)
Q4FZC9 SYNE3_MOUSE Nesprin-3
Nucleus outer 
membrane; Single-
pass type IV 
membrane protein; 
Mus 
musculus 
(Mouse)
O35136 NCAM2_MOUSE
Neural cell adhesion molecule 2 (N-CAM-2) 
(NCAM-2) (Neural cell adhesion molecule 
RB-8) (R4B12)
Cell membrane; 
Single-pass type I 
membrane protein;   
Lipid-anchor;GPI-
anchor; 
Mus 
musculus 
(Mouse)
Q9EPN1 NBEA_MOUSE
Neurobeachin (Lysosomal-trafficking 
regulator 2)
Membrane; Perip-
heral membrane 
protein; Endo-
membrane system; 
Cell junction  sy-
napse ;postsynaptic 
cell membrane; 
Mus 
musculus 
(Mouse)
Q80TN7 NAV3_MOUSE
Neuron navigator 3 (Pore membrane and/or 
filament-interacting-like protein 1)
Nucleus outer 
membrane; 
Mus 
musculus 
(Mouse)
Q91XT9 ASAH2_RAT
Neutral ceramidase (N-CDase) (NCDase) 
(EC 3;5;1;23) (Acylsphingosine deacylase 2) 
(N-acylsphingosine amidohydrolase 2) 
Cell membrane; 
Single-pass type II 
membrane protein; 
Rattus 
norvegicus 
(Rat)
P29476 NOS1_RAT
Nitric oxide synthase; brain (EC 1;14;13;39) 
(BNOS) (Constitutive NOS) (NC-NOS) 
(NOS type I) (Neuronal NOS) (N-NOS) 
(nNOS) (Peptidyl-cysteine S-nitrosylase 
NOS1)
Cell membrane 
Peripheral 
membrane protein; 
Cell projection; 
dendritic spine; 
Rattus 
norvegicus 
(Rat)
Q9Z0J4 NOS1_MOUSE
Nitric oxide synthase; brain (EC 1;14;13;39)  
(Constitutive NOS) (NC-NOS) (NOS type I) 
(Neuronal NOS) (N-NOS) (nNOS) (Peptidyl-
cysteine S-nitrosylase NOS1) (bNOS)
Cell membrane 
Peripheral 
membrane protein; 
Cell projection 
;dendritic spine; 
Mus musculus 
(Mouse)
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Q3TL44 NLRX1_MOUSE NLR family member X1
Mitochondrion 
outer membrane; 
Mus 
musculus 
(Mouse)
Q99P88 NU155_MOUSE
Nuclear pore complex protein Nup155 (155 
kDa nucleoporin) (Nucleoporin Nup155)
Nucleus;nuclear 
pore complex; 
Nucleus membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Nucleus membrane; 
Peripheral 
membrane protein; 
Nucleoplasmic 
side; 
Mus 
musculus 
(Mouse)
P37199 NU155_RAT
Nuclear pore complex protein Nup155 (155 
kDa nucleoporin) (Nucleoporin Nup155) 
(P140)
Nucleus; nuclear 
pore complex; 
Nucleus membrane;  
Peripheral 
membrane protein; 
Cytoplasmic side; 
Nucleus membrane;  
Nucleoplasmic 
side; 
Rattus 
norvegicus 
(Rat)
P11654 PO210_RAT
Nuclear pore membrane glycoprotein 210 
(Nuclear pore protein gp210) (Nuclear 
envelope pore membrane protein POM 210) 
(POM210) (Nucleoporin Nup210) (Pore 
membrane protein of 210 kDa)
Nucleus ;nuclear 
pore complex; 
Nucleus membrane; 
Single-pass type I 
membrane protein; 
Endoplasmic 
reticulum 
membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q9D2F7 P210L_MOUSE
Nuclear pore membrane glycoprotein 210-
like (Nucleoporin 210 kDa-like) 
(Nucleoporin Nup210-like)
Membrane; Single-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
P31662 S6A17_RAT
Orphan sodium- and chloride-dependent 
neurotransmitter transporter NTT4 (Solute 
carrier family 6 member 17)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
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Q9ESF1 OTOF_MOUSE Otoferlin (Fer-1-like protein 2)
Cytoplasmic 
vesicle;secretory 
vesicle; synaptic 
vesicle membrane; 
Single-pass type II 
mem-brane protein; 
Baso-lateral cell 
membrane;  Endo-
plasmic reticulum 
mem-brane; Cell 
membrane; 
Mus 
musculus 
(Mouse)
Q9ERC5 OTOF_RAT Otoferlin (Fer-1-like protein 2)
Cytoplasmic 
vesicle;secretory 
vesicle ;synaptic 
vesicle membrane; 
Single-pass type II 
membrane protein; 
Basolateral cell 
membrane;  
Endoplasmic 
reticulum 
membrane; Cell 
membrane; 
Rattus 
norvegicus 
(Rat)
Q9CWU2 ZDH13_MOUSE
Palmitoyltransferase ZDHHC13 (EC 2;3;1;-) 
(Huntingtin-interacting protein 14-related 
protein) (HIP14-related protein) (Zinc finger 
DHHC domain-containing protein 13) 
(DHHC-13)
Golgi apparatus 
membrane; Multi-
pass membrane 
protein; 
Cytoplasmic vesicle 
membrane; 
Mus 
musculus 
(Mouse)
Q3ULF4 SPG7_MOUSE Paraplegin (EC 3;4;24;-)
Mitochondrion 
membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q9Z340 PARD3_RAT
Partitioning defective 3 homolog (PAR-3) 
(PARD-3) (Atypical PKC isotype-specific-
interacting protein) (ASIP) (Atypical PKC-
specific-binding protein) (ASBP)
Endomembrane 
system; Cell 
junction;tight 
junction; Cytoplasm 
; cell cortex; 
Cytoplasm; 
cytoskeleton; 
Rattus 
norvegicus 
(Rat)
Q99NH2 PARD3_MOUSE
Partitioning defective 3 homolog (PAR-3) 
(PARD-3) (Atypical PKC isotype-specific-
interacting protein) (ASIP) (Ephrin-
interacting protein) (PHIP)
Endomembrane 
system; Cell 
junction; tight 
junction; Cytoplasm 
;cell cortex; 
Cytoplasm;cytoskel
eton; 
Mus musculus 
(Mouse)
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Q5BK26 PLPL7_RAT
Patatin-like phospholipase domain-containing 
protein 7 (EC 3;1;1;-) (Liver NTE-related 
protein 1) (NTE-related esterase)
Membrane; Single-
pass membrane 
protein; Nucleus 
membrane;  
Mitochondrion 
membrane; 
Lysosome 
membrane; 
Microsome 
membrane;  
Rattus 
norvegicus 
(Rat)
Q5DU28 PCX2_MOUSE Pecanex-like protein 2
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q9R155 S26A4_MOUSE
Pendrin (Sodium-independent chloride/iodide 
transporter) (Solute carrier family 26 member 
4)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q9R154 S26A4_RAT
Pendrin (Sodium-independent chloride/iodide 
transporter) (Solute carrier family 26 member 
4)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q63425 PRAX_RAT Periaxin
Nucleus; Cell 
projection ;axon; 
Cytoplasm; Cell 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Rattus 
norvegicus 
(Rat)
Q62915 CSKP_RAT
Peripheral plasma membrane protein CASK 
(EC 2;7;11;1) (Calcium/calmodulin-
dependent serine protein kinase)
Nucleus; 
Cytoplasm; Cell 
membrane; 
Peripheral 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q9R269 PEPL_MOUSE Periplakin
Cell 
junction;desmosom
e; Cytoplasm 
;cytoskeleton; Cell 
membrane; 
Nucleus; 
Mitochondrion; 
Mus 
musculus 
(Mouse)
Q2PFD7 PSD3_MOUSE
PH and SEC7 domain-containing protein 3 
(Exchange factor for ADP-ribosylation factor 
guanine nucleotide factor 6) (Pleckstrin 
homology and SEC7 domain-containing 
protein 3)
Cell 
junction;synapse 
;postsynaptic cell 
membrane;postsyna
ptic density; 
Mus 
musculus 
(Mouse)
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Q9WTR8 PHLP1_RAT
PH domain leucine-rich repeat protein 
phosphatase 1 (EC 3;1;3;16) (Pleckstrin 
homology domain-containing family E 
member 1) (PH domain-containing family E 
member 1) 
Cytoplasm; 
Membrane; 
Peripheral 
membrane protein; 
Nucleus; 
Rattus 
norvegicus 
(Rat)
P97573 SHIP1_RAT
Phosphatidylinositol-3;4;5-trisphosphate 5-
phosphatase 1 (EC 3;1;3;n1) (SH2 domain-
containing inositol-5'-phosphatase 1) (SH2 
domain-containing inositol phosphatase 1) 
Cytoplasm; 
Membrane; 
Peripheral 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q61194 P3C2A_MOUSE
Phosphatidylinositol-4-phosphate 3-kinase 
C2 domain-containing subunit alpha (PI3K-
C2-alpha) (PtdIns-3-kinase C2 subunit alpha) 
(EC 2;7;1;154) (Cpk-m) (Phosphoinositide 3-
kinase-C2-alpha) (p170)
Cell membrane; 
Golgi apparatus; 
Cytoplasmic vesicle 
;clathrin-coated 
vesicle; Nucleus; 
Cytoplasm; 
Mus 
musculus 
(Mouse)
Q3TTY0 PLB1_MOUSE
Phospholipase B1; membrane-associated 
(Phospholipase B) (Phospholipase B/lipase) 
(PLB/LIP) [Includes: Phospholipase A2 (EC 
3;1;1;4); Lysophospholipase (EC 3;1;1;5)]
Apical cell 
membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
O54728 PLB1_RAT
Phospholipase B1; membrane-associated 
(Phospholipase B) (Phospholipase B/lipase) 
(PLB/LIP) [Includes: Phospholipase A2 (EC 
3;1;1;4); Lysophospholipase (EC 3;1;1;5)]
Apical cell 
membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
O08684 PLD1_CRIGR
Phospholipase D1 (PLD 1) (EC 3;1;4;4) 
(Choline phosphatase 1) 
(Phosphatidylcholine-hydrolyzing 
phospholipase D1)
Cytoplasm peri-
nuclear region; 
Endoplasmic reti-
culum membrane; 
Lipid-anchor; 
Cytoplasmic side; 
Golgi apparatus 
membrane; 
Cytoplasmic side; 
Late endosome 
membrane; Lipid-
anchor; 
Cricetulus 
griseus 
(Chinese 
hamster)
P70496 PLD1_RAT
Phospholipase D1 (PLD 1) (rPLD1) (EC 
3;1;4;4) (Choline phosphatase 1) 
(Phosphatidylcholine-hydrolyzing 
phospholipase D1)
Cytoplasm peri-
nuclear region; 
Endoplasmic reti-
culum membrane; 
Lipid-anchor; Golgi  
apparatus 
membrane; Lipid-
anchor; Late 
endosome 
membrane; Lipid-
anchor; 
Rattus 
norvegicus 
(Rat)
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P11506 AT2B2_RAT
Plasma membrane calcium-transporting 
ATPase 2 (PMCA2) (EC 3;6;3;8) (Plasma 
membrane calcium ATPase isoform 2) 
(Plasma membrane calcium pump isoform 2)
Cell membrane; 
Multi-pass 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q64542 AT2B4_RAT
Plasma membrane calcium-transporting 
ATPase 4 (PMCA4) (EC 3;6;3;8) (Plasma 
membrane calcium ATPase isoform 4) 
(Plasma membrane calcium pump isoform 4)
Cell membrane; 
Multi-pass 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q8C115 PKHH2_MOUSE
Pleckstrin homology domain-containing 
family H member 2
Membrane; Single-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
P70206 PLXA1_MOUSE Plexin-A1 (Plex 1) (Plexin-1)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
P70207 PLXA2_MOUSE Plexin-A2 (Plex 2) (Plexin-2)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9QZC2 PLXC1_MOUSE
Plexin-C1 (Virus-encoded semaphorin protein 
receptor) (CD antigen CD232)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
O88422 GALT5_RAT
Polypeptide N-acetylgalactosaminyl-
transferase 5 (EC 2;4;1;41) (Polypeptide 
GalNAc transferase 5) (GalNAc-T5) (pp-
GaNTase 5) (Protein-UDP acetylgalactos-
aminyltransferase 5) 
Golgi apparatus 
membrane; Single-
pass type II 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q91WF7 FIG4_MOUSE
Polyphosphoinositide phosphatase (EC 
3;1;3;-) (Phosphatidylinositol 3;5-
bisphosphate 5-phos-phatase) (SAC domain-
containing protein 3)
Endosome 
membrane; 
Mus 
musculus 
(Mouse)
Q9Z258 KCNT1_RAT
Potassium channel subfamily T member 1 
(Sequence like a calcium-activated potassium 
channel subunit)
Cell membrane; 
Multi-pass 
membrane protein; 
Rattus 
norvegicus 
(Rat)
P15387 KCNB1_RAT
Potassium voltage-gated channel subfamily B 
member 1 (Delayed rectifier potassium 
channel 1) (DRK1) (Voltage-gated potassium 
channel subunit Kv2;1)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q03717 KCNB1_MOUSE
Potassium voltage-gated channel subfamily B  
member 1 (Voltage-gated potassium channel 
subunit Kv2;1) (mShab)
Membrane; Multi-
pass membrane 
protein; 
Mus musculus 
(Mouse)
Q9QWS8 KCNH8_RAT
Potassium voltage-gated channel subfamily H 
member 8 (Ether-a-go-go-like potassium 
channel 3) (ELK channel 3) (Voltage-gated 
potassium channel subunit Kv12;1)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
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Q64436 ATP4A_MOUSE
Potassium-transporting ATPase alpha chain 1 
(EC 3;6;3;10) (Gastric H(+)/K(+) ATPase 
subunit alpha) (Proton pump)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
P09626 ATP4A_RAT
Potassium-transporting ATPase alpha chain 
1 (EC 3;6;3;10) (Gastric H(+)/K(+) ATPase 
subunit alpha) (Proton pump)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q80Y24 PRIC2_MOUSE Prickle-like protein 2
Nucleus 
membrane; 
Mus 
musculus 
(Mouse)
Q9EPE9 AT131_MOUSE
Probable cation-transporting ATPase 13A1 
(CATP) (EC 3;6;3;-)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q5XF89 AT133_MOUSE
Probable cation-transporting ATPase 13A3 
(EC 3;6;3;-)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q5XF90 AT134_MOUSE
Probable cation-transporting ATPase 13A4 
(EC 3;6;3;-) (P5-ATPase isoform 4)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q9WVT0 GP116_RAT
Probable G-protein coupled receptor 116 (G-
protein coupled hepta-helical receptor Ig-
hepta)
Cell membrane; 
Multi-pass 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q7TT36 GP125_MOUSE Probable G-protein coupled receptor 125
Cell membrane; 
Multi-pass 
membrane protein; 
Mus 
musculus 
(Mouse)
Q8K451 GP156_RAT
Probable G-protein coupled receptor 156 
(GABAB-related G-protein coupled receptor)
Cell membrane; 
Multi-pass 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q8C419 GP158_MOUSE Probable G-protein coupled receptor 158
Cell membrane; 
Multi-pass 
membrane protein; 
Mus 
musculus 
(Mouse)
A3FIN4 AT8B5_MOUSE
Probable phospholipid-transporting ATPase 
FetA (EC 3;6;3;1) (ATPase class I type 8B 
member 2-like protein) (ATPase class I type 
8B member 5) (Flippase expressed in testis 
A)
Cytoplasmic 
vesicle;secretory 
vesicle ;acrosome 
membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
P98195 ATP9B_MOUSE
Probable phospholipid-transporting ATPase 
IIB (EC 3;6;3;1) (ATPase class II type 9B)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
P01132 EGF_MOUSE
Pro-epidermal growth factor (EGF) [Cleaved 
into: Epidermal growth factor]
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
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Q91ZX7 LRP1_MOUSE
Prolow-density lipoprotein receptor-related 
protein 1 (LRP-1) (Alpha-2-macroglobulin 
receptor) (A2MR) (CD antigen CD91) 
[Cleaved into: Low-density lipoprotein 
receptor-related protein 1 85 kDa subunit 
(LRP-85); Low-density lipoprotein receptor-
related protein 1 515 kDa subunit (LRP-515); 
Low-density lipoprotein receptor-related 
protein 1 intracellular domain (LRPICD)]
Cell membrane; 
Single-pass type I 
membrane protein; 
Membrane;coated 
pit;  Peripheral 
membrane protein; 
Extracellular side; 
Membrane ;coated 
pit;  Cytoplasm; 
Nucleus; 
Mus 
musculus 
(Mouse)
P41413 PCSK5_RAT
Proprotein convertase subtilisin/kexin type 5 
(EC 3;4;21;-) (Proprotein convertase 5) (PC5) 
(Proprotein convertase 6) (PC6) 
(Subtilisin/kexin-like protease PC5) (rPC5) 
(Fragment)
Secreted;  
Endomembrane 
system; Single-pass 
type I membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q04592 PCSK5_MOUSE
Proprotein convertase subtilisin/kexin type 5 
(EC 3;4;21;-) (Proprotein convertase 5) (PC5) 
(Proprotein convertase 6) (PC6) (Subtilisin-
like proprotein convertase 6) (SPC6) 
(Subtilisin/kexin-like protease PC5)
Secreted;  
Endomembrane 
system; Single-pass 
type I membrane 
protein; 
Mus 
musculus 
(Mouse)
Q62786 FPRP_RAT
Prostaglandin F2 receptor negative regulator 
(Prostaglandin F2-alpha receptor regulatory 
protein) (Prostaglandin F2-alpha receptor-
associated protein) (CD antigen CD315)
Endoplasmic 
reticulum 
membrane; Single-
pass type I 
membrane protein; 
Golgi 
apparatus;trans-
Golgi network 
membrane; 
Rattus 
norvegicus 
(Rat)
Q6R0H6 ALEX_MOUSE
Protein ALEX (Alternative gene product 
encoded by XL-exon)
Cell membrane; 
Peripheral 
membrane protein; 
Cell projection 
;ruffle; 
Mus 
musculus 
(Mouse)
P38660 PDIA6_MESAU
Protein disulfide-isomerase A6 (EC 5;3;4;1) 
(Protein disulfide isomerase P5)
Endoplasmic 
reticulum lumen; 
Cell membrane; 
Melanosome; 
Mesocricetus 
auratus 
(Golden 
hamster)
Q5DTZ0 NYNRI_MOUSE
Protein NYNRIN (NYN domain and 
retroviral integrase catalytic domain-
containing protein) (Pol-like protein)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q9JIG4 PPR3F_MOUSE Protein phosphatase 1 regulatory subunit 3F
Membrane; Single-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
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Q0KL00 PIEZ1_RAT
Protein PIEZO1 (Membrane protein induced 
by beta-amyloid treatment) (Mib) (Protein 
FAM38B)
Endoplasmic 
reticulum 
membrane; Multi-
pass mem-brane 
protein; Endo-
plasmic reticulum-
Golgi intermediate 
compartment;Cell 
membrane; 
Rattus 
norvegicus 
(Rat)
Q80U72 SCRIB_MOUSE
Protein scribble homolog (Scribble) (Protein 
LAP4)
Cell membrane; 
Peripheral 
membrane protein; 
Cell 
junction;adherens 
junction; 
Cytoplasm; 
Mus 
musculus 
(Mouse)
Q7TP36 SHRM2_RAT
Protein Shroom2 (Liver regeneration-related 
protein LRRG167) (Protein Apxl)
Apical cell 
membrane; Cell 
junction ;tight 
junction; 
Cytoplasm;cytoskel
eton; 
Rattus 
norvegicus 
(Rat)
Q3UH53 SDK1_MOUSE Protein sidekick-1
Membrane; Single-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q6V4S5 SDK2_MOUSE Protein sidekick-2
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q91VM4 SPNS2_MOUSE Protein spinster homolog 2
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q0VGY8 TANC1_MOUSE
Protein TANC1 (Tetratricopeptide repeat; 
ankyrin repeat and coiled-coil domain-
containing protein 1)
Cell junction 
;synapse;postsynapt
ic cell membrane 
;postsynaptic 
density; 
Mus 
musculus 
(Mouse)
Q6F6B3 TANC1_RAT
Protein TANC1 (TPR domain; ankyrin-repeat  
and coiled-coil domain-containing protein 1)
Cell 
junction;synapse 
;postsynaptic cell 
membrane;postsyna
ptic density; 
Rattus 
norvegicus 
(Rat)
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Q3UPL0 SC31A_MOUSE
Protein transport protein Sec31A (SEC31-like 
protein 1) (SEC31-related protein A)
Cytoplasm; 
Cytoplasmic vesicle 
;COPII-coated 
vesicle membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Endoplasmic 
reticulum 
membrane; 
Mus 
musculus 
(Mouse)
Q9Z2Q1 SC31A_RAT
Protein transport protein Sec31A (SEC31-
like protein 1) (SEC31-related protein A) 
(Vesicle-associated protein 1)
Cytoplasm; 
Cytoplasmic 
vesicle;COPII-
coated vesicle 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Endoplasmic 
reticulum 
membrane; 
Rattus 
norvegicus 
(Rat)
Q62768 UN13A_RAT Protein unc-13 homolog A (Munc13-1)
Cytoplasm; Cell 
membrane; 
Peripheral 
membrane protein; 
Cell junction 
;synapse;presynapti
c cell membrane;  
Rattus 
norvegicus 
(Rat)
Q8K0T7 UN13C_MOUSE Protein unc-13 homolog C (Munc13-3)
Cytoplasm; 
Membrane; Peri-
pheral membrane 
protein; Cell 
junction 
;synapse;presynapti
c cell membrane; 
Mus 
musculus 
(Mouse)
Q62770 UN13C_RAT Protein unc-13 homolog C (Munc13-3)
Cytoplasm; 
Membrane; 
Peripheral 
membrane protein; 
Cell junction 
;synapse;presynapti
c cell membrane; ; 
Rattus 
norvegicus 
(Rat)
Q0KK59 UNC79_MOUSE Protein unc-79 homolog
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
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Q8BLN6 UNC80_MOUSE Protein unc-80 homolog (mUNC-80)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q5RJS8 TPST2_RAT
Protein-tyrosine sulfotransferase 2 (EC 
2;8;2;20) (Tyrosylprotein sulfotransferase 2) 
(TPST-2)
Golgi apparatus 
membrane; Single-
pass type II 
membrane protein; 
Rattus 
norvegicus 
(Rat)
O88277 FAT2_RAT
Protocadherin Fat 2 (Multiple epidermal 
growth factor-like domains protein 1) 
(Multiple EGF-like domains protein 1)
Cell membrane; 
Single-pass 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q8BNA6 FAT3_MOUSE
Protocadherin Fat 3 (FAT tumor suppressor 
homolog 3)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q8R508 FAT3_RAT Protocadherin Fat 3 (FAT tumor suppressor homolog 3)
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
P35546 RET_MOUSE
Proto-oncogene tyrosine-protein kinase 
receptor Ret (EC 2;7;10;1) (Proto-oncogene 
c-Ret)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9D620 RFIP1_MOUSE
Rab11 family-interacting protein 1 (Rab11-
FIP1) (Rab-coupling protein)
Recycling 
endosome; 
Cytoplasmic 
vesicle;phagosome 
membrane; 
Mus 
musculus 
(Mouse)
P31750 AKT1_MOUSE
RAC-alpha serine/threonine-protein kinase 
(EC 2;7;11;1) (AKT1 kinase) (Protein kinase 
B) (PKB) (Proto-oncogene c-Akt) (RAC-PK-
alpha) (Thymoma viral proto-oncogene)
Cytoplasm; 
Nucleus; Cell 
membrane; 
Mus 
musculus 
(Mouse)
Q8CHG7 RPGF2_MOUSE
Rap guanine nucleotide exchange factor 2 
(Neural RAP guanine nucleotide exchange 
protein) (nRap GEP) (PDZ domain-
containing guanine nucleotide exchange 
factor 1) (PDZ-GEF1) (Fragment)
Cell membrane; 
Mus 
musculus 
(Mouse)
Q9QUH6 SYGP1_RAT
Ras GTPase-activating protein SynGAP 
(Neuronal RasGAP) (Synaptic Ras GTPase-
activating protein 1) (Synaptic Ras-GAP 1) 
(p135 SynGAP)
Membrane; 
Peripheral 
membrane protein; 
Cell junction 
;synapse; 
Rattus 
norvegicus 
(Rat)
Q9JKF1 IQGA1_MOUSE Ras GTPase-activating-like protein IQGAP1
Cell membrane; 
Mus 
musculus 
(Mouse)
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P35285 RB22A_MOUSE
Ras-related protein Rab-22A (Rab-22) (Rab-
14)
Endosome 
membrane; Lipid-
anchor; Cell 
membrane; Lipid-
anchor; 
Mus 
musculus 
(Mouse)
Q9ERD6 RGPS2_MOUSE
Ras-specific guanine nucleotide-releasing 
factor RalGPS2 (Ral GEF with PH domain 
and SH3-binding motif 2) (RalA exchange 
factor RalGPS2)
Cytoplasm; Cell 
membrane; 
Mus 
musculus 
(Mouse)
P60603 ROMO1_MOUSE
Reactive oxygen species modulator 1 (ROS 
modulator 1) (Protein MGR2 homolog)
Mitochondrion 
membrane; Single-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q62799 ERBB3_RAT
Receptor tyrosine-protein kinase erbB-3 (EC 
2;7;10;1) (Proto-oncogene-like protein c-
ErbB-3)
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
B2RU80 PTPRB_MOUSE
Receptor-type tyrosine-protein phosphatase 
beta (Protein-tyrosine phosphatase beta) (R-
PTP-beta) (EC 3;1;3;48) (Vascular 
endothelial protein tyrosine phosphatase) 
(VE-PTP)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q64487 PTPRD_MOUSE
Receptor-type tyrosine-protein phosphatase 
delta (Protein-tyrosine phosphatase delta) (R-
PTP-delta) (EC 3;1;3;48)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
P49446 PTPRE_MOUSE
Receptor-type tyrosine-protein phosphatase 
epsilon (Protein-tyrosine phosphatase 
epsilon) (R-PTP-epsilon) (EC 3;1;3;48)
Cell membrane; 
Single-pass type I 
membrane protein;  
Cytoplasm; 
Mus 
musculus 
(Mouse)
A2A8L5 PTPRF_MOUSE
Receptor-type tyrosine-protein phosphatase F 
(EC 3;1;3;48) (Leukocyte common antigen 
related) (LAR)
Membrane; Single-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q64604 PTPRF_RAT
Receptor-type tyrosine-protein phosphatase F  
(EC 3;1;3;48) (Leukocyte common antigen 
related) (LAR)
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q05909 PTPRG_MOUSE
Receptor-type tyrosine-protein phosphatase 
gamma (Protein-tyrosine phosphatase 
gamma) (R-PTP-gamma) (EC 3;1;3;48)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q6Y5D8 RHG10_MOUSE
Rho GTPase-activating protein 10 (PH and 
SH3 domain-containing rhoGAP protein) 
(PS-GAP) (PSGAP) (Rho-type GTPase-
activating protein 10)
Cytoplasm; 
Cytoplasm;perinucl
ear region; Cell 
membrane; 
Mus 
musculus 
(Mouse)
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Q6DFV3 RHG21_MOUSE
Rho GTPase-activating protein 21 (Rho 
GTPase-activating protein 10) (Rho-type 
GTPase-activating protein 21)
Golgi apparatus 
membrane; 
Peripheral 
membrane protein; 
Cell junction; 
Cytoplasmic vesicle 
membrane; 
Peripheral 
membrane protein; 
Cytoplasm 
;cytoskeleton; 
Mus 
musculus 
(Mouse)
Q6TLK4 RHG27_RAT
Rho GTPase-activating protein 27 (CIN85-
associated multi-domain-containing Rho 
GTPase-activating protein 1) (Rho-type 
GTPase-activating protein 27)
Cytoplasm; 
Membrane; 
Peripheral 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q811P8 RHG32_MOUSE
Rho GTPase-activating protein 32 (Brain-
specific Rho GTPase-activating protein) 
(GAB-associated Cdc42/Rac GTPase-
activating protein) (GC-GAP) (Rho-type 
GTPase-activating protein 32) 
(Rho/Cdc42/Rac GTPase-activating protein 
RICS) (RhoGAP involved in the beta-
catenin-N-cadherin and NMDA receptor 
signaling) (p200RhoGAP) (p250GAP)
Cell junction; 
synapse post-
synaptic cell 
membrane post-
synaptic density; 
Cell projection 
dendritic spine; 
Cytoplasm;cell 
cortex; Endosome 
membrane; Golgi 
apparatus mem-
brane; Endoplasmic 
reticulum mem-
brane; Membrane; 
Mus 
musculus 
(Mouse)
P97393 RHG05_MOUSE
Rho GTPase-activating protein 5 (Rho-type 
GTPase-activating protein 5) (p190-B)
Cytoplasm; 
Membrane; 
Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
Q61210 ARHG1_MOUSE
Rho guanine nucleotide exchange factor 1 
(Lbc's second cousin) (Lymphoid blast crisis-
like 2)
Cytoplasm; 
Membrane; 
Mus 
musculus 
(Mouse)
Q63644 ROCK1_RAT
Rho-associated protein kinase 1 (EC 
2;7;11;1) (Liver regeneration-related protein 
LRRG199) (Rho-associated; coiled-coil-
containing protein kinase 1) (p150 RhoA-
binding kinase ROK beta) (p160 ROCK-1) 
(p160ROCK)
Cytoplasm; 
Cytoplasm ;cyto-
skeleton;centro-
some ;centriole; 
Golgi apparatus 
membrane; 
Peripheral 
membrane protein; 
Rattus 
norvegicus 
(Rat)
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P70336 ROCK2_MOUSE
Rho-associated protein kinase 2 (EC 
2;7;11;1) (Rho-associated; coiled-coil-
containing protein kinase 2) (p164 ROCK-2)
Cytoplasm; Cell 
membrane; 
Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
Q62868 ROCK2_RAT
Rho-associated protein kinase 2 (EC 
2;7;11;1) (Rho-associated; coiled-coil-
containing protein kinase 2) (RhoA-binding 
kinase 2) (p150 ROK-alpha) (ROKalpha) 
(p164 ROCK-2)
Cytoplasm; Cell 
membrane; 
Peripheral 
membrane protein; 
Rattus 
norvegicus 
(Rat)
P0C6P5 RGNEF_RAT
Rho-guanine nucleotide exchange factor (190 
kDa guanine nucleotide exchange factor) 
(p190-RhoGEF) (p190RhoGEF)
Cytoplasm; Cell 
membrane; 
Rattus 
norvegicus 
(Rat)
Q99PL5 RRBP1_MOUSE
Ribosome-binding protein 1 (Ribosome 
receptor protein) (RRp) (mRRp)
Endoplasmic 
reticulum 
membrane; Single-
pass type III 
membrane protein; 
Mus 
musculus 
(Mouse)
P0C219 SLMAP_RAT Sarcolemmal membrane-associated protein
Cell 
membrane;sarcolem
ma; Single-pass 
type IV membrane 
protein; 
Cytoplasm 
;cytoskeleton;centro
some; 
Rattus 
norvegicus 
(Rat)
Q62028 PLA2R_MOUSE
Secretory phospholipase A2 receptor (PLA2-
R) (PLA2R) (180 kDa secretory 
phospholipase A2 receptor) (M-type receptor) 
[Cleaved into: Soluble secretory 
phospholipase A2 receptor (Soluble PLA2-R) 
(Soluble PLA2R)]
Cell membrane; 
Single-pass type I 
membrane protein;  
Secreted; 
Mus 
musculus 
(Mouse)
P42346 MTOR_RAT
Serine/threonine-protein kinase mTOR (EC 
2;7;11;1) (FK506-binding protein 12-
rapamycin complex-associated protein 1) 
(FKBP12-rapamycin complex-associated 
protein) (Mammalian target of rapamycin) 
(mTOR) (Mechanistic target of rapamycin) 
(Rapamycin target protein 1) (RAPT1)
Endoplasmic 
reticulum 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Golgi apparatus 
membrane; 
Mitochondrion 
outer membrane; 
Cytoplasmic side; 
Lysosome; 
Rattus 
norvegicus 
(Rat)
 -188-
Analysing the surface of suspension growth adapted CHO cells                                                          
Accession Entry name Protein names Subcellular locations Organism
Q6ZQ29 TAOK2_MOUSE
Serine/threonine-protein kinase TAO2 (EC 
2;7;11;1) (Thousand and one amino acid 
protein 2)
Cytoplasmic vesicle 
membrane; Multi-
pass membrane 
protein; 
Cytoplasm 
;cytoskeleton;  Cell 
projection;dendrite; 
Mus 
musculus 
(Mouse)
Q9JLS3 TAOK2_RAT
Serine/threonine-protein kinase TAO2 (EC 
2;7;11;1) (Thousand and one amino acid 
protein 2)
Cytoplasmic vesicle  
membrane; Multi-
pass membrane 
protein; 
Cytoplasm 
;cytoskeleton;  Cell 
projection;dendrite; 
Rattus 
norvegicus 
(Rat)
Q9WV48 SHAN1_RAT
SH3 and multiple ankyrin repeat domains 
protein 1 (Shank1) (GKAP/SAPAP-
interacting protein) (SPANK-1) (Somatostatin 
receptor-interacting protein) (SSTR-
interacting protein) (SSTRIP) (Synamon)
Cytoplasm; Cell 
junction ;synapse; 
Cell 
junction;synapse 
;postsynaptic cell 
membrane 
Rattus 
norvegicus 
(Rat)
Q925N2 SFXN2_MOUSE Sideroflexin-2
Mitochondrion 
membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q8C0T5 SI1L1_MOUSE
Signal-induced proliferation-associated 1-like 
protein 1 (SIPA1-like protein 1)
Cytoplasm;cyto-
skeleton; Cell junc-
tion ;synapse;post-
synaptic cell 
membrane ;post-
synaptic density; 
Cell junction; 
;synaptosome; 
Mus 
musculus 
(Mouse)
O35412 SI1L1_RAT
Signal-induced proliferation-associated 1-
like protein 1 (SIPA1-like protein 1) (SPA-1-
like protein p1294) (Spine-associated Rap 
GTPase-activating protein) (SPAR)
Cytoplasm;cytoskel
eton; Cell 
junction 
;synapse;postsynapt
ic cell membrane 
;postsynaptic 
density; Cell 
junction;synapse 
;synaptosome; 
Rattus 
norvegicus 
(Rat)
P0C1S9 DGLB_RAT
Sn1-specific diacylglycerol lipase beta (DGL-
beta) (EC 3;1;1;-)
Cell membrane; 
Multi-pass 
membrane protein; 
Rattus 
norvegicus 
(Rat)
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Q6QIY3 SCNAA_MOUSE
Sodium channel protein type 10 subunit alpha 
(Peripheral nerve sodium channel 3) (PN3) 
(Sensory neuron sodium channel) (Sodium 
channel protein type X subunit alpha) 
(Voltage-gated sodium channel subunit alpha 
Nav1;8)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
O88457 SCNBA_RAT
Sodium channel protein type 11 subunit alpha 
(NaN) (Sensory neuron sodium channel 2) 
(Sodium channel protein type XI subunit 
alpha) (Voltage-gated sodium channel subunit 
alpha Nav1;9)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q9ER60 SCN4A_MOUSE
Sodium channel protein type 4 subunit alpha 
(Sodium channel protein skeletal muscle 
subunit alpha) (Sodium channel protein type 
IV subunit alpha) (Voltage-gated sodium 
channel subunit alpha Nav1;4)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q9WTU3 SCN8A_MOUSE
Sodium channel protein type 8 subunit alpha 
(Sodium channel protein type VIII subunit 
alpha) (Voltage-gated sodium channel subunit 
alpha Nav1;6)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q6Q760 NALCN_RAT
Sodium leak channel non-selective protein 
(Four domain-type voltage-gated ion channel 
alpha-1 subunit) (Voltage gated channel-like 
protein 1)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q8BXR5 NALCN_MOUSE
Sodium leak channel non-selective protein 
(Voltage gated channel-like protein 1)
Membrane; Multi-
pass membrane 
protein; 
Mus musculus 
(Mouse)
Q8C3K6 SC5A1_MOUSE
Sodium/glucose cotransporter 1 
(Na(+)/glucose cotransporter 1) (High affinity 
sodium-glucose cotransporter) (Solute carrier 
family 5 member 1)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q8BLV3 SL9A7_MOUSE
Sodium/hydrogen exchanger 7 (Na(+)/H(+) 
exchanger 7) (NHE-7) (Solute carrier family 
9 member 7)
Golgi 
apparatus;trans-
Golgi network 
membrane; Multi-
pass membrane 
protein; Recycling 
endosome 
membrane; 
Mus 
musculus 
(Mouse)
Q6PIE5 AT1A2_MOUSE
Sodium/potassium-transporting ATPase 
subunit alpha-2 (Na(+)/K(+) ATPase alpha-2 
subunit) (EC 3;6;3;9) (Na(+)/K(+) ATPase 
alpha(+) subunit) (Sodium pump subunit 
alpha-2)
Membrane; Multi-
pass membrane 
protein; Cell 
membrane; 
Mus 
musculus 
(Mouse)
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Q3UHA3 SPTCS_MOUSE
Spatacsin (Spastic paraplegia 11 protein 
homolog)
Membrane; Multi-
pass membrane 
protein; 
Cytoplasm ;cytosol; 
Nucleus; 
Mus 
musculus 
(Mouse)
Q62261 SPTB2_MOUSE
Spectrin beta chain; brain 1 (Beta-II spectrin) 
(Embryonic liver fodrin) (Fodrin beta chain) 
(Spectrin; non-erythroid beta chain 1)
Cytoplasm;cytoskel
eton; Cytoplasm 
;myofibril;sarcomer
e ;M-band;  Cell 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Mus 
musculus 
(Mouse)
Q9QWI6 SRCN1_MOUSE
SRC kinase signaling inhibitor 1 (SNAP-25-
interacting protein) (SNIP) (p130Cas-
associated protein) (p140Cap)
Cytoplasm; 
Cytoplasm;cytoskel
eton; Cell projection 
;axon; Cell 
projection;dendrite; 
Cell junction 
;synapse; Cell 
junction;synapse 
;postsynaptic cell 
membrane;postsyna
ptic density; 
Mus 
musculus 
(Mouse)
Q9QXY2 SRCN1_RAT
SRC kinase signaling inhibitor 1 (SNAP-25-
interacting protein) (SNIP) (p130Cas-
associated protein) (p140Cap)
Cytoplasm; 
Cytoplasm 
;cytoskeleton; Cell 
projection;axon; 
Cell projection 
;dendrite; Cell 
junction;synapse; 
Cell junction 
;synapse;postsynapt
ic cell membrane 
;postsynaptic 
density; 
Rattus 
norvegicus 
(Rat)
Q4QR83 STRA6_RAT
Stimulated by retinoic acid gene 6 protein 
homolog
Cell membrane; 
Multi-pass 
membrane protein; 
Rattus 
norvegicus 
(Rat)
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Q8K4L3 SVIL_MOUSE Supervillin (Archvillin) (p205/p250)
Cell membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cytoplasm;cytoskel
eton; Cell projection 
;invadopodium; 
Cell 
projection;podosom
e; 
Mus 
musculus 
(Mouse)
P0C6B8 SVEP1_RAT
Sushi; von Willebrand factor type A; EGF 
and pentraxin domain-containing protein 1
Secreted; 
Cytoplasm; 
Membrane; 
Peripheral 
membrane protein; 
Rattus 
norvegicus 
(Rat)
A2AVA0 SVEP1_MOUSE
Sushi; von Willebrand factor type A; EGF 
and pentraxin domain-containing protein 1 
(Polydom)
Secreted; 
Cytoplasm; 
Membrane; 
Peripheral 
membrane protein; 
Mus musculus 
(Mouse)
Q80X82 SYMPK_MOUSE Symplekin
Cytoplasm ;cyto-
skeleton; Cell 
junction; tight junc-
tion; Cell 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Nucleus;nucleoplas
m; 
Mus 
musculus 
(Mouse)
Q63564 SV2B_RAT
Synaptic vesicle glycoprotein 2B (Synaptic 
vesicle protein 2B)
Cytoplasmic vesicle 
;secretory 
vesicle;synaptic 
vesicle membrane; 
Multi-pass 
membrane protein; 
Cytoplasmic vesicle 
;secretory 
vesicle;acrosome; 
Rattus 
norvegicus 
(Rat)
Q5SV85 SYNRG_MOUSE
Synergin gamma (AP1 subunit gamma-
binding protein 1) (Gamma-synergin)
Cytoplasm ;cytosol; 
Golgi 
apparatus;trans-
Golgi network 
membrane; 
Peripheral 
membrane protein;
 
Mus 
musculus 
(Mouse)
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Q9JKC9 SYNRG_RAT
Synergin gamma (AP1 subunit gamma-
binding protein 1) (Gamma-synergin)
Cytoplasm; Golgi 
apparatus ;trans-
Golgi network 
membrane; 
Peripheral 
membrane protein; 
Rattus 
norvegicus 
(Rat)
P26039 TLN1_MOUSE Talin-1
Cell 
projection;ruffle 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cytoplasm 
;cytoskeleton; 
Mus 
musculus 
(Mouse)
Q71LX4 TLN2_MOUSE Talin-2
Cell junction;focal 
adhesion; Cell 
junction ;synapse; 
Cell membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cytoplasm;cytoskel
eton; 
Mus 
musculus 
(Mouse)
Q5SVR0 TBC9B_MOUSE TBC1 domain family member 9B
Membrane; Single-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q9R1K2 TEN2_RAT
Teneurin-2 (Ten-2) (Neurestin) (Protein Odd 
Oz/ten-m homolog 2) (Tenascin-M2) (Ten-
m2)
Membrane; Single-
pass type II 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q9WTS5 TEN2_MOUSE
Teneurin-2 (Ten-2) (Protein Odd Oz/ten-m 
homolog 2) (Tenascin-M2) (Ten-m2)
Membrane; Single-
pass type II 
membrane protein; 
Mus musculus 
(Mouse)
Q9WTS6 TEN3_MOUSE
Teneurin-3 (Ten-3) (Protein Odd Oz/ten-m 
homolog 3) (Tenascin-M3) (Ten-m3)
Membrane; Single-
pass type II 
membrane protein; 
Mus 
musculus 
(Mouse)
Q3UHK6 TEN4_MOUSE
Teneurin-4 (Ten-4) (Downstream of CHOP4) 
(Protein Odd Oz/ten-m homolog 4) 
(Tenascin-M4) (Ten-m4)
Membrane; Single-
pass type II 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9JM61 THSD1_MOUSE
Thrombospondin type-1 domain-containing 
protein 1 (Transmembrane molecule with 
thrombospondin module)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9QX05 TLR4_RAT
Toll-like receptor 4 (Toll4) (CD antigen 
CD284)
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
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Q91YD4 TRPM2_MOUSE
Transient receptor potential cation channel 
subfamily M member 2 (EC 3;6;1;13) (Long 
transient receptor potential channel 2) 
(LTrpC-2) (LTrpC2) (Transient receptor 
potential channel 7) (TrpC7)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q8CIR4 TRPM6_MOUSE
Transient receptor potential cation channel 
subfamily M member 6 (EC 2;7;11;1) 
(Channel kinase 2) (Melastatin-related TRP 
cation channel 6)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q925B3 TRPM7_RAT
Transient receptor potential cation channel 
subfamily M member 7 (EC 2;7;11;1) (Long 
transient receptor potential channel 7) 
(LTrpC-7) (LTrpC7) (Transient receptor 
potential-phospholipase C-interacting kinase) 
(TRP-PLIK)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q8R455 TRPM8_RAT
Transient receptor potential cation channel 
subfamily M member 8 (Cold menthol 
receptor 1)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q56A06 TMTC2_MOUSE
Transmembrane and TPR repeat-containing 
protein 2
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q80WF4 T132A_RAT
Transmembrane protein 132A (GRP78-
binding protein) (HSPA5-binding protein 1)
Golgi apparatus 
membrane; Single-
pass type I 
membrane protein; 
Endoplasmic 
reticulum 
membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q91VX9 TM168_MOUSE Transmembrane protein 168
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q9DBS1 TMM43_MOUSE Transmembrane protein 43 (Protein LUMA)
Endoplasmic 
reticulum; Nucleus 
inner membrane; 
Multi-pass 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9ESN3 TMM8A_MOUSE
Transmembrane protein 8A (M83 protein) 
(Transmembrane protein 8)
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
P52332 JAK1_MOUSE
Tyrosine-protein kinase JAK1 (EC 2;7;10;2) 
(Janus kinase 1) (JAK-1)
Endomembrane 
system; Peripheral 
membrane protein; 
Mus 
musculus 
(Mouse)
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Q07014 LYN_RAT Tyrosine-protein kinase Lyn (EC 2;7;10;2)
Cell membrane; 
Nucleus; 
Cytoplasm; 
Cytoplasm 
;perinuclear region; 
Golgi apparatus; 
Rattus 
norvegicus 
(Rat)
P55144 TYRO3_MOUSE
Tyrosine-protein kinase receptor TYRO3 (EC 
2;7;10;1) (Etk2/tyro3) (TK19-2) (Tyrosine-
protein kinase DTK) (Tyrosine-protein kinase 
RSE)
Cell membrane; 
Single-pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
A2AVR2 CA175_MOUSE Uncharacterized protein C1orf175 homolog
Membrane; Multi-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
A2RUW0 CA175_RAT Uncharacterized protein C1orf175 homolog
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q6NZL0 CF174_MOUSE Uncharacterized protein C6orf174 homolog
Membrane; Single-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
A2AAE1 K1109_MOUSE
Uncharacterized protein KIAA1109 (Fragile 
site-associated protein homolog)
Membrane; Single-
pass membrane 
protein; 
Mus 
musculus 
(Mouse)
Q2QI47 USH2A_MOUSE
Usherin (Usher syndrome type IIa protein 
homolog) (Usher syndrome type-2A protein 
homolog)
Cell 
projection;stereocili
um membrane; 
Single-pass type I 
membrane protein;  
Secreted; 
Mus 
musculus 
(Mouse)
A1A535 MELT_MOUSE
Ventricular zone-expressed PH domain-
containing protein 1 (Protein melted 
homolog)
Cell membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Mus 
musculus 
(Mouse)
P50544 ACADV_MOUSE
Very long-chain specific acyl-CoA 
dehydrogenase; mitochondrial (EC 1;3;99;-) 
(MVLCAD) (VLCAD)
Mitochondrion 
inner membrane; 
Mus 
musculus 
(Mouse)
P45953 ACADV_RAT
Very long-chain specific acyl-CoA 
dehydrogenase; mitochondrial (VLCAD) (EC 
1;3;99;-)
Mitochondrion 
inner membrane; 
Rattus 
norvegicus 
(Rat)
P98166 VLDLR_RAT
Very low-density lipoprotein receptor (VLDL 
receptor) (VLDL-R)
Membrane; Single-
pass type I 
membrane protein; 
Membrane 
;clathrin-coated pit; 
Single-pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
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Q64727 VINC_MOUSE Vinculin (Metavinculin)
Cytoplasm;cytoskel
eton; Cell 
junction ;adherens 
junction; Cell 
membrane; 
Peripheral 
membrane protein; 
Cytoplasmic side; 
Cell junction; 
Mus 
musculus 
(Mouse)
P54290 CA2D1_RAT
Voltage-dependent calcium channel subunit 
alpha-2/delta-1 (Voltage-gated calcium 
channel subunit alpha-2/delta-1)
Membrane; Single-
pass type I 
membrane protein; 
Rattus 
norvegicus 
(Rat)
Q01815 CAC1C_MOUSE
Voltage-dependent L-type calcium channel 
subunit alpha-1C (Calcium channel; L type; 
alpha-1 polypeptide; isoform 1; cardiac 
muscle) (MELC-CC) (Mouse brain class C) 
(MBC) (Voltage-gated calcium channel 
subunit alpha Cav1;2)
Membrane; Multi-
pass membrane 
protein; Cell 
membrane; 
Mus 
musculus 
(Mouse)
P22002 CAC1C_RAT
Voltage-dependent L-type calcium channel 
subunit alpha-1C (Calcium channel; L type; 
alpha-1 polypeptide; isoform 1; cardiac 
muscle) (Rat brain class C) (RBC) (Voltage-
gated calcium channel subunit alpha Cav1;2)
Membrane; Multi-
pass membrane 
protein; Cell 
membrane; 
Rattus 
norvegicus 
(Rat)
P27732 CAC1D_RAT
Voltage-dependent L-type calcium channel 
subunit alpha-1D (Calcium channel; L type; 
alpha-1 polypeptide; isoform 2) (Voltage-
gated calcium channel subunit alpha Cav1;3)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q02485 CAC1S_RAT
Voltage-dependent L-type calcium channel 
subunit alpha-1S (Calcium channel; L type; 
alpha-1 polypeptide; isoform 3; skeletal 
muscle) (ROB1) (Voltage-gated calcium 
channel subunit alpha Cav1;1) (Fragment)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q02789 CAC1S_MOUSE
Voltage-dependent L-type calcium channel 
subunit alpha-1S (Calcium channel; L type; 
alpha-1 polypeptide; isoform 3; skeletal 
muscle) (Voltage-gated calcium channel 
subunit alpha Cav1;1)
Membrane; Multi-
pass membrane 
protein; 
Mus musculus 
(Mouse)
Q02294 CAC1B_RAT
Voltage-dependent N-type calcium channel 
subunit alpha-1B (Brain calcium channel III) 
(BIII) (Calcium channel; L type; alpha-1 
polypeptide isoform 5) (Voltage-gated 
calcium channel subunit alpha Cav2;2)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
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P54282 CAC1A_RAT
Voltage-dependent P/Q-type calcium channel 
subunit alpha-1A (Brain calcium channel I) 
(BI) (Calcium channel; L type; alpha-1 
polypeptide; isoform 4) (Rat brain class A) 
(RBA-I) (Voltage-gated calcium channel 
subunit alpha Cav2;1)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q07652 CAC1E_RAT
Voltage-dependent R-type calcium channel 
subunit alpha-1E (BII) (Brain calcium 
channel II) (Calcium channel; L type; alpha-1 
polypeptide; isoform 6) (RBE-II) (RBE2) 
(Voltage-gated calcium channel subunit alpha 
Cav2;3)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q61290 CAC1E_MOUSE
Voltage-dependent R-type calcium channel 
subunit alpha-1E (Brain calcium channel II) 
(BII) (Calcium channel; L type; alpha-1 
polypeptide; isoform 6) (Voltage-gated 
calcium channel subunit alpha Cav2;3)
Membrane; Multi-
pass membrane 
protein; 
Mus musculus 
(Mouse)
Q9Z0Y8 CAC1I_RAT
Voltage-dependent T-type calcium channel 
subunit alpha-1I (CaVT;3) (Voltage-gated 
calcium channel subunit alpha Cav3;3)
Membrane; Multi-
pass membrane 
protein; 
Rattus 
norvegicus 
(Rat)
Q9EPR5 SORC2_MOUSE VPS10 domain-containing receptor SorCS2
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
P15920 VPP2_MOUSE
V-type proton ATPase 116 kDa subunit a 
isoform 2 (V-ATPase 116 kDa isoform a2) 
(Immune suppressor factor J6B7) (ISF) 
(Lysosomal H(+)-transporting ATPase V0 
subunit a2) (ShIF) (Vacuolar proton 
translocating ATPase 116 kDa subunit a 
isoform 2)
Cell membrane; 
Multi-pass 
membrane protein; 
Endosome 
membrane; 
Mus 
musculus 
(Mouse)
Q6PDJ1 CAHD1_MOUSE
VWFA and cache domain-containing protein 
1 (Cache domain-containing protein 1)
Membrane; Single-
pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9R037 WDR44_RAT
WD repeat-containing protein 44 (Rabphilin-
11)
Cytoplasm;cytosol; 
Cytoplasm 
;perinuclear region; 
Endosome 
membrane; Golgi 
apparatus;trans-
Golgi network; 
Rattus 
norvegicus 
(Rat)
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Q9EPL0 XYLT2_MOUSE
Xylosyltransferase 2 (EC 2;4;2;26) (Peptide 
O-xylosyltransferase 2) (Xylosyltransferase 
II)
Endoplasmic 
reticulum 
membrane; Single-
pass type II 
membrane protein; 
Golgi apparatus 
membrane; Single-
pass type II 
membrane protein; 
Mus 
musculus 
(Mouse)
Q9EPI0 XYLT2_RAT
Xylosyltransferase 2 (EC 2;4;2;26) (Peptide 
O-xylosyltransferase 2) (Xylosyltransferase 
II)
Endoplasmic 
reticulum 
membrane; Single-
pass type II 
membrane protein; 
Golgi apparatus 
membrane; 
Rattus 
norvegicus 
(Rat)
O88799 ZAN_MOUSE Zonadhesin
Cell membrane; 
Single-pass type I 
membrane protein; 
Mus 
musculus 
(Mouse)
10.2 Structure of sulfo-NHS-SS-biotin
Figure 10.1 Structure of sulfo-NHS-SS-biotin.
To the left the sulfo-NHS-ester group is shown, in the middle the spacer containing a cleavable 
disulfide bridge, to the right the biotin molecule itself.
10.3 Actin conformation in reversed growth conditions –  S cells and 
CHO-S
Figure 10.2 shows the actin conformation of CHO-S and S cells in adherent growth conditions in 
comparison to the conformation seen in CCL61. 
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10.4 Determination of cytochalasin D concentration 
Figure 10.3 shows the effect of different cytochalasin D concentrations on the actin and integrin 
beta 1 conformation in CCL61 and S cells grown in suspension. This experiment was used to 
determine a suitable cytochalasin D concentration to induce integrin beta 1 clustering on CCL61 in 
suspension growth conditions.
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Figure 10.2: Conformation of actin in S cells and CHO-S under adherent condi-
tions compared to adherent CCL61 
Cells were stained using phalloidin Alexa 546 after a culture period of three days. Imaging 
was performed using an inverted Zeiss LSM510 Meta confocal microscope. Mounted cell 
samples were analysed using a plan apochromat 63x/ 1.4 oil DIC objective. Excitation of 
the fluorochrome was at 514nm by an argon laser. Emission was collected using a long 
pass 560 nm filter. Pinhole was 106 µm  for S cells and CCl61, and 111 µm for CHO-S. 
Laser transmission was 13%. All scale bars equal 10 µm.  
CHO-S in adherent conditions S cells in adherent conditions 
CCL61  
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0 µM 1 µM  cytochalasin D: 5 µM  
A) CCL61 
B) S cells 
actin 
integrin beta 1 
actin 
integrin beta 1 
Figure 10.3: Variation of cytochalasin D concentration and its effect on actin and 
integrin beta 1 conformation for CCL61 and S cells in suspension. 
CCL61 and S cells were transferred into PSM suspension culture with different cytochalas-
in D concentrations After 8 hours of suspension culture, the cells were washed to remove 
cytochalasin D (CD) and cells were analysed for actin and integrin beta 1 conformation 
after CD treatment. Imaging was performed using an inverted Zeiss LSM510 Meta confo-
cal microscope. Mounted cell samples were analysed using a plan apochromat 63x/ 1.4 oil 
DIC objective. Excitation and emission was set as described before. As 5 µM cytochalasin 
D had an effect on the actin and the integrin beta 1 conformation this concentration was 
chosen for further experiments. All scale bars equal 10 µm.  
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